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Summary
The human heme oxygenase 1 (HO-1) gene is strongly activated following UVA irradiation 
of normal human dermal fibroblasts (FEK4) and this response is being used as a marker of 
oxidative stress in cells. Evidence suggests that the activation of HO-1 gene by UVA 
radiation occurs via a singlet oxygen ( ^ 2) mediated pathway. Carotenoids are potent * 0 2  
quenchers and are expected to effectively suppress the UVA induced HO-1 gene 
expression. However, approximately 10% of carotenoids also function as vitamin A 
precursors and it is possible that the biological activity of carotenoids might be due to 
retinoid signalling. We used a provitamin A carotenoid ((3-carotene) and a non-provitamin 
A carotenoid (lycopene) for studying the modulation of the UVA induced HO-1 mRNA 
levels by carotenoids.
This is the first study to show a concentration-dependent suppression of the UVA (250 
kJ/m ) induced of HO-1 mRNA levels after incubation of FEK4 cells with a series of six 
all-trans-p-carotene concentrations (0.07, 0.2, 0.8, 2.3, 8.0, 21 pM) in the culture medium 
and a contrasting lack of suppression of the UVA (100 kJ/m2) induced HO-1 mRNA levels 
following incubation with (3-carotene at all the above concentrations, except for the highest 
(21 pM).
This is also the first study to show a suppression of UVA (100 kJ/m ) induction of HO-1 
mRNA levels after incubation of FEK4 cells with a series of five lycopene concentrations 
in the culture medium. The UVA (250 kJ/m2) induced HO-1 levels were suppressed 
following incubation of FEK4 cells with lycopene at the lowest concentrations (0.1, 0.3 and
1.2 pM) tested. The corresponding levels of |3-carotene and lycopene uptake by FEK4 cells, 
as well as isomerisation and apo-carotenal formation, were measured following HPLC 
separation. The findings of this study support the hypothesis of singlet oxygen quenching 
as the mode of action of lycopene for reducing UVA mediated oxidative stress, but the 
possibility that |3-carotene exerts its effects through retinoid signalling could also be 
considered.
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Solar radiation has long been known to have beneficial as well as deleterious effects on 
humans. Beneficial effects of solar UV include an essential role in the production of 
vitamin D3 as well as regulation of vitamin D metabolism. This vitamin is essential for 
maintaining blood calcium levels within a normal range and therefore for the growth 
and maintenance of a healthy skeleton. Hallmarks of therapeutic advances have been the 
introduction of artificial ultraviolet lamps and sunlight for the treatment of skin 
tuberculosis by Finsen in 1900 and of photochemotherapy with oral psoralen and long 
wave UV in by Parish in 1974. Ultraviolet and visible light alone (phototherapy) or in 
combination with chemical agents (photochemotherapy, photodynamic therapy) are 
now used in a variety of medical interventions. These include the treatment of 
hyperbilirubinemia in the newborn, treatment of psoriasis, atopic dermatitis and 
photodynamic therapy for tumors. However, strong evidence has been accumulated in 
the last decades implicating solar UV in various physiological and pathological states. 
These include erythema, sunburn pigmentation hyperplasia, photodermatosis, premature 
skin aging, immunosuppression, activation of infections, cataract formation, melanoma- 
and non-melanoma-type skin cancers (for reviews see: Applegate and Frenk, 1995; 
Tyrrell, 1994; 1996; 1997; Pourzand eta l, 2000; Termorshuizena, 2002).
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Developing strategies for protection against the adverse effects of solar radiation is a 
desirable goal. The means for protection against UV in humans can be divided into two 
categories: topical and systemic protection. Research is involved in the development of 
sunscreen formulations that protect against UV induced erythema, immunosuppression 
(Fourtanier et a l , 2000) and DNA damage related to skin cancer (Young et al., 2000). 
Recently, the use of retinoic acid has been proposed for preventing functional vitamin A 
deficiency in human skin by solar radiation (Wang et a l , 1999a). No systemic drugs are 
generally recommended for protection of normal human skin against solar exposure. 
High doses of p-carotene are effective in reducing photosensitivity in patients with 
erythropoietic protoporphyria (Mathews-Roth, 1993). p-carotene when administered 
intraperitoneally has been shown to inhibit UV induced epidermal damage and tumor 
formation in a mouse model (Epstein, 1977). Epidemiological evidence suggests an 
inverse relationship between high levels of circulating carotenoids and cancer incidence 
in humans (for review see Mayne, 1996; Peto et al., 1981; Block et al., 1992; Ziegler, 
1989). However, Greenberg and colleagues (Greenberg et a l , 1990) demonstrated that 
supplementation with p-carotene did not reduce the occurrence of new skin cancers in 
patients with a previous history of non-melanoma skin cancer.
In this thesis we initially gather together lines of evidence regarding the effects of the 
UVA component of sunlight on cells in culture and on the pathways that mediate these 
effects (section 1.2). The next part of the introduction is concerned with possible 
physiological roles of the HO gene and the inducible HO-1 isoform (section 1.3). The 
chemical and biological properties of carotenoids, as well as the results of 
epidemiological studies and intervention trials are summarised in section 1.4. As 
carotenoid metabolites have been shown to interact with nuclear receptors that are major 
transcriptional regulators, a main concern in the literature is whether the actions of 
carotenoids in cells and tissues are intrinsic to carotenoids or due to activation of 
nuclear receptors. Section 1.5 is a brief overview of the nuclear receptors especially of 
those likely to interact with the experimental results. The particularities of carotenoid 
work are presented in the final part of the introduction (section 1 .6 ).
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1.2 The UV component of sunlight
UV radiation that reaches the biosphere can cause damage to many biomolecules 
including nucleic acids, proteins and lipids. The first step in a photochemical reaction is 
the absorption of a single photon by a molecule (chromophore) and the production of 
an excited state in which one electron of the absorbing molecule is raised to a higher 
energy level.
The primary products generated by UV absorption are generally either reactive oxygen 
species in a metastable excited state or free radicals, both of which are formed fast. 
Dark chemical reactions occur then within psecs, but may last for hours. Finally, these 
reactions are translated into photobiological responses, which may also occur rapidly 
but can also take years or decades to be manifested. Photons may interact directly with 
important biological molecules, events which mostly occur with wavelengths that fall in 
the UVB range or, alternatively, the energy of a photon might be absorbed by another 
molecule, the photosensitizer. The excited photosensitizer can then transfer its energy 
by various mechanisms to the target molecule. Certain photosensitising chemicals do 
not require oxygen to be active, but others known as photodynamic sensitizers have an 
oxygen requirement. Photodynamic sensitizers can lead to type I or type II 
photooxidation, according to how they interact with oxygen. In type I reactions, the 
UV-excited sensitizer molecule combines with oxygen to form a reactive radical. In 
type II reactions, the energy is transferred to oxygen to produce active oxygen 
intermediates, which in turn can interact with cellular components.
The biological effects of solar UV light change as a function of wavelength. The solar 
UV spectrum that reaches the surface of the earth is divided into 2 different major 
regions, which differ quite sharply in their biological effects- the UVB (290-320nm) 
and the UVA (320-380nm) regions, also known as mid- and near ultraviolet ranges. The 
UVB region has been thought to be the most deleterious portion of the solar UV 
spectrum, as it has been shown to be responsible for many damaging effects including 
sunburn, mutation induction, cell mortality and skin cancer. However, wavelengths in 
the UVA region are also potentially carcinogenic. UVA is weakly absorbed by most 
biomolecules but is oxidative in nature and the cellular modifications it produces
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overlap considerably with those induced by oxidative damage, whereas UVB, while it 
does have an oxidative component, is absorbed at biologically relevant levels by critical 
macromolecules, including DNA and proteins. Consequently, it is a very strong DNA 
damaging agent. The UVB component of sunlight is several orders of magnitude more 
effective per unit dose (J/m2) than the UVA, as exemplified by the UV dose producing 
minimal erythema (MED) in humans (Harrison and Young, 2002; Applegate and Frenk, 
1995). Because of reduced molecular absorption, tissue transmission increases with 
wavelength, so that UVB and to a greater extent UVA radiation, reach targets well 
below the surface of the skin. A small but probably relevant quantity of UVA is 
predicted to be absorbed by blood components (Tyrrell, 1996b). UVA radiation 
constitutes a very significant oxidative stress and the cellular defense pathways against 
UVA have more in common with antioxidant pathways than with the DNA repair 
pathways induced primarily by the UVB radiation (for review see Tyrrell, 1995).
1.2.1 Interaction of UV with biomolecules
At shorter wavelengths, that fall in the UVB range direct absorption by cellular 
macromolecules including DNA and proteins, occurs with a high probability and the 
biological effects of DNA photodamage and mutagenesis are dominant (Pourzand and 
Tyrrell, 1999; Young, 1997). At longer wavelengths, which fall in the UVA range, 
weak absorption by most biomolecules occurs and different chromophores absorb and 
generate a variety of active intermediates, including reactive oxygen species 
(ROS)[mkti]. Overall, UVA radiation is oxidative in nature and UVA inactivation of 
mammalian cells is strongly oxygen dependent, so that ROS are certainly involved in 
the process. As the predominant type of damage changes with wavelength, the 
predominant cellular defense pathways also change. Repair of damage to DNA is 
important at shorter wavelengths (UVB), whereas free radical scavenging pathways and 




Since the chromophore is the molecule, which initially absorbs the incident UV energy, 
the critical chromophores will change as a function of wavelength. Peak absorption of 
DNA occurs at 260nm (UVC region) and its absorption drops sharply as wavelengths 
increase. In contrast, proteins absorb in all UV ranges depending on their composition. 
Several cellular components such as quinones, flavins, steroids and porphyrins are 
important UVA chromophores.
Protoporphyrin (PP) IX the immediate precursor to heme is a strong photosensitizer and 
the insertion of iron into the PPIX macrocycle produces heme, which is relatively to 
protoporphyrin IX, less photoactive. Iron-free porphyrins generate singlet oxygen upon 
irradiation. In addition, other small molecules also have the potential to generate active 
oxygen intermediates after absorption of UVA. An important example is the 
photochemical degradation of tryptophan that generates hydrogen peroxide (Tyrrell, 
1991). The level of hydrogen peroxide generated in vivo from such a pathway would 
appear to be in the low micromolar range. Nevertheless, it could be crucial to biological 
processes, because iron complexes that are present in the cytoplasm will react with 
hydrogen peroxide to generate the highly reactive hydroxyl radical (in a superoxide- 
driven Fenton reaction). Furthermore, both hydrogen peroxide and superoxide anion are 
generated by UVA irradiation of NADH and NADPH. In addition, cells contain many 
chromophores that may generate singlet oxygen via a type II photodynamic process. In 
this case, the excited triplet state sensitizer will react with oxygen in the ground state to 
give ground state sensitizer and singlet oxygen. The most common groups of 
compounds of this type are the flavins, quinones and porphyrins.
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1.2.2 Reactive Oxygen Species (ROS)
Molecular oxygen is an essential element for the survival of all aerobic organisms and 
reactive oxygen species (ROS) are generated as by-products of normal cellular 
metabolism, primarily in the mitochondria. The term reactive oxygen species (ROS) is a 
collective term that includes not only oxygen-centred radicals such as superoxide anion 
(O2**) and hydroxyl radical (OH*), but also some nonradical derivatives of oxygen, such 
as hydrogen peroxide (H2 O2 ) and singlet oxygen ( ^ 2) (for review see Halliwell and 
Gutteridge, 1999).
Reactive oxygen species are produced within the cell at various organelles during 
normal cellular metabolic processes. Any electron transferring protein or enzymatic 
system can result in the formation of ROS as by-products of electron transfer reactions. 
During aerobic energy metabolism, the oxidoreduction energy of mitochondrial electron 
transport chain is converted to the high-energy phosphate bond of ATP and O2 serves as 
the final electron acceptor for cytochrome—c oxidase, the terminal enzymatic component 
of this mitochondrial enzymatic complex that catalyses the four electron production to 
H2 O. Partially reduced and highly reactive metabolites of O2  may be produced during 
electron transfer reactions. These O2  metabolites include superoxide anion (O2 .") and 
hydrogen peroxide (H2 O2 ), formed by one and two electron reductions of O2 , 
respectively. In the presence of transition metal ions the even more reactive hydroxyl 
radical (OH*) may be formed.
The smooth endoplasmic reticulum (ER) contains enzymes that catalyse a series of 
reactions to detoxify lipid-soluble drugs and other harmful metabolic products. The 
most extensively studied of these are the cytochrome P-450 and bs families of enzymes 
that can oxidise unsaturated fatty acids and xenobiotics and reduce molecular O2  to 
produce O2 ’' and /or H2 O2 . Cytochrome oxidases and electron transport systems are also 
contained in nuclear membranes.
Peroxisomes are another important source of total cellular H2 O2  production. They 
contain a number of H2 C>2 -generating enzymes, including glycolate oxidase, D-amino 
acid oxidase, urate oxidase, L-a- hydroxyacid oxidase, and fatty acyl-CoA oxidase.
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Only a small fraction of H2 O2 generated in peroxisomes appears to escape peroxisomal 
peroxidase. In addition to intracellular membrane -associated oxidases, soluble 
enzymes such as xanthine oxidase, aldehyde oxidase, dihydroorotate dehydrogenase, 
flavoprotein dehydrogenase and tryptophan dioxygenase can generate ROS during 
catalytic cycling.
When cellular production of ROS overwhelms its antioxidant capacity, damage of 
cellular macromolecules such as lipids, proteins, and DNA may ensue. Such a state of 
‘oxidative stress’ is thought to contribute to aging and pathogenesis of a number of 
diseases including cancer and those of the lung. Recent studies have implicated ROS 
that are generated by specialised plasma membrane oxidases in normal physiological 
signalling by growth factors and cytokines. The mechanism by which ROS transduce 
their cellular signals is not well understood. The emerging concept on the signal 
transduction by ROS involves alterations in the cellular redox state and the oxidative 
modification of proteins (for review see Thannickal and Famburg, 2000; Dalton et al.,
1999).
In a variety of non-phagocytic cells types including fibroblasts, there is a marked rise of 
intracellular (ROS) including O2’ and H2 O2 , after activation of Platelet derived Growth 
Factor (PDGF) receptor or Epidermal growth factor (EGF) receptor stimulation. This is 
dependent upon the small GTP-binding protein Racl and phosphatidylinositol 3 kinase 
(PI3K) (Irani et al., 1997; Sundaresan, 1996; Bae, 1999; Bae, 2000). It has been shown 
that UVA irradiation leads to an, at least partial, functional EGF- and PDGF- receptor 
autophosphorylation (Schlessinger, 2000) and that this is dose dependent. It has been 
suggested that the mechanism for this may be related to a ROS mediated inhibition of 
tyrosine dephosphorylation of receptor tyrosine kinases (RTKs) by inactivation of 
membrane bound protein tyrosine phosphatases (Knebel, 1996). ROS synthesis is 
diminished in keratinocytes in which the integrity of membrane domains was disrupted 
by cholesterol sequestration with methyl-P-cyclodextrin and fillipin. A reduced level of 
ROS synthesis was also shown in UVA irradiated cells treated with these agents relative 
to controls (Gniadecki et a l , 2002)
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1.2.2.1 Singlet Oxygen ( ^ 2)
Singlet molecular oxygen ( ^ 2 ) is a highly reactive form of molecular oxygen that may 
oxidise critical organic molecules (Vile and Tyrrell, 1995). * 0 2  is a derivative of 
molecular oxygen in which all valence electrons are spin paired. The electronic 
configuration of singlet oxygen (*Ag, !C>2) is simplified as (7i*2 px) 2, (7t*2 py)°, illustrating 
its non radical nature. Singlet oxygen exists in two forms (!Ag, ^ 2 ) and a higher energy 
form (Zg+, 10 2 ), which decays to the *Ag, * 0 2  immediately upon formation and is thus 
thought to irrelevant to biological systems.
The lifetime of * 0 2  is approximately 10 fold longer in deuterium oxide (D2 O) than in 
water or aqueous solutions (Merkel and Kearns, 1972). Thus, biological responses are 
often compared by replacing H2 O in a system with D2 O, as a test for * ( > 2  involvement. 
Enhancement of a biological reaction in this way may be taken as strong evidence of 
* 0 2  involvement, assuming that isotope effects are negligible (Ryter and Tyrrell, 1998; 
Pourzand et a l , 2000). Other tests for detecting * 0 2  involvement in reactions is the use 
of agents that function as ! 0 2  quenchers of varying specificities such as 1,4- 
diazabicyclooctane (DABCO), p-carotene, sodium azide (NaNa) and L-histidine or 
chemical traps such as 1,3-diphenylisobenzofuran and cholesterol (Kulig and Smith, 
1973; Oosthuizen and Greyling, 1999; Osada and Sevanian, 2000). The addition of 
these compounds should inhibit a reaction dependent on 10 2 . If these compounds do not 
inhibit the biological effect under study when added at adequate concentrations, it is 
likely that * 0 2  is not involved in the process. However, if the given effect is quenched 
by these scavengers in cellular systems, this does not provide absolute proof of * 0 2  
involvement, as these compounds are not totally specific for lOi and they could react 
with other reactive oxygen species (ROS) or strong oxidants and * 0 2  could be 
quenched by competing organic molecules (Ryter and Tyrrell, 1998).
Overall, several parameters have to be taken into account. For example, azide, although 
a scavenger has also many other cellular effects including inhibition of RNA 
polymerase (Tyrrell, 1997) so this must be considered if the biological end-point is 
dependent on transcription. The quenching by L-histidine also provides valuable 
information about the superoxide anion involvement, since it has a negligible
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interaction with superoxide anion and quenching by this compound indicates that the 
involvement of this anion is unlikely. Both azide and histidine react with very reactive 
radicals (such as hydroxyl radical) so that quenching alone is not diagnostic. 
Furthermore, DABCO and diphenylisobenzofuran also react with RO2 ' radicals (for 
review see Pourzand et al., 2000). As corroborative evidence for ! 0 2  involvement in a 
given effect, the effect should be also seen after appropriate generation of this 
intermediate. It is has been proposed that the best way to generate this compound is to 
irradiate a sensitizer (e.g. Rose Bengal) attached to beads or to a membrane in close 
vicinity to the target cells but with an air interface (for review see Tyrrell, 1997; Ryter 
and Tyrrell, 1998).
1.2.2.2 UVA effects mediated by singlet oxygen
Many of the damaging effects of UVA radiation in vitro can be attributed to the 
generation of singlet oxygen (Tyrrell, 2000). This intermediate is clearly a major factor 
in mediating UVA peroxidation of membrane lipids (Vile and Tyrrell, 1995), in UVA 
mediated DNA damage (Peak et al., 1987; Kvam and Tyrrell, 1997) and in UVA 
induced necrotic cell death (Tyrrell and Pidoux, 1989). There is also evidence that this 
agent is involved in UVA activation of gene expression. Such evidence exists for the 
UVA dependent activation of heme oxygenase (Basu Modak and Tyrrell, 1993). Similar 
data exist for activation of the collagenase gene (MMP-1) in human fibroblasts 
(Wlaschek et al., 1997). Singlet oxygen has also been implicated in UVA mediated 
activation of signal transduction pathways, including p38 and c-jun-N-terminal kinases 
but not extracellular regulated kinases (Klotz et a l, 1999; 1997).
1.2.3 Protein damage by UVA
Studies at the beginning of the 20th century showed that certain enzymes, including 
amylase, catalase, pepsin and tyrosinase are inactivated in an oxygen-dependent process 
by UVA irradiation (Agulhon, 1912). Proteins containing cystine residues are the most
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labile targets because of the high reactivity of the sulphide bond but aromatic amino 
acids (tryptophan, phenylalanine, and tyrosine) are also sensitive because they absorb in 
the UV range (see Tyrrell 1984). Among the antioxidant enzymes, both peroxidase and 
catalase are heme containing proteins which are UVA chromophores and may generate 
active oxygen species. Catalase exhibits an absorption maximum in the UVA range with 
a peak close to 400nm. Studies have shown that it is rapidly destroyed by UVA 
radiation (Mitchell and Andersen, 1965) and that it may act as an endogenous 
photosensitizer (Eisenstark and Perrot, 1987).
Oxygen radicals and other activated oxygen species cause modifications of the amino 
acids of proteins that frequently result in functional changes of structural or enzymatic 
proteins (Stadtman, 1992). Protein carbonyls may be formed either by oxidative 
cleavage of proteins or by direct oxidation of lysine, arginine, proline, and threonine 
residues (Levine et al., 1994). Oxidative modification of proteins appears to mark them 
for degradation (Stadtman, 1990).
1.2.4 DNA damage
Wavelengths in the UVA waveband cause various types of DNA damage, including 
cyclobutane-type pyrimidine dimers (Tyrrell, 1973), strand breaks (Peak et al., 1987; 
Rosenstein, 1983) and DNA protein crosslinks (Peak and Peak, 1991). The latter two 
classes become more important as wavelength increases. Dimer formation does not 
appear to be influenced by reducing the oxygen tension, so active oxygen species are 
unlikely to be involved. However, fluence dependent induction of DNA strand breaks in 
the DNA of Escherichia coli is completely prevented by irradiation under anaerobic 
conditions (Tyrrell et al., 1974), although this damage does not appear to contribute to 
cell death. It has also been shown that strand break induction by irradiation (365nm) of 
human cells is enhanced in the presence of deuterium oxide, an agent that increases the 
singlet oxygen lifetime, possibly implicating singlet oxygen (Peak et al., 1987).
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1.2.5 UVA mediated membrane damage
The lipid membrane is readily susceptible to attack by active oxygen intermediates. 
Lipid peroxidation and peroxidative breakdown of membranes are well established as 
types of damage induced by UVA (Niki et a l , 1991; Skoog et a l , 1997) and these 
effects are known to be catalysed by heme proteins such as cytochrome c and catalase 
(Tyrrell, 1991; Applegate and Frenk, 1995). Furthermore, UV induces changes in the 
membrane’s fluidity (Tyrrell, 1991; Gaboriau, 1993). An agent that enhances singlet 
oxygen lifetime, D2 O, enhances the level of membrane damage, sensitivity to UVA and 
lipid peroxidation (Chamberlain and Moss, 1987; Vile and Tyrrell, 1995).
Peroxidation of membrane lipids can occur nonenzymatically as well as enzymatically 
in UVA irradiated mammalian cells (Vile and Tyrrell, 1995; Hanson and DeLeo, 1990). 
During non- enzymatic peroxidation, active oxygen species initiate the process and the 
resulting lipid radicals propagate the peroxidation process, which lead to an 
accumulation of lipid hydroperoxides. Their decomposition leads to a variety of end 
products, the major being malonaldehyde (MDA), hexanal and 4-hydroxynonenal (4- 
HNE). 4-HNE activates adenylate cyclase and phosphatidyl inositol 4,5 biphosphate 
phospholipase C (PI(4 ,5 )P2 -phospholipase C) (Rossi et al., 2001) and phospholipase D 
(Natarajan et a l , 1993) in cells. Adenylate cyclase increases the intracellular 
concentration of cAMP, which activates cAMP dependent kinases. PI(4 ,5 )P2 - 
phospholipase C catalyses the hydrolysis of PIP2 to IP3 and diacylglycerol (DAG). In 
enzymatic lipid peroxidation oxidised fatty acids are released from membrane lipids by 
phospholipases and other lipases. UVA irradiation stimulates arachidonic acid (AA) 
release from membrane phospholipids. Arachidonic acid, which is released by 
phospholipase A2 , is a substrate for synthesis of eicosanoids by lipoxygenases (LOXs), 
cycloxygenases (COXs) and epoxigenases, namely leukotrienes, prostaglandins and 
thromboxane. The cyclooxygenase metabolites of arachidonic acid could then activate 
signal transduction events involved in UVA mediated HO-1 induction (Basu-Modak et 
al., 1996).
It has been shown that a variety of proteins involved in cell signaling are concentrated 
in cholesterol-rich domains of the membrane designated “membrane rafts” or “lipid
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rafts” (Simons and Ikonen, 1997; Simons and Toomre, 2000). It is thought that 
“membrane rafts” function as sites of assembly of proteins involved in cell signaling 
including cell surface receptors, GPI- anchored proteins, Src kinases, and Ras proteins 
(Brown and London, 2000). One subset of lipid rafts is found in cell surface 
invaginations called caveolae. Caveolae are formed from lipid rafts by polymerisation 
of caveolins- integral membrane proteins that tightly bind cholesterol. Cholesterol is a 
major constituent of lipid rafts and caveolae, which are sites where signalling molecules 
are concentrated. Recently a model has been suggested to describe the physical 
properties of cholesterol/phospholipid/glycophospholipid mixtures that must play an 
important role in the regulation of their synthesis, transport and localisation in cell 
membranes (Radhakrishnan et al., 2000).
In monolayers, there is experimental and theoretical evidence for a strong (step-like) 
increase of cholesterol chemical activity on increasing cholesterol concentration beyond 
the complex stoichiometric composition. It is thought that the “condensed complexes 
rich phase” is likely to be present in lipid rafts of animal cell membranes and has a 
major effect in determining the chemical activity of cholesterol, which affects its 
binding to proteins. A putative raft domain may include many hundreds of complexes 
along with small amounts of uncomplexed lipids (Radhakrishnan et al., 2000). It is 
suggested that the chemical activity of cholesterol plays an essential role in the 
regulation of cholesterol biosynthesis (Radhakrishnan and McConnell, 2000).
To perform these functions, membrane cholesterol must be kept at constant level 
(Brown and Goldstein, 1999). This homeostasis is achieved by a feedback regulatory 
system that senses the level of cholesterol in cell membranes and modulates the 
transcription of genes encoding enzymes of cholesterol, unsaturated fatty acid and 
triglyceride biosynthesis and uptake from plasma lipoproteins. The modulators are a 
family of endoplasmic reticulum membrane-bound transcription factors, called sterol 
regulatory element binding proteins (SREBPs) that activate genes encoding enzymes of 
cholesterol and fatty acid biosynthesis in sterol depleted cells. This activation of 
transcription is blocked when sterols build up in cells. SREBPs need to be released 
proteolytically from membranes to act. Following cleavage, the NH2 -terminal domain 
of SREBPs is released and travels to the nucleus, where it binds to SREs in the
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enhancers of target genes. The NH2 -terminal domains of SREBPs are transcription 
factors of the basic-loop-helix-leucine zipper (bHLH-Zip) family. The extreme NH2 -  
terminus contains a stretch of acidic amino acids that recruits coactivators including 
CBP (Brown and Goldstein, 1999; Swinnen et al., 1997; Scheek et al., 1997; Edwards 
et al., 2 0 0 0 ).
The most important role of lipid rafts at the cell surface may be their function in signal 
transduction. Lipid rafts containing a given set of proteins can change their size and 
composition in response to stimuli. This favours specific protein-protein interactions, 
resulting in the activation of signalling cascades. As an example, in the case of tyrosine 
kinase signalling (e.g. EGFR activation by UVA), adaptors, scaffolds and enzymes are 
recruited to the cytoplasmic side of the plasma membrane as a result of activation. Even 
a small change of partitioning into rafts can initiate signaling cascades (Simons and 
Ikonen, 2000).
One way to consider rafts is that they form concentrating platforms for individual 
receptors activated from ligand binding. In general, raft binding recruits proteins to a 
new micro-environment, where the phosphorylation state can be modified by local 
kinases and phosphatases resulting in downstream signalling (Simons and Ikonen, 1997; 
Simons and Toomre, 2000).
1.2.6 Inactivation of mammalian cells
Populations of human cells (Hela) or Chinese hamster cells are inactivated in a salts 
buffer by monochromatic radiation in the UVA range (365nm) (Danpure and Tyrrell, 
1976). The inactivation is strongly dependent upon the presence of oxygen, suggesting 
that active oxygen intermediates are involved in the observed effect. Furthermore, 
irradiation in the presence of sodium azide (NaN3 - a quencher of singlet oxygen) or 
D2 O (which enhances the singlet oxygen lifetime) lead to significant levels of protection 
or sensitisation, respectively.
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1.2.7 UVA irradiation and constitutive cellular defense pathways
1.2.7.1 Small antioxidant molecules
Glutathione (GSH) is present in most mammalian cells at high concentrations and is 
believed to play a crucial role in protection of cells against oxidative damage. GSH is 
synthesized from its constituent amino acids by a sequential action of y- 
glutamylcysteine synthetase (y-CGS) and GSH synthetase. The activity of y-CGS 
determines the rate of GSH synthesis and is feedback inhibited by GSH (Meister and 
Anderson, 1983; Rahman and MacNee, 2000). One of the immediate cellular effects of 
physiologically relevant UVA doses is depletion of cellular GSH content (Wheeler et al. 
1986; Connor and Wheeler, 1987) and this is not affected by the presence of lipophilic 
antioxidants (Basu-Modak et a l , 1996; Ossola and Tomaro, 1998). In cell culture 
models using human cells it has been shown that glutathione depletion, using D,L- 
buthionine-S, i^-sulfoxime (BSO) (an inhibitor of y-CGS), sensitizes cells to UVA 
(Tyrrell and Pidoux, 1986; 1988). Glutathione provides an important intracellular free 
radical scavenging system and constitutes the most abundant non-protein free thiol in 
mammalian cells. Additionally GSH is also a cofactor for antioxidant enzymes 
important in drug detoxification such as glutathione peroxidase, transhydrogenases and 
glutathione transferases (Applegate and Frenk, 1995). The protection it affords to UVA 
challenged cells, might be due to its action as a unique hydrogen donor for glutathione 
peroxidase (Tyrrell and Pidoux, 1988).
Recently, a different and new physiological role has been defined for these compounds 
because of their involvement in nitric oxide binding and transport in biological systems 
(Foresti et al., 1997). It appears that NO is stabilised by thiols through the formation of 
S-nitrosothiols and a dynamic equilibrium among free NO, O2 ' and endogenous 
glutathione might constitute an interactive signalling mechanism modulating stress and 
adaptive responses in tissues.
Thiols also play an important role by interacting with the oxidised cysteine residues in 
the active center of protein tyrosine phosphatases (PTPs) and reversing their
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inactivation by UVA and metal toxins. UVA interacts with receptor tyrosine kinases 
(RTKs) (e.g. Epidermal growth factor (EGFR) and platelet-derived growth factor 
receptor (PDGFR) (Knebel et al, 1996) that initiate intracellular phoshorylating 
cascades counteracted by action of regulatory molecules that involve protein tyrosine 
phosphatases (PTPs). The “repair” of PTPs by thiols is of physiological significance 
(A.slund and Beckwith, 1999; Herrlich and Boehmer, 2000).
1.2.7.2 Antioxidant enzymes
The major classes of antioxidant enzymes include superoxide dismutases (SODs), 
catalase (CAT) and glutathione peroxidases (GSH-Px).
Superoxide dismutase enzymes (SODs) remove 02’‘ by accelerating its conversion to 
H2 O2 . Human cells have a SOD enzyme containing manganese at its active site 
(MnSOD) in the mitochondria. A SOD with copper and zinc at the active site 
(CuZnSOD) is also present, but largely in the cytosol. Catalase enzymes convert H2 O2  
to water and O2 . However, it is noteworthy that neither SODs nor CAT alone play major 
role in protecting cells from the lethal effects of UVA irradiation (Tyrrell and Pidoux, 
1989).
On the other hand, glutathione peroxidases (GSH-Px) (selenium glutathione peroxidase 
and phospholipid hydroperoxide peroxidase) are important enzymes in the cellular 
defense against UVA induced damage (Tyrrell and Pidoux, 1988; Lautier et al., 1992; 
Jomot and Junot, 1993). Glutathione peroxidase (GPx) catalyzes the conversion of UV- 
induced H2 O2 in to water and oxygen and the reduction of toxic lipid peroxides to less 
toxic hydroxy fatty acids utilizing glutathione as a co-factor. Selenium-dependent GPx 
exhibits high reactivity toward both H2 O2  and organic hydroperoxides and it is found 
both in cytosol and mitochondria. The activity of this enzyme is not strongly affected by 
UV and is considered to be a most important antioxidant defense system in the skin 
(Shindo et al., 1994; Halliwell and Gutteridge, 1999).
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Whereas high UV doses and ROS levels are known to overwhelm the antioxidant 
enzymatic defense system, clinical studies have shown that repetitive low UV doses 
prevent phototoxicity and UV-induced pathologies upon subsequent higher UV doses, 
(Rucker et a l , 1991) indirectly suggesting an inducible adaptive antioxidant defense 
response.
1.2.8 UVA induced gene expression
UVA is effective at inducing expression of numerous genes in human cells. These genes 
include collagenase (Scharffetter-Kochanek et al., 1993); IL-1 and IL- 6  (Wlaschek et 
al., 1997), ICAM-1 (Krutmann et a l, 1995), c-fos and c-jun (Soriani et al., 2000), heme 
oxygenase-1, cyclooxygenase 2 (for review see Tyrrell, 1994; 1996; 1996b) inducible 
nitric oxide synthase (Suschek et a l, 2001) and manganese superoxide dismutase 
(MnSOD) (Possig et a l, 1999).
Another UVA induced gene is CL-100, whose transcription is also strongly activated by 
oxidants (Keyse, 1995). CL-100 encodes a dual specificity (tyrosine/threonine) protein 
phosphatase that specifically inactivates cellular mitogen -activated protein (MAP) 
kinases and is therefore implicated in the modulation of signal transduction events 
involved in the cellular stress response (Keyse, 1995; Tyrrell, 1996b).
Also the inducible form of cyclooxygenase, cyclooxygenase 2, has been shown to be 
induced in normal human skin fibroblasts by UVA (Feng et a l, 1995; Soriani et al, 
1998).
UVA has been shown to activate activator protein 1 (AP-1) (c-Fos/c-Jun) in a human 
keratinocyte line (Silvers et al., 2002) and in fibroblasts (Nakano et al., 2001). AP-1 
activity is known to play a key role in the regulated expression of important components 
of the cytokine network, cell surface receptors and proteases, which orchestrate the 
process of wound healing (for review see Angel et a l, 2001; Sen and Packer, 1996; 
Allen and Tresini, 2000).
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1.3 Heme oxygenase-1
Heme oxygenase (HO) is the major heme-degrading enzyme and provides a vital 
physiologic function in regulating the intracellular concentration of heme in mammalian 
tissues. HO catalyses the first and rate limiting step in the degradation of heme in 
eukaryotic cells, leading to the formation of biliverdin IXa, carbon monoxide (CO), and 
free iron. Biliverdin is subsequently converted to bilirubin with action of biliverdin 
reductase and free iron is sequestered in ferritin. The degradation of heme by HO 
requires the action of the microsomal enzyme NADPH cytochrome cP450 reductase, 
which serves to donate electrons to the reaction. The demonstration that oxidative stress 
in general was causing strong transcriptional activation of the gene led to the hypothesis 
of a new function of HO-1 in cellular defense. The reaction products of HO activity, 
biliverdin and its subsequent metabolite bilirubin, have antioxidant properties. Potential 
pro-oxidant consequences of HO activity are related to the production of iron, which 
could be involved in reactions that compete with iron reutilization and sequestration 
pathways (for review see Ryter and Tyrrell, 2000).
Three mammalian isoforms of heme oxygenase (HO) that catalyse the degradation of 
heme have been identified to date: heme oxygenase-1 (HO-1), heme oxygenase-2 (HO- 
2) and heme oxygenase-3 (HO-3) (McCourbey et al., 1997; Otterbein et al, 2000). 
They are products of three different genes. HO-1 is a 32-kDa protein that is induced in 
response to numerous stimuli.
Although heme is the typical HO-1 inducer it has been clearly shown that HO-1 activity 
can also be stimulated by a variety of non-heme inducers including UVA irradiation, 
endotoxin, heavy metals and oxidants, such as hydrogen peroxide (Keyse and Tyrrell, 
1989; Keyse et a l, 1990; Vile and Tyrrell, 1993; Ossola and Tomaro, 1998). 
Glutathione depletion strongly enhances both, basal and oxidant induced expression of 
HO-1 (Lautier et al., 1992; Pourzand et al., 2000; Rahman and MacNee, 2000). The 
enhanced expression of the HO-1 gene by UVA and other agents can be accounted for 
by a strong enhancement in transcription rate (Keyse et al., 1990). Redox signaling 
appears to play a major role in HO-1 regulation, however various redox-independent 
pathways are also involved in HO-1 gene regulation (Maines, 1996).
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This enzyme is most highly concentrated in tissues that are heavily involved in the 
catabolism of heme proteins. HO-2, a 36-kDa protein is a non-inducible isoform that is 
present in highest concentrations in brain and testes. HO-3, a 33-kDa protein, also 
catalyses heme degradation, but with a much lower catalytic activity than the HO-2 
protein isoform. The physiologic role of this protein remains uncertain (Galbraith, 1999; 
Ortiz de Montelano, 2000). The three isoforms have little in common in primary 
structure, regulation, or tissue distribution. In mammals the measured heme oxygenase 
activity is the sum of HO-1, HO-2 and HO-3 activities (Maines, 1997).
The carbon monoxide (CO) released from heme during HO activity may function as a 
soluble second messenger gas molecule in a fashion that resembles that of the free 
radical gas nitric oxide (NO*) (Verma et a l , 1993). In contrast to NO, however, which 
forms peroxynitrite with superoxide, CO does not form radicals. In the liver, CO is 
involved in the regulation of cytochrome P450-dependent biotransformation. HO-1- 
derived CO has been shown to protect the hepatic microcirculation under stress 
conditions (Suematsu et al., 2000). Furthermore, CO appears to play a prominent 
regulatory role for the tone of the cardiovascular system by promoting vasodilatation 
(Sammut et a l , 1998)
It has been shown that up-regulation of transcription of the HO-1 gene by heme was 
reduced after an initial exposure to heme. In this study, a second exposure to heme: 
albumin given at a time when HO-1 mRNA accumulation was highest following the 
first induction led to a lower than expected transcriptional activation. UVA also leads to 
development of refractoriness to activation of this gene (Noel and Tyrrell, 1997).
The immediate release of heme, the heme oxygenase substrate, from microsomal 
proteins by UVA irradiation of human skin fibroblasts, has been suggested to occur via 
a cyclooxygenase dependent mechanism, since indomethacin an inhibitor of 
cyclooxygenase 1 and 2 (Willoughby et al, 2000; Mitchell and Warner, 1999) inhibited 
the UVA dependent release of heme (Kvam et a l , 1999). HO not only controls the 
availability of heme for the synthesis of heme proteins, but also is responsible for the 
generation of CO, which binds to the heme moiety of heme proteins thus affecting their 
enzymatic activity. It has been shown (Haider et al., 2002) that the heme-HO system
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regulates COX enzyme expression and activity in rabbit vascular endothelial 
c e l l S { p R r v A T E  " T Y P E = p ic T ;A L T = a ip h a"} and that the increase in HO activity was associated with 
a subsequent decrease in COX activity, which returned to normal levels following 
normalisation of HO activity, {p r i v a t e  " T Y P E = p iC T ;A L T = a ip h a  "} The degree of HO-1 
expression and, consequently, the level of cellular heme, were directly related to COX 
activity. The authors concluded that the heme-HO system can function as a cellular 
regulator of the expression of vascular COX, thus influencing the generation of 
prostanoids, PGE2 and PGI2 , known to play a role in vascular homeostasis. A similar 
finding was published regarding the regulation of COX activity by the HO system in 
rats (Botros et al., 2002).
HO-1 induction has also been implicated in a photoimmunoprotective activity of UVA 
in the skin of UVB irradiated mice (Reeve and Tyrrell, 1999). Furthermore, HO-1 is 
induced in a number of experimental injuries and diseases including congestive heart 
failure (Raju et al., 1999), kidney reperfusion injury (Raju and Maines, 1996), corneal 
inflammation (Laniado et al., 1997) and ischemic stroke (Panahian et al., 1999).
There is strong evidence that the induction of HO-1 has therapeutic implications in 
diseases associated with oxidative stress (for review see Immenschuh and Ramadori,
2000). However, it has also been shown that HO-1 gene activation is not protective 
under certain experimental circumstances (Platt and Nath, 1998; Suttner and Dennery, 
1999; Lamb et a l, 1999; Nutter et al., 1994; Dennery et al., 2003). The therapeutic 
potential of targeted HO-1 gene transfer has been investigated in diseases such as 
ischemic stroke (Panahian et al., 1999) and inflammatory lung injury caused by 
hyperoxia (Otterbein et a l, 1999). A significant therapeutic potential of modulation of 
HO-1 gene induction has been implicated in various immune functions, particularly 
important in transplantation medicine (DeBruyne et al., 2000).
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1.4 Carotenoids
Carotenoids are a class of hydrocarbons (carotenes) and their oxygenated derivatives 
(xanthophylls) with more than 600 naturally occurring members known to date. They 
are important plant pigments found in the photosynthetic pigment protein complex of 
plants, photosynthetic bacteria and algae and are responsible for the bright colours of 
many fruits, vegetables and flowers, as well as for the colours of many birds and marine 
animals. Carotenoids are unique in that their diversity of function is unmatched by any 
other class of pigments found in photosynthetic organisms (Faure et a l, 1999).
The carotenoids are not synthesised in animals and their circulating levels in humans are 
a result of dietary intake (Rock, 1997; IARC Working Group for the evaluation for 
cancer, 1998; Faure et a l, 1999; Stahl and Sies, 1996). Approximately 60 carotenoids 
can be metabolised to retinol and function as Vitamin A precursors in mammals. The 
predominant carotenoids observed in the plasma are p-carotene, lycopene, lutein, p- 
cryptoxanthin and a-carotene, which account for 90% or more of the circulating 
carotenoids in humans (Rock, 1997).
Carotenoids consist of eight isoprenoid units joined in such a manner that the 
arrangement is reversed at the centre of the molecule so that the two central methyl 
groups are in a 1 ,6 -positional relationship and that the remaining non-terminal methyl 
groups are in a 1,5-positional relationship. The most striking and characteristic feature 
of the carotenoid structure is the long system of alternating double and single bonds that 
they carry (Britton, 1995). This constitutes a conjugated system in which the 7i-electrons 
are effectively delocalised over the entire length of the polyene chain. All carotenoids 
may be formally derived from the acyclic C4 0 H5 6 structure (lycopene) illustrated in Fig. 
1.4-1. after steps of hydrogenation, dehydrogenation, cyclisation, oxidation or any 
combination of these processes. The International Union of Pure and Applied Chemistry 
(IUPAC) and the IUPAC-Intemational Union of Biochemistry Commissions on 
Biochemical nomenclature have published rules for the nomenclature of carotenoids. 
All specific names are based on the stem name “carotene”, which corresponds to the 
structure and numbering shown in Fig. 1.4-2. The name of a specific compound is 
constructed by adding as prefixes two Greek letters that specify the two end C9 end
20
groups Fig. 1.4-3. The structures of some important retinoids can be seen in Fig. 1.4-4. 
Chirality and geometric configuration are designated as R/S or E/Z respectively (IARC 
Working Group for the Evaluation of Cancer, 1998). In this thesis, the term trans is also 
used for the E and cis for the Z geometric configuration. Derivatives in which the 
carbon skeleton has been shortened by the formal removal of fragments from one end of 
a carotenoid are named “apocarotenoids” the position of the point of cleavage being 
indicated e.g. P-apo-8’-apocarotenal.
The cis-trans isomerism of the carbon-carbon double bonds is an important feature, 
because these geometric isomers may have different biological properties. These forms 
may be interconverted by light, thermal energy, or chemical reactions (Rock, 1997). 
Carotenoids usually occur in nature as all-trans isomers and many cis isomers that are 
described in the literature, as natural products may be artefacts (IARC Working Group 
for the Evaluation of Cancer, 1998).
Fig. 1.4-1. The basic carotenoid skeleton, constructed from eight isoprenoid units (The figure is 
reproduced from IARC Working Group for the Evaluation of Cancer, 1998)
Fig. 1.4-2. Numbering scheme for carotenoids (The figure is reproduced from IARC Working 
Group for the Evaluation of Cancer, 1998)
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Fig. 1.4-3. The seven end groups in carotenoids (The figure is reproduced from IARC working 
Group for the Evaluation of Cancer, 1998)
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Fig. 1.4-4. Structures of important retinoids (The figure is reproduced from IARC working 
Group for the evaluation of Cancer, 1998)
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1.4.1 General properties of carotenes
The natural functions and biological actions of carotenoids are determined by the 
physical and chemical properties of the molecules, which are defined by their molecular 
structure. All carotenoids in the all-trans configuration are linear, rigid molecules. The 
conjugated double bond system also determines their chemical and photochemical 
properties that form the basis of their biological properties. A third factor is interaction 
between carotenoids and other molecules in their immediate vicinity, which can greatly 
alter the properties of the carotenoids and thus affect their functioning in vivo. The 
carotenes are a group of extremely hydrophobic molecules with no solubility in water. 
They are thus expected to be restricted to hydrophobic areas in the cell, such as the 
inner core of membranes, except when association with proteins allows them to access 
an aqueous environment (Gruszecki, 1999). Although their shape in the all-trans 
configuration is linear, the overall shape of the cis isomers differs substantially from 
that of the all-trans form, so their ability to fit in subcellular structures may differ. The 
shape and size of end groups are also important factors. Acyclic carotenoids such as 
lycopene are essentially long, linear molecules with flexible end groups. Cyclisation 
shortens the overall length of the molecule and the space they occupy (Britton, 1995).
1.4.2 Light absorption
The absorption of light energy by an organic molecule produces a higher-energy excited 
state of that molecule. In the case of carotenoids the relevant transition is a 7i->7i* 
transition, in which on of the bonding 7i-electrons of the conjugated double bonds is 
promoted to a previously unoccupied n* antibonding orbital. The 7i-electrons are highly 
delocalised and the excited state is of comparatively low energy. The energy needed for 
the transition is small and corresponds to light in the visible region in the wavelength 
range of 400-5OOnm. Carotenoids are therefore intensely coloured yellow, orange or 
red. The relationship between chromophore and light absorption properties is used for 
their identification (Britton, 1995). The characteristic strong absorbance of light in the 
vis is attributed to a transition from the ground state So to the second singlet excited
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state S2 (1!Bu). The energy levels of the S2 state and the somewhat lower first excited 
state Si ( l JAg) that can be formed from its internal conversion, lie close to but above 
those of chlorophyll, so that singlet-singlet energy transfer can take place form excited 
carotenoid to generate the excited singlet state chlorophyll Si, which is active in 
photosynthesis. Direct formation of the carotenoid triplet state (Ti) from the excited 
singlet states S2 , or Si via singlet -triplet intersystem crossing is not favoured. Its 
formation by energy transfer from other triplet state molecules e.g. photosensitizers can 
be very efficient, provided that that the carotenoid contains more than seven conjugated 
double bonds, because the carotenoid triplet-state energy is low. Transfer of energy 
from triplet state chlorophyll and other porphyrins to carotenoids occurs much more 
readily than the alternative energy transfer to oxygen to form singlet oxygen. 
Carotenoids can also accept excitation energy from 1C>2 . The triplet state carotenoid is of 
such low energy that it is unable to form other species by energy transfer and dissipates 
its excitation energy to its surroundings (for review see Britton, 1995).
1.4.3 Chemical properties
The conjugated polyene system is a reactive electron-rich system that is susceptible to 
attack by electrophilic reagents and is responsible for the instability of carotenoids 
towards oxidation. It is the most important part of the molecule in relation to free- 
radical chemistry (Britton, 1995). Pure carotenoids, even in the crystalline state, are 
susceptible after isolation to oxidation and may be broken down rapidly if samples are 
stored in the presence of even traces of oxygen. In vivo, however, the carotenoids are 
usually stabilised to a considerable degree by proteins and other molecules in their 
immediate vicinity. Even in vivo carotenoids are still susceptible to oxidative damage if 
they become exposed to oxidising species. Oxidative breakdown is also caused by free 
radical reactions; rapid bleaching by hydroxyl radicals is well known (Young and Lowe, 
2001; Krinsky, 1989).
Recent work has concentrated on the reactions of carotenoids with peroxy radicals 
generated in some cases by pulse radiolysis mostly by use of azo-initiators such as 2,2'- 
azo-bis-2-4-dimethyl valeronitrile (AMVN) (Woodall et al, 1997, Young and Lowe, 
2001). A wide variety of products have been detected in these studies. Most seem to be
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apocarotenals or apocarotenones of various chain lengths produced by cleavage of any 
double bond in the polyene chain; epoxides are also commonly found (IARC Working 
Group for the valuation of Cancer, 1998).
Similar chemical reactions occur between carotenoids and singlet oxygen and again 
produce apocarotenals and apocarotenones as the major products. The mechanism 
though might be different and may involve the addition of ^  to a double bond to form 
a labile dioxetane, which is then cleaved to give the corresponding carbonyl products.
Carotenoids are rapidly destroyed by oxidation, especially by free radicals such as the
hydroxy radical and various peroxy radicals. The important fundamental chemistry of
carotenoid radicals and of the reaction of carotenoids with oxidising free radicals is not
well understood. Carotenoid radicals are charged or neutral and are very short lived
species. In principle, removal of one electron from the carotenoid molecule by oxidation
gives the radical cation Car+* whereas the addition of one electron by reduction
generates the radical anion Car-*. These charged radicals can be detected by their
distinctive spectroscopic properties in the near infrared region. The abstraction of a
hydrogen atom from a saturated carbon atom in a position allylic to the polyene chain,
♦by homolytic cleavage, would generate a neutral radical Car . In all these radicals, 
delocalisation of the unpaired electron over the conjugated polyene chromophore has a 
stabilising effect and allows subsequent reactions to take place in many parts of the 
molecule. The same is true for carotenoid -adduct radicals, which could be generated by 
the addition of a radical species such as a peroxy radical ROO* or a hydroxy radical 
HO* to the polyene chain. A series of apocarotenoids of different chain length have 
been reported to be products of chemical and free radical oxidation of carotenoids. They 
could be produced in tissues by non-specific chemical or enzymatic reactions or by 
specific excentric cleavage of carotenoids in the intestine (for review see IARC 
Working Group for the Evaluation of Cancer, 1998).
Burton and Ingold (1984) have shown that the radical trapping antioxidant behaviour of 
p-carotene in chlorobenzene changes as a function of oxygen partial pressure so that at 
high oxygen pressure it loses its antioxidant activity especially at high concentrations.
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This is especially important regarding the effects of carotenoids in humans since low 
partial pressures are found in most tissues under physiological conditions.
1.4.4 Singlet Oxygen Quenching by Carotenoids
An important feature of carotenoids is their ability to quench singlet oxygen. Numerous 
in vitro studies have been employed to unravel the mechanism by which p-carotene and 
other carotenoids quench singlet oxygen.
Two major mechanisms have been proposed in the literature, physical and chemical 
quenching, and it is likely that both contribute to an extent. Most commonly, 
carotenoids catalytically quench singlet oxygen through an almost diffusion-controlled 
energy transfer process (physical pathway). Physical quenching involves the transfer of 
excitation energy from 1C> 2 to the carotenoid thereby producing ground state oxygen and 
a carotenoid in the excited triplet state. The excess energy is dissipated as heat through 
rotational and vibrational interactions with the surrounding solvent and structures. The 
regeneration of the ground state carotenoid allows it to function as a catalyst and 
undergo additional cycles of !C>2 quenching. In contrast to physical quenching, less 
efficient but concomitant processes exist involving real chemical reactions (Garavelli et 
al, 1998).
Quenching constants for J02 have been determined for a range of carotenoids in 
solution and a relationship between the length of the conjugated C=C chain and ability 
to quench *02 by energy transfer has been demonstrated. This ability is also influenced 
by the end- (e.g. for p-carotene and lycopene) and substituent groups (DiMascio et a l, 
1989; Conn et al., 1991; Stahl and Sies, 1993). The singlet oxygen quenching second 
order rate constants for different carotenoids in benzene can be seen in Table 1.4.4-1 
(Edge and Truscott, 1999). Carotenoids may undergo trans- or cis-isomer 
interconversion by quenching *02 (Stahl and Sies, 1993). Chemical quenching, as 
opposed to physical quenching of J 0 2  by carotenoids leads to the destruction 
(bleaching) of the carotenoid molecule and the major products are apocarotenals and 
apocarotenones.
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It is noteworthy though that, to date, the majority of the fundamental information 
regarding *02 quenching by carotenoids has been gathered in vitro. While experiments 
in organic solvents and simple micelles and liposomes provide valuable fundamental 
information on the interactions between carotenoids and *02 they do not adequately 
represent the complex in vivo situation. In vivo carotenoids rather than being free in 
solution they are predominantly found associated with protein or lipoprotein structures. 
The immediate environment of the carotenoid molecule may have a profound effect on 
its properties and will affect its interaction with other compounds. The extent to which 
they play a role in protecting cells against ^ -re la te d  biological damage remains 
unknown (for review see Young and Lowe, 2001).
Carotenoid N Kq/xlOyM '1s






Astaxanthin 11 (+2C=0) 14.0
8-apo-(3-carotenal 9 (+1C=0) 5.27
Violaxanthin 9 16.0
Lutein 10 6.64
Table 1.4.4-1. Singlet oxygen rate constants for various carotenoids in benzene (from Edge and 
Truscott, 1999).
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1.4.5 Absorption transport and storage of carotenoids
Absorption and metabolism of carotenoids varies among animal species. In humans and 
only a few other mammals (e.g. the ferret (Liu et a l , 2000; Wang et al, 1999b)) an 
appreciable amount of the carotenoids can be absorbed intact by the mucosal cells and 
subsequently appear unchanged in the circulation. Thus plasma concentrations in most 
laboratory animals are normally very low and tissue distribution is not comparable with 
that in humans. In humans, variable proportions of the carotenoids taken up by the 
intestinal mucosal cells are metabolised in the process of absorption and this 
complicates the interpretation of the plasma carotenoid response as an indicator of 
uptake after administration, when this approach is used in investigations (Parker, 1996).
After uptake by the enterocytes, carotenoids are incorporated into chylomicra and 
secreted in the lymph, followed by liver uptake and release back into the circulation is 
association with very low density lipoproteins (VLDL) and ultimately in association 
with low density lipoproteins (LDL) (Erdman et a l , 1993). Carotenoids in the 
circulation are transported with lipoproteins with a distribution similar to that of 
cholesterol, so plasma cholesterol concentrations are highly correlated with (and 
predictive of) circulating carotenoid concentrations (Clevidence and Bieri, 1993; Olson 
1994b). Overall approximately 75% of the plasma carotenoids are associated with LDL 
and the remainder are distributed between VLDL and high density lipoproteins.
Adipose tissue and liver are the major storage depots for carotenoids and high 
concentrations are found in tissues that are rich in LDL receptors, such as the corpus 
luteum, adrenal tissue and testes (Woutersen et a l , 1999; Rock, 1997).
Differences in the proportionate distribution among isomeric forms have been observed, 
between the plasma and peripheral tissues for different carotenoids, e.g. P-carotene and 
lycopene. The amount of all-trans p-carotene greatly exceeds cis-p-carotene in the 
circulation (>95%), whereas an increased proportion of the cis isomer is observed in 
tissues.
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The proportion of all-trans lycopene in the plasma is <50% of total lycopene and the cis 
isomers account for more than 79% in prostate tissue (Clinton et al., 1998).
Recently some proteins that bind carotenoids (carotenoproteins) have been identified 
and characterised in animals and this is expected to shed light on the storage, transport 
and targeting of carotenoids in animal tissues. This work is complicated by the 
difficulty of formulating an appropriate aqueous medium for the extraction of such a 
carotenoid-protein complex. A mammalian p-carotene binding protein of 67 kDa 
(CCBP) was purified and partially characterised from ferret liver (Rao et al., 1997). In 
contrast to a molecular size of 67kDa for the mammalian CCBP, the size of 
carotenoproteins from various lower organisms vary between 18 and 350kDa in their 
sizes. Alpha-crustacyanine, an astaxanthin-binding protein from the carapace of the 
lobster is a 350 kDa protein (Keen et a l, 1991) and a lutein binding protein isolated and 
characterised from the silk gland of Bombyx mori larvae (Tabunoki et a l, 2002) is a 33 
kDa protein. The well-characterised cellular retinoid binding proteins (CRBPs), which 
have been shown to be essential for vitamin A homeostasis (Ghyselinck et al., 1999) 
and the cellular retinoic acid binding proteins (CRABPs) are in the 15 kDa range and 
have been shown to be members of the fatty acid binding proteins (FABPs) (Vogel et 
a l, 2001). Furthermore, the CRBPII and CRABP II proteins have been shown to be 
transcriptionally controlled through the nuclear receptors, which are the PPARcx/RXRa 
(Suruga et al, 1999) and RARa/RXRa heterodimers (Delva et al., 1999; Bastie et a l, 
2001), respectively.
1.4.6 Metabolism of P-carotene
P-carotene is the most important provitamin A carotenoid and the most extensively 
studied so far. Its metabolism in cells can occur via two major p-carotene enzymatic 
cleavage pathways, the central and/or excentric cleavage pathway.
In the case of central (symmetric) cleavage, p-carotene is metabolised to retinal by p,p- 
carotene 15,15'-monooxygenase (formerly p,P-carotene 15,15'-dioxygenase (E C.
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1.13.11.21)), an enzyme catalysing the central cleavage of p-carotene into two 
molecules of retinal (cloned and characterised in drosophila (von Lintig and Vogt, 
2000), chicken (Wyss et al, 2000), mouse (Redmond et a l , 2000) and human (Yan et 
a l , 2001). The produced retinal product can be reversibly converted to retinol by action 
of members of either the alcohol dehydrogenase (ADH) and/or short-chain 
dehydrogenase/ reductase (SDR) enzyme families or oxidised to retinoic acid (RA) by 
the action of members of the aldehyde dehydrogenase (ALDH) family (Duester, 2000). 
Retinoic acid (RA) is a possible product of p-carotene metabolism (Wang et al., 1991). 
RA is the active Vitamin A derivative whose pleiotropic effects are transduced by 
Retinoic Acid Receptors (RARs) and Retinoid X Receptors (RXRs) that are involved in 
the regulation of gene transcription (Heyman et a l, 1992; Mangelsdorf and Evans, 
1995; Chambon, 1996).
A recent publication demonstrates that the enzymatic activity of p,p-carotene 15,15- 
monooxygenase is regulated by RA by a feedback mechanism in intestinal tissue, but 
not in lung and liver, of rats and chickens (Bachmann et a l, 2002).
In the case of excentric (asymmetric) cleavage of P-carotene two molecules of P- 
apocarotenal with different chain lengths are formed. An enzyme catalysing exclusively 
the asymmetric cleavage of p-carotene at the 9’-10’, double bond and resulting in the 
formation of p-apo-lO’-carotenal has been recently cloned and characterised in mouse 
(Kiefer et al, 2001). In contrast to Drosophila, both symmetric and asymmetric 
cleavage pathways exist in vertebrates. For retinoic acid (RA) formation, the p- 
apocarotenal with the longer chain length can be oxidised to a p-apocarotenoic acid and 
then shortened, yielding one molecule of RA. For this, a mechanism similar to the p- 
oxidation of fatty acids has been proposed (Wang et al., 1996). Fig. 1.4.6-1 shows a 
representation of the mechanism. Evidence from studies in which the human (Wang et 
al., 1994) and the ferret (Hebuteme et a l, 1995) intestinal tissue liver were employed 
indicate that 9-cis-p-carotene functions as a precursor of 9-cis retinoic acid, a retinoid 
with strong affinity to both RARs and RXRs whereas the all trans isomer has a selective 
affinity for RARs (see subsection 1.3.8). Liver cytochromes P450 have been shown to 
take part in the metabolism of retinol and retinoic acid to polar metabolites (White et 
al., 1997), so the possibility of the involvement of that system in carotenoid metabolism
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is feasible. Overall, the conversion of P-carotene to vitamin A appears to be tightly 
regulated through vitamin A homeostasis (Olson, 1994a). It is dependent on the food 
matrix (De Pee, et al., 1998), food processing (Rock et al., 1998), fat intake (Takyi, 
1999), protein intake and vitamin A status (Ribaya-Mercado et al., 2000). It has been 
demonstrated that the conversion of p-carotene to vitamin A diminishes inversely to the 
intake of P-carotene (Brubacher and Weiser, 1985; Olson 1994b), so skin can yellow 
with excessive dosing (hypercarotenemia) and no symptoms of hypervitaminosis A are 
associated with hypercarotenemia (Dawson, 2000).
Fig. 1.4.6-1. The central and excentric cleavage of P-carotene (reproduced from Wang 
etal, 1996)
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1.4.7 Lycopene and metabolism
Lycopene is one of the predominant carotenoids in human plasma (Rock, 1997). It is an 
acyclic carotenoid with 11 linearly arranged conjugated bonds and two non conjugated 
double bonds and the most potent *02 quencher of all the carotenoids (DiMascio et al., 
1989). Lycopene lacks the (3-ionone ring structure and is devoid of provitamin A 
activity. The enzyme catalysing the asymmetric cleavage of p-carotene at the 9’-10’ 
double bond is active with lycopene as well, in a reaction producing apo-lycopenals of 
different chain lengths (Kiefer et al., 2001).
In studies aimed at determining whether lycopene or a compound shown to be produced 
by the oxidation of lycopene (Kim et a l, 2001), namely acyclo-retinoic acid (the open 
chain analog of RA), would activate RARs it was shown that it could activate RARs 
with a 100-fold lower potency than retinoic acid (Ben-Dor et al., 2001).
1.4.8 Functions and biological activities of carotenoids
The antioxidant actions of P-carotene have been demonstrated in many studies 
(Woodall et al., 1997; Krinsky, 1993) and many studies support the fact that p carotene 
exhibits protective effects against lipid peroxidation resulting from free radicals or 
singlet oxygen. This occurs in organic solution, liposomes, liver microsomes and cells 
in culture. The antioxidant effect of carotenoids in LDL has been suggested to be the 
biological link between higher level of dietary carotenoids and reduced risk for 
cardiovascular disease (Krinky, 1994). However in vivo this relation between 
carotenoids and LDL oxidation has not been consistent. A biological explanation is that 
the presence of a-tocopherol in LDL is of greater importance in the prevention of LDL 
oxidation (Krinsky, 2001; Rock, 1997; Young and Lowe, 2001).
Carotenoids react rapidly with oxidising agents and free radicals and at the end of the 
reaction carotenoid products have been detected in small quantities and most of the
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carotenoid has disappeared. The products depend on the oxidising conditions, arising 
from a variety of oxidation reactions that affect different parts of the molecule (cleavage 
of the polyene chain, epoxidation of endocyclic double bonds or reactions at allylic 
positions). Mechanisms proposed for these reactions include the addition of peroxyl 
radicals to the polyene chain, electron capture from the carotenoid, and hydrogen 
abstraction from allylic positions (Woodall et a l , 1997; Burton and Ingold, 1984). 
Although most work on the antioxidant actions of carotenoids has been carried out with 
p-carotene studies comparing carotenoids also exist.
In a study of Woodall and associates carried out in solution, all carotenoids reduced 
lipid peroxidation of egg yolk phosphatidyl choline (EYPC) from 2,2’-azobis(2,4’- 
dimethylvaleronitrile (AMVN)-derived peroxyl radicals and a clear correlation between 
inhibition of lipid peroxidation and destruction of the carotenoid was observed for all 
carotenoids apart from lycopene. Lycopene was found to react more rapidly than the 
other carotenoids, but this was not associated with increased antioxidant activity. When 
the carotenoids were incorporated in liposomes the results were similar in that they 
exhibited antioxidant activity, but the order of potency of the carotenoids was different 
and the level of destruction of the carotenoids was much lower than in solution. The 
effects of the carotenoids regarding membrane protection were different when they were 
tested against AAPH induced oxidation (production of peroxyl radicals in the aqueous 
phase) the carotenoids that afforded the least protection were P-carotene or lycopene 
However both p-carotene and lycopene would be expected to be restricted to the inner 
core of the membranes and the collision rates with peroxyl radicals in the aqueous phase 
would be expected to be very low (Woodall et a l , 1997).
The antioxidant activity of p-carotene and other carotenoids has been suggested to shift 
into a prooxidant activity depending on the redox potential of the carotenoid molecule 
as well as the biological environment in which it acts. The prooxidant potency of 
carotenoids is influenced by several factors, including pC>2 , carotenoid concentration 
and interaction with other antioxidants (for review see Palozza, 1998 and Young and 
Lowe, 2001). The procarcinogenic effects of oxidation products (typically epoxides but 
also apocarotenals) of carotenoids has been proposed. For example the binding of 
benzo[a]pyrene to DNA is promoted in the presence of oxidation products of P-
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carotene, but inhibited in the presence of p-carotene itself (Salgo et a l, 1998). Elevated 
levels of such oxidative products have been observed in vitro in the lungs of tissues 
from smoke-exposed ferrets compared to controls. High levels of these products have 
been shown to downregulate the RARp-gene (Liu et a l, 2000; Wang and Russell, 
1999). In the presence of H2 O2 or xanthine/xanthine oxidase the ability of p-carotene 
and lycopene to protect against DNA damage (single strand breaks as measured by the 
Comet Assay) in HT29 adenocarcinoma cells, was inversely related to carotenoid dose 
(Lowe et al, 1999). Relatively high doses of p-carotene also failed to protect against 
H2 O2  and tertbutyl hydroperoxide induced DNA damage in HepG2 cells, as measured 
by the Comet assay (Woods et a l, 1999). It is known that different carotenoids 
influence the properties of membranes into which they are incorporated in a different 
manner but also that their effectiveness against ROS in the aqueous and lipid phase is 
quite different (Woodall et al, 1997a; 1997b).
P-carotene and lycopene are derived from plants and they share similar initial synthetic 
pathways with cholesterol, which is synthesized in animals but not in plant cells (Stahl 
and Sies, 1996; Fuhrman, 1997). The investigators examined the effect of the 
carotenoids on macrophage cholesterol metabolism. The cellular cholesterol synthesis 
from acetate was suppressed. Interestingly, lycopene and p-carotene augmented the 
activity of the macrophage receptor similarly to the effect of lovastatin. The authors 
concluded that dietary carotenoids may act as moderate hypocholesterolemic agents, 
secondary to their effects on macrophage 3-hydroxy-3 methyl-glutaryl coenzyme A 
reductase, the rate limiting enzyme in cholesterol biosynthesis (Fuhrman et al, 1997).
Anticarcinogenic activities have been demonstrated for both provitamin A and 
nonprovitamin A carotenoids in animal models (Krinsky, 1993). However, no animal 
experiments had been reported on the effect of high doses of BC on lung carcinogenesis 
prior to the human intervention trials. An arising question is whether high doses of BC 
fed to experimental animals reach the target tissues. This problem was corrected by the 
introduction of the ferret as an experimental animal (Liu et al, 2000, Wang et al., 
1999b; Wolf, 2002).
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Several studies reported antiproliferative effects of lycopene against cancer cells in 
culture (Livny et al., 2002; Nara et al., 2001; Karas et al., 2000; Ben Dor et al., 2001, 
Prakash et al., 2001) by interfering with growth factor receptor signalling and cell cycle 
progression (Levy et al., 1995) or by enhancing gap-junctional communication (Livny 
et al., 2002). In several types of cell cultures P-carotene, lycopene as well as other 
carotenoids have been shown to promote inhibition of malignant transformation. The 
prevention of malignant transformation in mouse fibroblast cells is found to be 
mediated by increased gap junctional communication between cells, and this was shown 
to be due to the up-regulation of the connexin 43 gene (Bertram, 1991; Bertram and 
Bortkiewicz, 1995). These effects were observed in response to both provitamin A and 
non-provitamin A carotenoids, with using concentrations in the cell culture medium that 
are achievable by increased dietary intake. Other investigators examined the ability of 
canthaxanthin to increase the expression of a reporter gene driven by the RAR-P 
promoter. The gene was activated, and an active retinoid (4-oxoretinoic acid) that was 
shown chemically to be produced from canthaxanthin. (Nikawa et al., 1995). Also 
acyclo retinoic acid (the open chain analog of RA) has been shown to activate RARs, 
however, with a 100-fold lower potency than retinoic acid (Ben-Dor et al., 2001).
Carotenoids have also been shown to exert effects on cell differentiation. These 
compounds were, however much less active than retinoic acid, which is now used 
clinically to induce differentiation in promyelocytic leukaemia. The potential clinical 
relevance of a relationship between carotenoids and immune responses is illustrated by 
the observation that p-carotene supplementation could prevent the photosuppression of 
delayed type hypersensitivity (Fuller et al., 1992; Herraiz et al., 1998). p-carotene and 
other carotenoids have been shown to enhance the release of ILa and TNFa from 
glycogen induced murine peritoneal adherent cells (Okai and Higashi-Okai, 1996). 
Incubation of human peripheral blood mononuclear cells for 72h with P-carotene or 
canthaxanthin at 10‘8 mol/L in EtOH increased the number of cells expressing markers 
for natural killer cells and IL-2 receptor. Similar changes were seen after exposure to 
retinoids (for review see IARC Working Group for the Evaluation of Cancer, 1998).
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1.4.9 Carotenoids in chemoprevention and treatment
P-carotene supplementation is recognised as an effective treatment modality in the 
management of the genetic photosensitivity disease, erythropoietic porphyria. The 
treatment is based on the function of carotenoid pigments in plants and microorganims. 
Erythropoietic porphyria is characterised by defective ferrochelatase, the enzyme that 
inserts iron into protoporphyrin to produce heme, and this results in an accumulation of 
protoporphyrin. Presumably the accumulation of carotenoids in the tissue [skin] 
prevents photosensitization by the porphyrins (Mathews -Roth, 1993).
p-carotene plasma levels are a result of dietary intake and the range among different 
individuals is very large. The means of circulating levels in European and American 
populations have been reported from several studies and are in the range of 0.17-2.25 
pM (Armstrong et al., 1997; Heseker et al., 1991; The a-tocopherol and p-carotene 
study group (ATBC), 1994; Omenn et al., 1996, Carotene and Retinol Efficacy Trial 
(CARET); Hennekens et al., 1996, Physicians Health Study (PHS)). The tissue levels 
for p-carotene are shown on Table 1.4.9-1.
As previously reviewed (Mayne, 1996; Peto et al., 1981; Block et a l , 1992; Ziegler, 
1989) epidemiological evidence has strongly linked higher levels of circulating 
carotenoids with reduced risk of many cancers, cardiovascular disease, cataracts and. 
macular degeneration. On the basis of the substantial epidemiological evidence linking 
carotenoids to reduced chronic diseases especially lung cancer and on the basis of basic 
and experimental supportive evidence, several large clinical trials were initiated to test 
the effect of intervention. Six large multicenter clinical trials were conducted to test the 
effect of the intervention with p-carotene (ATBC study group, 1994; Omenn et al., 1996 
[CARET]; Hennekens et a l , 1996 [PHS], Greenberg et al., 1990, Greenberg et al., 
1994; Blot et a l , 1993) and failed to confirm this association in well nourished 
populations (Cook et al., 2000; Rock et al., 1997; Bertram, 1999; Wang et a l, 1999b). 
The results of the major intervention trials are summarised on Table 1.4.9-2. It has 
been suggested that the difference between observational and intervention studies 
regarding P-carotene may be a consequence of the use of different populations with 
varying nutritional status and smoking habits, different tumor sites, combination
36
supplements vs single agent supplements and perhaps even different formulations. 
Furthermore, dietary blood or tissue carotenoids might primarily serve as a marker of 
other protective factors and p-carotene may act synergistically with other compounds 
found in a natural food matrix, and finally, p-carotene may have been administered too 
late in the carcinogenic process (Mayne, 1996). In the intervention trials the load of p- 
carotene was similar, but the resulting average plasma levels after supplementation 
differed substantially (ATBC 5.5 pM; CARET 3.9 pM; PHS 2.2 pM; Linxian: 0.86 
pM). Understanding the mechanisms related to high dose p-carotene supplementation is 
important, due to a continuing interest in the potential of P-carotene as a 
chemopreventive agent (Liu, 2000).
Serum concentrations of lycopene in humans range from 0.01-1.9 [PBNi2 ]pM although 
interindividual variation is very large with standard deviations in the range of 50% of 
the mean or more (Gerster, 1997; Campbell et al., 1994; Brady et al., 1996; Ribaya- 
Mercado et al., 1995; Stahl et al., 1992; Carughi et al., 1994; Micozzi et al., 1992; Peng 
et al., 1995; Clinton et al., 1996).
Increased levels of lycopene in the diet and in plasma have been associated with 
decreased risk of prostate (Giovanucci et al., 1995; Giovanucci, 1999; Lu et al., 2002) 
and cervical cancer (Kanetsky et al., 1998).
Protective effects of lycopene towards oxidative stress mediated damage of the skin 
were suggested following a study on carotenoid levels in human skin upon irradiation 
with UV light. When skin was subjected to UV light stress, more skin lycopene was 
destroyed than P-carotene. Because carotenoids are consumed in the process of radical 
quenching, a preferential protective role of lycopene has been suggested (Ribayo- 
Mercado et al., 1995). Also, lycopene when supplemented as tomato paste with olive oil 
has also been shown to protect against UV induced erythema after a 10-week 
supplementation (Stahl et al., 2002). The tissue levels of lycopene are shown on Table 
1.4.9-1.
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Tissue p-carotene (nmol/gwet weight) Lycopene (nmol/gwet weight)
Liver
3.02 (Stahl and Sies, 1996) 
1.82 (Kaplan, 1990)
1.28 (Stahl and Sies, 1996) 
2.45 (Kaplan, 1990)
Kidnev
0.55 (Stahl and Sies, 1996) 
0.31 (Kaplan, 1990)
0.15 (Stahl and Sies, 1996) 
0.39 (Kaplan, 1990)
Adrenal
5.60 (Stahl and Sies, 1996) 
9.39 (Kaplan, 1990)
1.9 (Stahl and Sies, 1996) 
21.60 (Kaplan, 1990)
Testes
2.68 (Stahl and Sies, 1996) 
4.36 (Kaplan, 1990)
4.34 (Stahl and Sies, 1996) 
21.36 (Kaplan, 1990)
Ovarv
0.45 (Stahl and Sies, 1996) 
0.97 (Kaplan, 1990)
0.25 (Stahl and Sies, 1996) 
0.28 (Kaplan, 1990)
Adipose
0.38 (Stahl and Sies, 1996) 
0.38 (Kaplan, 1990)
0.20 (Stahl and Sies, 1996) 
1.30 (Kaplan, 1990)
Lung 0.22 (Nierenberg and Nann, 1992)
Skin
0.27 (Nierenberg and Nann, 1992)
1.41 (Ribaya-Mercado et al., 1995)
0.42 (Nierenberg and Nann, 1992) 
1.60 (Ribaya-Mercado et al., 1995)
Prostate 0.09-1.7 (Clinton et al., 1996) 0-2.58 (Clinton et al., 1996)
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Table 1.4.9-2 Table summarising the results of the major intervention trials with (3-carotene. 
Abbreviations used in Table, [3c: (3-carotene; CARET: Carotene and Retinol Efficacy Trial; 
ATBC: a-tocopherol and p-carotene study; PHS: Physicians Health Study; CVD: 
cardiovascular disease; GI; gastrointestinal.
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1.5 Nuclear Receptors (RARs, RXRs, PPARs)
Nuclear receptors comprise a superfamily of ligand activated transcription factors that 
regulate the expression of genes involved in the development and adult physiology 
(Mangelsdorf and Evans, 1995). They provide multicellular organisms with a means to 
directly control gene expression in response to a wide range of developmental, 
physiological and environmental stimuli (Giguere, 1999).
Retinoic acid receptors are members of the nuclear receptor superfamily that includes 
the 9-cis retinoic acid receptors (RXR a,p,y) and orphan receptors. Orphan receptors are 
nuclear receptors whose cognate ligands are (or were) unknown and have been the 
subject of intense study over the past decade. Retinoic Acid Receptors (RAR a, p, y), 
Peroxisome proliferator activated Receptors (PPAR a, y, 8), Chicken ovalbumin 
upstream promoter transcription factor (COUP) and Nerve Growth Factor Receptor 
Induced (NGFI-B) belong to the orphan receptor family. Upon ligand binding nuclear 
receptors modulate gene expression.
Retinoid response pathways are mediated by two classes of receptors, the retinoic acid 
receptors (RARs) and the retinoid X receptors (RXRs) (Zhang et a l , 1992; Kastner et 
al., 1997). RXRs can bind to DNA both as homo- and heterodimers and the 
homodimers are induced exclusively by 9-cis retinoic acid. RXRs are major regulators 
of gene expression and serve as a common heterodimeric partner for RARs, PPARs, 
liver receptors (LXRs) and numerous other nuclear receptors (LeBlanc and 
Stunnenberg, 1995; Giguere, 1999). 9-cis RA is a ligand for both RARs and RXRs and 
all-trans RA is a ligand for RARs only (Mangelsdorf and Evans, 1995).
The PPAR subfamily includes three isoforms (a, p or 8, and y) involved in the 
maintenance of lipid and glucose homeostasis. All PPAR isoforms bind to PPAR 
response elements (PPRE) as a heterodimer with RXR located in the promoter of target 
genes (Schoonjans et al., 1997, Shi et a l , 2002, Chinetti et al., 2000). In the 
PPAR/RXR heterodimer, both receptors are independently responsive and 
synergistically activated in the presence of both ligands (Desvergne and Wahli, 1999).
40
Several studies have demonstrated that PPARa regulates fatty acid uptake, activation 
into acyl-CoA esters, and P- and co-oxidation of fatty acids. Natural ligands for PPARa 
include among others eicosanoids derived from arachidonic acid (for review see Reddy 
and Hashimoto, 2001; Chinetti et a l, 2000). Among the naturally occurring 
eicosanoids 15-deoxy-A-12,14-prostaglandin J2  (PGJ2) is the compound with highest 
affinity on PPARy. PPARy has been shown to play a central role in activating 
adipogenesis both in vitro and in vivo (Tontonoz et a l , 1994) and to play a role in the 
development of the atherogenic lesion (Kliewer, 1999). The PPAR8 isoform is 
ubiquitously expressed at moderate levels in humans with a higher expression in the 
placenta and the large intestine. PPAR8 is related as well as PPARa with increased 
expression of fatty acid binding proteins (FABPs) and the cellular binding proteins 
(CRBP) (for review see Desvergne and Wahli, 1999).
It has been demonstrated that nuclear hormone receptors as well AP-1, basic-loop -  
helix factors, STATs, cAMP response element-binding protein, and nuclear factor-xB 
(NF-kB) utilise the CREB binding protein (CBP) or its homolog (p300) to function as a 
nuclear receptor cofactor. CBP/p300 are viewed as integrators of multiple signalling 
pathways, linking membrane receptor signalling and nuclear receptor activation 
pathways, as well as being a key limiting factor for which all the above mentioned 
pathways must compete (for review see Goodman and Smolik, 2000; Desvergne and 
Wahli, 1999).
Non-liganded receptors may associate with transcriptional co-repressors such as 
silencing mediator for RARs and TRs (SMRT) and nuclear receptor co-repressor 
(NcoR) resulting in suppression of basal transcriptional activity (Nagy et al., 1997; 
Chen and Evans, 1995; Sande and Privalsky, 1996). Thus, hormone dependent 
dissociation of SMRT from a RXR-RAR heterodimer displaces the mSin3 /FIDAC 1 
complex from a chromatin bound complex (Nagy et a l , 1997). Phosphorylation is one 
potential candidate for mediating receptor function by such a pathway. Another 
mechanism by which receptors can modulate gene expression is by cross-coupling to 
augment or inhibit signalling pathways mediated by other classes of transcription 
factors. A very good example, is the inhibition of AP-1, by retinoids, thyroid hormones 
and glucocorticoids (Beato et a l, 1995).
41
Evidence exists suggesting that carotenoids including p-carotene can upregulate 
expression of retinoic acid receptors in various cell types (Ponnamperuma et al., 2000; 
Ben-Dor et al., 2001; Liu et al., 2000; Wang et al., 1999b).
RARa and RXRy transcripts, the main nuclear retinoid receptors in human skin, are 
essentially absent in undifferentiated squamous cell carcinomas in man. UV induced 
upregulation of AP-1 activity and AP-1 driven matrix degrading metalloproteinase 
genes can be inhibited in human skin by pretreatment of skin with retinoic acid (RA). 
UVB irradiation at 2MED (twice minimal erythema dose) causes a rapid reduction of 
RARa and RXRy, at protein and mRNA level and a near total loss of RA induction of 
the RARa and RXRy induced genes cellular retinoid acid binding protein II (CRABP- 
II) and RA 4-hydroxylase (Wang et al., 1999a).
1.6 Special features of carotenoid work
As carotenoids are less stable than many other substances, precautions and special 
procedures must be used to minimise the risk of degradation and formation of artefacts. 
In particular exposure to oxygen, heat, light, acid and in some cases bases must be 
avoided whenever possible (Britton, 1995; IARC Working Group for the Evaluation of 
Cancer, 1998). All operations should be carried out in an inert atmosphere (Nitrogen or 
Argon), at low temperature (room temperature, about 20°C) in the dark or diffuse light, 
under acid free conditions and peroxide free solvents. The usual indication of carotenoid 
breakdown is bleaching, i.e. loss of the colour, due to breakage of the chromophore. A 
variety of breakdown products have been detected, most often apocarotenoids of various 
chain lengths, produced by cleavage of any of the double bonds in the polyene chain 
(Palozza and Krinsky, 1992b; Liebler, 1993). Similar products are derived from the 
chemical reaction between carotenoids and singlet oxygen or other oxidising agents.
Geometrical (cis-trans) isomerisation occurs readily when carotenoids are exposed to 
factors such as heat and light (Britton, 1995). As most carotenoids of interest are highly 
lipophilic and they are virtually insoluble in water, supplying these compounds in a
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bioavailable form has been a major problem. This has been achieved in several ways. 
Tetrahydrofuran (THF) has been widely used as a solvent since its introduction for this 
purpose (Bertram et al., 1991). If suitable precautions are taken, this solvent is not toxic 
and produces a pseudo-emulsion with high bioavailability (Cooney et a l, 1993). A 
second successful method of delivery involves incorporating carotenoids in liposomes. 
Here too adequate uptake of carotenoids into cells has been demonstrated. An 
increasing number of carotenoids are also available commercially in the form of 
beadlets composed of a protein and carbohydrate matrix containing micro-dispersed 
carotenoid in oil-control beadlets are also available, containing all of the packaging but 
no carotenoid. (the principal disadvantage of these beadlets is that they contain 90% 
packaging material that includes antioxidants).
1.7 Aims and Objectives
The aim of this study is to investigate the modulation of the level of UVA induced 
transcriptional activation of heme oxygenase 1 (HO-1) by p-carotene and lycopene. 
Previous studies have shown that the UVA induced HO-1 gene activation occurs via 
singlet oxygen mediated pathway. Carotenoids are potent singlet oxygen quenchers and 
they are expected to suppress the UVA induced HO-1 mRNA accumulation.
Objectives
Experiments were designed to investigate whether cultured FEK4 cells take up intact 
(the lipophilic and oxygen labile) all-trans-p-carotene and to select an appropriate 
method for the delivery of p-carotene to FEK4 cells in culture.
In order to determine this, the time kinetics of p-carotene uptake by FEK4 cells, its 
stability in the growth medium of cultured FEK4 cells in different growth phases 
(exponentially growing, confluent and growth arrested cells), as well as the time 
kinetics and the level of uptake of lycopene by exponentially growing FEK4 cells and 
the isomerisation pattern of lycopene in cells and medium will be monitored.
As detailed in the introduction, there is evidence that specific isomers and metabolites 
of P-carotene might be involved in the biological activity of the carotenoid, so the level 
of isomerisation, retinol and apocarotenal formation in cells will be monitored in sham 
and UVA irradiated cells.
43
Published literature is consistent with the notion that carotenoids (including (3-carotene) 
can promote health when taken at dietary levels, but may have adverse effects when 
taken in high dose.
In order to establish the modulation of UVA (100 and 250 kJ/m2) induced HO-1 mRNA 
by (3-carotene, the cells will be incubated with a large range of concentrations of the 
carotenoid in the cell culture medium prior to irradiation. This will be examined in 
detail and UVA dose response experiments will be carried out following incubation of 
FEK4 cells with a single concentration of P-carotene in the medium.
The experiments with lycopene will be based on the same principles.
We also plan to test the modulation of UVA induced HO-1 mRNA levels in different 
growth phases of FEK4 cells, since especially growth arrested cells resemble more the 
state in which dermal fibroblasts are found in human skin.
Real Time Reverse Transcription Polymerase Chain Reaction will be developed to 
replace the Northern Blot Analysis for measurements of the ratio of HO-1 mRNA 
versus GAPDH in experimental samples, as this is a very sensitive technique.
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2 MATERIALS AND METHODS
2.1 Chemicals and Reagents.
All the chemicals used were supplied by BDH, Dorset, UK., except for:
-  99% all-trans-p-carotene and 96.7% all-trans lycopene (provided by Hoffman-La 
Roche, Switzerland).
-  Tetrahydrofuran (THF 99.7% containing 0.025% BHT), Ethanol (99.7-100%) and 
(3-[N-morpholino] propanesulphonic acid) (MOPS) (Sigma, Aldrich, UK).
-  Foetal calf serum (PAA laboratories, GmbH, Linz, Austria).
-  Phosphate Buffered Saline (PBS) (Oxoid, Basingstoke, UK).
-  32P dCTP (Amersham, Buckinghamshire, UK).
-  Sodium carbonate, Glutamine, Penicillin and Streptomycin, Trypsin, Trizol 
reagent, oligo (dT^-is) primers, primers PI, P2, P3, P4, Gl, G2, R1 and R2 (5 
pM), Platinum Taq DNA polymerase, Superscript II RNase H' Reverse 
Transcriptase and Superscript First Strand Synthesis System for RT-PCR (Gibco 
BRL, Life Technologies, Scotland-Invitrogen, Paisley, UK).
-  SYBR Green I containing Taq DNA polymerase, reaction buffer, dNTP mix, 
SYBR Green I dye, and lOmM MgCl2  (Roche Diagnostics, East Sussex, UK ).
-  Hind III (10 000 units/ml), EcoR I (60 000 units/ml) (Promega, UK).
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2.2 Cell culture
The normal human skin fibroblast cell line FEK4 (Tyrrell and Pidoux, 1986) was 
derived from a foreskin biopsy and cultured routinely in Earle’s modified minimal 
essential medium (EMEM) supplemented with 15% (unless otherwise noted) foetal calf 
serum (FCS) (inactivated at 56°C for 45 minutes), glutamine (2mM), sodium 
bicarbonate (0.2% w/v), penicillin and streptomycin (50 IU/ml each). Cells were 
passaged by trypsinization once a week and were used for experiments between 
passages 11 and 13. Three different growth phases of FEK 4 were employed in our 
experiments (described as follows) in order to determine if this would affect the 
experimental outcome. In all experiments, cell monolayers were UVA irradiated after a 
three-day incubation period with the p-carotene solutions.
Growth arrested FEK4 monolayers. As previously described (Tyrrell, 1984) fibroblasts 
were seeded at a density of 3X105cells per 10cm dish in a 15%FCS growth medium. 
After they reached a confluency of approximately 60% (2.5 days), the medium was 
removed, medium traces washed off with PBS and a 0.5% FCS cell culture medium was 
introduced to the dishes. Cells were incubated for a further week prior to the addition of 
the P-carotene solutions to the conditioned medium.
Confluent FEK4 monolayers. Fibroblasts were seeded at a density of 3.5X105 per 10cm 
dish and grown to 100% confluency in four days prior to the introduction of the 
appropriate p-carotene solutions to the cell culture medium.
FEK4 in exponentially growing phase. The p-carotene or lycopene in THF solutions 
were added at initial seeding. For experiments with p-carotene the seeding density was 
3.5X105 cells per 10cm dish and cell monolayers were UVA irradiated after a 3.5 day 
incubation period, when the FEK4 monolayers were 85-95% confluent. For experiments 
with lycopene the seeding density was 4X105 cells per 10cm dish and cell monolayers 
were UVA irradiated after a 3.5 day period.
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Carotenoid solutions. The P-carotene or lycopene 2mM stock solutions in THF and 
appropriate dilutions of the stock solution were prepared in a glove box under Argon, 
gas-tight sealed and frozen (-80°C) to be used for experiments within a week.
A wavelength scan of each carotenoid in THF determined that the X,max for P-carotene is 
459nm and 479nm for lycopene in this solvent and that the range of concentrations that 
can be measured with this method is 2-5 pM.
After appropriate dilutions, spectrophotometry was performed to confirm the 
concentration of each p-carotene or lycopene solution to be added to the cell cultures 
(molar extinction coefficients in THF e 135110 cm2/mol, A,max 459 for p-carotene (Fig. 
3.1.4-1) and s 212620 cm2/mol, A,max480 for lycopene (Fig. 3.1.4-2)).
2.2.1 Delivery of carotenoids to the cultured cells.
In order to evaluate the best method for introducing p-carotene into FEK 4 cell cultures 
two methods were initially tested for their efficacy in delivering intact all-trans-p- 
carotene into the cells. The delivery systems were compared using either THF or 
THF/EtOH (1:1) and were tested beforehand for cytotoxicity (trypan blue dye exclusion 
assay). Neither of the solvents was found to be toxic to the cells at concentrations in the 
cell culture medium <0.5% for THF and <1% for THF/EtOH. Experiments were 
performed with final concentrations 1.5 and 4.5 pM P-carotene in the medium with the 
two carrier systems. At the selected intervals, (2.5, 5,24, 48, 72h) the cellular content in 
P-carotene was evaluated by HPLC analysis (Hoffman-La Roche laboratories) (see 
Appendix 1.1 for a description of the HPLC methodology used). Cell pellets were 
dispatched to Hoffman La Roche after thorough washing of the cell monolayers 
(Phosphate buffered saline (PBS) containing 2% bovine serum albumin (BSA) 6x5min 
at 37°C). This washing protocol was shown to be the most effective in preventing p- 
carotene from sticking to the outer surface of cells in preliminary experiments 
(unpublished results, R.G., Basel, Switzerland). The results of experiments performed to
47
compare the effectiveness of 6 different washing protocols are described in detail in 
Appendix 2.
Following the washing step the cells were detached from their plates by trypsinisation, 
pelleted and the cell pellets frozen (-80°C). In parallel, the stability of P-carotene in the 
growth medium under cell culture conditions was monitored (over the same period of 
time and at the same time intervals).
After the evaluation of the two methods for delivery of carotenoids to FEK4 cells THF 
was used as a delivery system of p-carotene and the cell monolayers were thoroughly 
washed (PBS+2%BSA 6x5min at 37°C) before UVA (or sham) irradiation. After the 
first experiments on modulation of UVA HO-1 mRNA by p-carotene that did not give 
reproducible results (results not shown) and in order to reduce a possible source of 
error, the final concentration of THF (containing 0.025% BHT) was 0.3% in all cell 
culture dishes of all experiments. The optimum time for introducing p-carotene to the 
cell culture for the purposes of this study proved to be at initial seeding, as the levels of 
HO-1 mRNA induction by UVA were lower at later times.
The protocol used for the delivery of p-carotene to FEK4 cells was used also for the 
delivery of lycopene to FEK4 cells. The protocol used for the HPLC analysis of content 
of medium samples and cell pellets in all-trans- and cis-lycopene is described in detail 
in Appendix 1.2.
2.3 UVA source and irradiation conditions
Cell populations grown at 85-100%confluency were irradiated using a UVASUN 3000 
lamp (Sellas, Munich, Germany), which emits broad-spectrum UVA light. The UVA 
dose was measured using an IL 1700 radiometer (International Light, Newbury, RI, 
USA). Irradiation was carried out to give total UVA doses of 50,100,200 and 250kJ/m2 
at a controlled room temperature of 25°C.
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Prior to irradiation, medium was removed and retained. The cell monolayers were 
washed 6X5min with PBS+2%BSA at 37°C and finally rinsed with PBS. Cells were 
UV- or sham irradiated in PBS supplemented with Ca2+/Mg2+ (0.01% each). After 
irradiation the original medium was added back and the cells incubated for 4-4.5h. The 
total time during which the cells were in PBS was 1.5-2 h prior to readdition of the 
original media.
2.4 Measurement of UVA induced HO-1 mRNA 
accumulation
Expression of the human HO-1 gene is induced by UVA at levels that permit 
modulation by carotenoids to be monitored. THF with 0.025% BHT was used as a 
delivery system for P-carotene and lycopene and for all experiments the cell monolayers 
were thoroughly washed (PBS+2%BSA, six times for 5 min) before UVA irradiation. 
The optimum time for introducing the carotenoids to the cell culture proved to be at 
initial seeding.
Total RNA was extracted from cells by the one step acid guanidinium 
thiocyanate/phenol/chloroform method or with Trizol® (Chomczynski and Sacchi, 
1987). The cells were lysed in 4 M guanidinium thiocyanate solution (0.5% sodium N- 
laurylsarcosine, 25 mM sodium citrate (pH 7.0) and 0.1 M p-mercaptoethanol. Protein 
extraction was done with water-saturated phenol and chloroform: isoamyl alcohol 
(49:1). RNA was redissolved in RNase -free water and quantified by absorption 
spectrophotometry. The HO-1 mRNA was measured either by Northern Blotting, 
Taqman or by Real Time PCR (LightCycler).
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2.4.1 Northern Blotting
First lOpg/sample total RNA was electrophoresed on a 3-[N-morpholino] 
propanesulphonic acid (MOPS)/formaldehyde agarose (1.3%) gel and transferred to a 
Zeta-Probe (Biorad, Hercules, CA, USA) nylon membrane by capillary blotting. After 
transfer, membranes were baked for 2 h at 80°C, prehybridised and hybridised at 68°C. 
Prehybridisation and hybridisation solutions were 7%SDS, 250 mM NaHPC>4 , lmM 
ethylenediamineacetate (EDTA). The HO-1 cDNA probe used was a lOOObp Eco RI 
fragment of the human heme oxygenase clone 2/10 (Keyse and Tyrrell, 1989). The 
glyceraldehyde phosphate dehydrogenase (GAPDH) GAPDH cDNA probe was a 
1400bp Hind III7 Eco RI fragment of the rat GAPDH gene. cDNA probes were 32P- 
labelled using a high prime enzyme kit (Boehringer Mannheim) according to 
manufacturers instructions, the labelled cDNA probe was then purified using Elutip-D 
column (Schleider and Schuell, Germany). Membranes were pre-hybridised and 
hybridised in a 7% w/v SDS, 250mM Na2 HP0 4 , lmM ethylenediaminetetraacetate 
(EDTA). The 32P-labelled HO-1 probe was added to the hybridisation solution. After 
hybridisation non-specifically bound probe was washed from the membrane using SDS 
(at a final concentration of 0.1% w/v) and 20X SSPE (3M NaCl, 0.2M Na2HP0 4 , 
20mM EDTA, pH 7.4). Washings were performed twice with 6X SSPE for 5 minutes 
at 37°C, twice with IX SSPE for 15 minutes at 37°C and twice with 2X SSPE for 15 
minutes at 68°C. The membranes were sealed in a plastic bag and exposed to a 
phosphorimager screen. After autoradiography, the HO-1 cDNA probe was stripped 
from the membrane by boiling in 0.3% w/v SDS (twice for 30 min each time), and blots 
were re-probed with the GAPDH cDNA probe for an internal control of loading 
between samples. RNA levels were quantified using a phosphorimmager (Molecular 
Dynamics, Sunnyvale, CA, USA) and use of the software; Image Quant 3.3.
2.4.2 Reverse transcriptase (RT)- PCR
RT-PCR represents a sensitive and powerful method for RNA analysis (Freeman et al, 
1999; Lie and Petropoulos; 1998, Ahmed et al., 1995) since it enables the detection and 
measurement of very low levels of mRNA, which are normally below the detection
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limit of other conventional methods. However, many errors could be introduced in the 
mRNA quantitation by RT-PCR. The RT-step is the source of most variability in a 
quantitative RT-PCR experiment. The reverse transcriptase is sensitive to salts, alcohols 
or phenol remaining from the RNA isolation. Inter-tube and inter-experiment variations 
are common in RT reactions (Freeman et al., 1999). For compensating for the 
variability of the efficiency of the reverse transcriptase reaction a reference gene can be 
assayed together with the unknown target and their final ratio evaluated (Orlando et al, 
1998). For relative quantification of RNA it is possible to use a DNA standard curve. 
Doing this requires the assumption that the reverse transcription of target genes is the 
same in all samples, but the exact efficiency of this process does not need not to be 
known. Following the RT reaction, the cDNA of target genes is amplified by PCR. We 
initially aimed to set up the conditions for competitive PCR quantitation of HO-1 
mRNA levels as previously described (Ahmed et al., 1995), but at the same time we had 
the opportunity to use Real Time PCR, a method that is increasingly used after reverse 
transcription (RT) for mRNA quantitation.
Two methods were used for the reverse transcription of the total RNA samples. 
METHOD 1.
Prior to reverse transcription, total RNA samples were treated with RQ1 Rnase-free 
DNase I (10 U/pl) and incubated at 37°C for 30 minutes, to degrade any contaminant 
DNA in the RNA samples. The reaction was set up as seen in Table 2.4.2-1. This step 
was followed by the addition of RQ1-DNase stop solution, 10 min incubation at 65°C 
and quick chill on ice to inactivate RQ1 Rnase-free DNase I. As a control for DNase 
treatment and also DNA contamination in the RNA samples, identical samples with no 
DNase treatment and a Nuclease free (NF) water control were included in every 
experiment at this point. For first strand cDNA synthesis, 2 pi of 50 pM oligo dTi2 -i8 
were added to 10 pi (1 pg) of the DNase treated RNA and this mixture was denatured at 
70°C for lOmin and immediately chilled on ice. A mixture of first strand buffer (5X), 
DTT, dNTPs in excess and RNasin ribonuclease inhibitor was prepared in the 
meantime, under the DNA free PCR hood to avoid contamination of the reagents with 
DNA. One pi of Superscript II (RT samples) or 1 pi of NF H2 O for the -RT controls
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(samples containing RNA which was not reverse transcribed) were added at this point to 
each sample. Finally, 12 pi of denatured RNA (1 pg) was added to give the final 20 pi 
reverse transcription mixture, see Table 2.4.2-2
Reactants Amount Final concentration
Total RNA sample 2 n g 0.1 pg/pl
First Strand Buffer (5x) 4 nl lx
Rnase-free Dnase I (10 
U/pl)
2 pi 20 units
NF H20 Up to 20 pi -
Total Volume 20 pi
Table 2.4.2-1 Removal of genomic DNA from total RNA by Rnase-free Dnase I. Samples 
were reverse transcribed at 42°C for 60 min, 95°C for 5 min and held at 4°C in a 2200 Perkin 
Elmer Thermocycler.
Reactants Volume per PCR 
tube (pi)
Final concentration
First strand Buffer (5X) 4 lx
DTT(lOOmM) 1 5mM











Table 2.4.2-2 Protocol for the reverse transcription of RNA using Superscript II RNase H 
Reverse Transcriptase.
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The newly synthesized cDNA was used as a template for conventional PCR 
amplification as follows:
A volume of 11.2 pi from each cDNA sample was prepared for PCR reaction. The 
oligonucleotides used to amplify a 242 bp fragment of the HO-1 gene corresponding to 
nucleotides 1198 to 1440 bp region of the published heme oxygenase sequence 
(Yoshida et a l , 1988), F: 5’-CCT TGT TGA CAC GGC CAT GAC CAC-3’ (PI), and 
R: 5’-AGT TAG ACC AAG GCC ACA GTG CCG-3’ (P2). The primers were 
purchased from GIBCO BRL, Life Technologies, UK.
Also the expression of GAPDH gene was monitored. The two oligonucleotides used to 
amplify a 178 bp fragment of the GAPDH gene were F: 5’-GAC ATC AAG AAG GTG 
GTG AA-3’ (Gl) and R: 5’-TGT CAT ACC AGG AAA TGA GC-3’ (G2).
For a final volume of 50 pi, the reaction mixture contained 5 pi 10XPCR buffer, lpl 
dNTP (0.2 mM each), 5 pi primer PI (0.6 pmoles), 5 pi primer P2 (0.6 pmoles), 0.5 pi 
of Platinum Taq Polymerase (2.5 U), 1.5 pi MgCk (50mM) and 31 pi NF water. The 
reaction mix was covered with 30 pi of paraffin oil to minimise evaporation. The 
polymerase reaction was initiated with a denaturation and enzyme activating step at 
94°C for 5 minutes and carried on for 35 cycles with the following steps: denaturation 
step (94°C for 30sec), annealing step (61°C for 30sec), extension step (72°C for 30sec) 
(last elongation step 7min). After the completion of the PCR reaction a 17 pi aliquot 
mixed with 3 pi of 6 x Loading Buffer was electrophoresed on a 2% agarose gel to be 
visualised
METHOD 2
cDNA synthesis was carried out using products from Life Technologies (lOx RT- 
buffer, dNTPs, MgCL, random hexamers, RNase H and Superscript II RNase H' 
Reverse Transcriptase (RT)).
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For cDNA synthesis and -RT controls (samples containing RNA which was not reverse 
transcribed), tubes with 3 jug RNA, 10 pi random hexamers (50 ng/pl), 2 pi dNTPs (10 
mM) and DEPC-treated water added to a volume of 20 pi were heated at 65°C for 5 min 
and then cooled on ice for at least 1 min. An 18 pi RT-premix containing 8  pi (25mM) 
MgCb, 4 pi lOx RT Buffer, 4 pi DTT (100 mM) and 2 pi (80U) RNase Inhibitor was 
added to the RNA containing mixture (total volume 38 pi). From this mixture 19 pi 
were separated in a different tube for cDNA synthesis and 1 pi (50U) of Superscript II 
was added to each tube. The cDNA and the -RT mixtures were incubated at room 
temperature for 10 min, at 42°C for 50 min, at 70°C for 15 min and then cooled on ice. 
One pi (2U) of RNase H was added to the cDNA samples followed by an incubation at 
37°C for 20 min. Finally the reactions were diluted 10 fold in DEPC treated water. Both 
the quality of the cDNA product and the absence of contaminant DNA in the -RT 
samples were tested with a conventional polymerase chain reaction (PCR) reaction that 
was run on a 2200 Perkin Elmer Thermocycler. The PCR amplifications were 
performed using primers: F: 5’-GAC CGT TCA GCT GGA TAT TAC-3' (RI) and R: 
5'-GAC ATG GAA GCC ATC ACA GAC-3' (R2) and visualised on a 2% agarose gel 
with ethidium bromide (EtBr). This reverse transcription protocol was followed by real 
time PCR using the ABI PRISM 7700 Sequence Detector (Taqman) (Hoffman La 
Roche Laboratories, Switzerland) or the LightCycler® (Roche Molecular Systems, 
Mannheim, Germany) (Home Lab).
2.4.2.1 Real Time Taqman PCR
This approach utilises the inherent 5’-3’ exonuclease activity of Taq DNA polymerase to 
cleave a specific oligonucleotide dual-labelled probe annealed to the target sequence 
during PCR amplification (Lie and Petropoulos, 1998; Holland et al., 1991). The probe 
is labelled with a reporter fluorophore at the 5’end of the probe and with a quencher 
fluorophore at the 3’ end. Cleavage of the probe during strand elongation releases the 
reporter from the probe and thus its proximity to the quencher, resulting in an increase 
in the reporter emission intensity. The cycle at which the emission intensity of the 
sample rises above the baseline is referred to as the theshold cycle (Ct) and is inversely 
proportional to the copy number of the target template. A duplex Taqman PCR was run
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to assess the level of HO-1 cDNA for each sample, with use of rRNA as an internal 
control in each PCR reaction well. Briefly, a 74bp fragment of the HO-1 cDNA was 
amplified by using the primers: F: 5’-AAG AGG CCA AGA CTG CGT TC-3' (P3) and 
R: 5-GGT GTC ATG GGT CAG CAG C-3’ (P4). A Taqman probe, 5’FAM (6 -carboxy 
fluorescein)-TCA ACA TCC AGC TCT TTG AGG AGT TGC AG-3’ TAMRA (6 - 
carboxy tetramethylrhodamine), which was designed to cover the exon3-exon 4 
boundary in the cDNA was included in the Taqman PCR Master Mix. The rRNA primer 
sequences were: F: 5’-CGG CTA CCA CAT CCA AGG AA-3’, R: 5’-GCT GGA ATT 
ACC GCG GCT-3’ and the Taqman rRNA probe VIC-5’-TGC TGG CAC CAG ACT 
TGC CCT C-3’-TAMRA (6 -carboxy tetramethylrhodamine).
2A.2.2 Real Time PCR LightCycler® (Roche Molecular Systems, 
Mannheim, Germany)
Following reverse transcription, Light Cycler Real time PCR was run to assess the level 
of HO-1 and GAPDH cDNAs for each sample using the double-strand-specific dye 
SYBR Green I. After developing the methodology (described in section 3.5.2) the 
standard protocols for PCR amplifications were as described in this paragraph. 
PCR reactions of a final volume of 18 pi containing 2 pi SYBR Green I, 1. 6  pi MgCh 
(25 mM), 2 pi each primer (5 pM) and 10.4 pi PCR grade water were prepared under 
the PCR Hood. To this mixture 2 pi aliquots of reverse transcribed RNA were added. 
The standard protocol for PCR amplification of a 74bp fragment of the HO-cDNA by 
using the primers: F: 5'-AAG AGG CCA AGA CTG CGT TC-3' and R: 5'-GGT GTC 
ATG GGT CAG CAG C-3' consisted of an initial denaturation step at 95 °C for 30sec 
followed by 30 cycles of 95 °C (Osec), 52°C (15sec), 72 °C (4sec), 81°C (3sec). The 
protocol for PCR amplification of a 178bp fragment of the GAPDH cDNA by using the 
primers F: 5’-GAC ATC AAG AAG GTG GTG AA-3' and R: 5’-TGT CAT AAC AGG 
AAA TGA GC-3' consisted of a denaturation step at 95°C for 30 sec followed by 40 
cycles of 95°C (0 sec), 55°C (5 sec), 72°C (7 sec). After the cycling protocol, a final 
step was applied to all reactions by monitoring fluorescence as a function of 
temperature transition at a rate of 0.2 °C/sec to generate a melting curve for each
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reaction (95 °C Osec, 55 °C 15sec, 95 °C Osec). Serial dilutions of linearised HO-1 
plasmid were used as template DNA at copy numbers ranging from 2.7x10 to 2.7x10 
to produce the standard curve. For the quantitation of the housekeeping gene GAPDH a 
human cDNA control probe (Clonetech laboratories, USA) was used as template DNA 
at copy numbers ranging from 8.3xl04to 8.3x107 to produce the standard curve for the 
quantitation of this gene. For each sample the ratio of copy numbers was calculated and 
normalised against control values.
2.5 Statistical analysis
Data are given as the arithmetical mean ± SD, n=3-4. Significances were calculated 
using Student’s t-Test. For the duplicate measurements on duplicate dishes, the data are 
given as the arithmetical mean of four measurements and the minimum and maximum 




3.1 Kinetics of P-carotene uptake by FEK4 cells and stability 
in medium under cell culture conditions.
3.1.1 Uptake of P-carotene by confluent FEK4 cells and stability in cell 
culture medium.
Two delivery methods were compared for their effectiveness in delivering p-carotene at 
1.5 and 4.5 pM concentrations from the culture medium to confluent normal human 
skin fibroblasts. The first involved a 1:1 mixture of tetrahydrofuran (THF) with ethanol 
(EtOH) with daily medium and P-carotene solution changes, and the other used THF 
and a single initial addition of p-carotene to the medium of FEK4 monolayers. Neither 
of the solvent combinations were found to be toxic to cells at concentrations in the cell 
culture medium of 0.5% for THF and <1% for THF/EtOH (Trypan blue dye exclusion 
assay) (results not shown). These solvent concentrations were not exceeded in our 
experiments. At the selected intervals (2.5, 5, 24, 48 and 72h) the cellular content of p- 
carotene was evaluated by HPLC analysis (Roche Vitamins A.G., Basel) (Nierenberg et 
a l , 1989).
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Briefly, after thorough washing of the cell monolayers (PBS+2% BSA, 6x5min at 37°C) 
the cells were detached from their plates by trypsinization, pelleted, and the pellets 
frozen (-80°C) for analysis. The stability of p-carotene in the growth medium under cell 
culture conditions was monitored at the same time intervals. Although THF without 
antioxidant is also well tolerated by FEK4 cells at this concentration, it has been 
reported to be occasionally cytotoxic after extended storage, possibly because of 
peroxide formation (Bertram et al., 1991). THF containing 0.025% BHT was therefore 
used in all our studies. Precipitation has been reported to occur upon addition of p- 
carotene solutions in THF (Bertram, 1991; Offord et al., 2002). No precipitation of p- 
carotene was observed upon addition of the p-carotene solutions to the cell culture 
medium with either of the tested methods, as determined with light microscopy.
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Fig. 3.1.1-1. Time dependence of cellular uptake of p-carotene. p-carotene uptake by 
confluent FEK4 cells when cultured for three days with 1.5 pM concentration in the growth 
medium, using either THF or THF/EtOH as a carrier. Results shown are the means of duplicate 
measurements on duplicate dishes, the minimum and maximum values represented as -.
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With both the carrier systems, the uptake was time- and concentration- dependent. The 
delivery of p-carotene to FEK4 was optimal when THF was used as a carrier. The 
uptake was 2.5 or 4 fold lower when the THF/EtOH mixture was used to deliver P- 
carotene from 1.5 or 4.5 pM in the medium respectively (Figs. 3.1.1-1,-2[M KT4]). 
The maximum cellular p-carotene concentration achieved was 220 pmol/106cells, after 
a 3-day incubation with p-carotene dissolved in THF applied to the cell monolayers at a 
final medium concentration o f 4.5 pM.
2 5 0
THF 4 .5  |iM p-carotene 
THF/EtOH 4.5 p-carotene
2 0 0 -
a>c
! ~  <5 =o ocL o
•E §
C :=
2  Ec  s i  
o  o
^ E»= CL






7 00 10 20 3 0 4 0 5 0 6 0
Time (h)
Fig. 3.1.1-2 Time dependence of cellular uptake of P-carotene. P-carotene uptake by 
confluent FEK4 cells when cultured for three days with 4.5 pM concentration in the growth 
medium, using either THF or THF/EtOH as a carrier. Results shown are the means of duplicate 
measurements on duplicate dishes, the minimum and maximum values represented as -.
The P-carotene concentrations in the cell culture medium were monitored over a three 
day period with both the delivery methods, p-carotene concentration in the medium 
remained constant when using THF/EtOH as a vehicle for the delivery of P-carotene to 
FEK4 cells. It should be noted, however, that this method included daily changes of 
medium and p-carotene solutions. The method using THF as vehicle for the delivery of 
P-carotene to FEK4 cells included a single addition of P-carotene in THF solutions and
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[3-carotene in the medium depleted in the 3 day observation period in a concentration 
dependent manner (Figs. 3.1.1-3,-4). The depletion of p-carotene in three days was 
calculated using the formula: (Initial p-carotene medium concentration -  p-carotene 
medium concentration 3 days later) xlOO/ Initial P-carotene medium concentration] and 
this gave a value of 3.3% when the initial concentration of p-carotene added to the 
medium was 1.52 pM. The amount o f p-carotene taken up by confluent FEK4 cells 
from this concentration was 61.78 pmoles. This amount accounts for the 24.7% of the 
difference between the initial medium concentration and the medium concentration after 
3 days (0.05 pM).
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Fig. 3.1.1-3. Stability of P-carotene 1.5 pM in the medium. Stability of 1.5 pM P-carotene in 
the medium of confluent FEK4 cells over a three-day period, using either THF (single addition) 
or THF/EtOH (daily medium and p-carotene solution changes) as a carrier. Results shown are 
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Fig. 3.1.1-4. Stability of p-carotene 4.5 pM in the medium. Stability of 4.5 pM p-carotene in 
the medium of confluent FEK4 cells over a three-day period, using either THF (single addition) 
or THF/EtOH (daily medium and p-carotene solution changes) as a carrier. Results shown are 
the means of duplicate measurements on duplicate dishes, the minimum and maximum values 
represented as -.
With THF/EtOH as a vehicle for the delivery of P-carotene to FEK4 cells no depletion 
was observed, because of the daily medium changes. With THF as a delivery system of 
P-carotene to FEK4 cells, depletion of a higher concentration (4.5 pM) of p-carotene in 
the medium reaches a level of 23.5% of the original concentration in three days. 
[MKT5]The amount of p-carotene taken up by confluent FEK4 cells by 4.5 pM in the 
medium (0.24 nmoles) accounts for the 4.5% of the difference between the initial P- 
carotene medium concentration and the medium concentration three days later.
For all the remaining following experiments we used THF as a carrier for delivering p- 
carotene to FEK4 cells, as higher cellular p-carotene levels would be expected to 
modulate the UVA induced HO-1 gene expression more effectively and the incubation 
time was at least 3 days (range 3-3.5).
In order to weigh p-carotene and prepare the p-carotene solutions to be added to the 
sterile cell cultures, procedures are carried out in the glove bag under inert gas, as even 
traces of oxygen could lead to rapid oxidation of the compound (Britton, 1995). The
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compound must also be shielded from light to avoid photo- bleaching and photo- 
isomerisation. Furthermore, the amounts of 99% all-trans-P-carotene are limiting. Each 
aliquot of crystalline p-carotene weighed out in the glove bag was approximately 1 0  
mg. After preparing the P-carotene solutions in THF (THF, containing 0.025% BHT), 
the solutions were measured spectrophotometrically and the volumes to be added to the 
cell cultures adjusted appropriately to correct for possible weighing errors. However, 
using this approach BHT, present in the solvent, ranged in the culture medium from 3.8 
to 5.8 pM. BHT is a well known lipophilic antioxidant and has been shown to slightly 
modulate UVA induced HO-1 accumulation (Kvam et al., 1999; Basu-Modak et al., 
1996). Bearing this in mind, for all following experiments we used the solvent at a 
constant volume concentration in the medium (0.3%) and measured the carotenoid 
solutions spectrophotometrically only as a rough control for errors. The final medium 
concentration in p-carotene was assessed by HPLC analysis that enables an accurate 
measurement not only of content in carotenoids but also of isomer and metabolite 
formation (Nierenberg et al., 1989; Stahl et a l, 1992; Liu et a l , 2000). It has been 
strongly suggested that investigators working with carotenoids in cell culture 
incorporate HPLC analysis of carotenoid stability, cellular concentrations and 
metabolism into their investigations in order to interpret the data obtained (Clinton, 
1998). A chromatogram of standards and typical chromatograms of the separation of p- 
carotene and metabolites in medium samples and cell pellets are shown in (Figs. 3.1.1-5 
A, B, C). From comparison with the standards on Fig. 3.1.1-5A the peak in Fig. 3.1.1- 
5B is identified as all-trans p-carotene and the peaks in Fig. 3.1.1-5C (from left to right) 
as apocarotenals, all-trans- and cis-P-carotene, respectively.
Interest in the cis-isomers of the carotenoids has been stimulated by the recognition of 
isomer specific biological functions that exist for the retinoids and may exist for the 
carotenoids (Stahl and Sies, 1993). We performed experiments designed to observe 
uptake of the carotenoid by FEK4 cells, stability in their growth medium, as well as 
isomerisation and apocarotenal formation in cells and medium samples.
P-carotene uptake from 1.1, 2.2 and 3.3 pM in the medium by FEK4 cells when THF 
was used at a constant volume concentration in the medium (0.3%) to deliver the 
carotenoid to the cells was time and concentration dependent (Fig. 3.1.1-6). The
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maximum cellular P-carotene concentration achieved was approximately 200 
pmol/million cells. In cells p-carotene cis-isomers were present at a range between 3 
and 6% of total p-carotene and apocarotenals at levels equivalent to 1.5-6% of total p- 
carotene (Fig. 3.1.1-7) whereas, no isomerisation or apocarotenal formation was 
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Fig. 3.1.1-5. Separation of carotenoids. (A) A mixture of 12’, 8 ’ and 4’apo-P-carotenals, all- 
rra«5-/-carotene, 13-c/5-/-carotene and (3-cryptoxanthin pelargonate (I.S.) in cell extracts 
prepared as described in Appendix 1. The compounds were detected by their absorbance at 450 
nm, sensitivity: 0.01 a.u.f.s. The separation was achieved with a flow rate of 1.5 ml/min 
producing a back pressure of 72 bar. (B) A chromatogram from a medium sample and (C) from 
the corresponding cell extract. The HPLC analysis was performed in Hoffman La Roche, Basel, 
Switzerland by G.Riss and the cell were cultured and incubated with p-carotene in the 
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Fig. 3.1.1-6. Time and concentration dependence of 3-day cellular uptake of P-carotene by 
confluent FEK4 cells. Beta-carotene uptake by confluent FEK4 over a 3-day period, when 
cultured with 3 different p-carotene concentrations (1.1, 2.2 and 3.3 pM) in the medium, using 
THF as a carrier. Results shown are the means of duplicate measurements on duplicate dishes, 
the minimum and maximum values represented as -.
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Fig. 3.1.1-7. Percentage of cis-p-carotene and apocarotenals of total cellular (3-carotene in 
confluent FEK4 cells. Percentage of cis-(3-carotene and apocarotenals of total cellular (3- 
carotene from 1.1, 2.2 and 3.3 pM in the medium over a 3-day period, using THF as a carrier. 
Results shown are the means of duplicate measurements on duplicate dishes, the minimum and 
maximum values represented as -.
As in the previous set of experiments, p-carotene in the medium depleted in a 
concentration dependent manner (Fig. 3.1.1-8). The maximum percentage of depletion 
of 1.1, 2.2 and 3.3 P-carotene was the depletion of 3.3 pM p-carotene in the 
medium and was approximately 20% (Fig. 3.1.1-9). The quantity of P-carotene taken up 
by confluent FEK4 cells at this concentration (3.3 pM) accounted for only the 5% of the 
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Fig. 3.1.1-8. Stability of 1.1, 2.2 and 3.3 pM P-carotene in the medium of confluent FEK4 
cells. Stability of 1.1, 2.2 and 3.3 pM p-carotene in the medium of confluent FEK4 cells over a 
three-day period, using THF as a carrier. Results shown are the means of two measurements. 
The minimum and maximum values represented as -. The signs for minimum and maximum 
values are not shown when they are almost identical to the means.
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Fig. 3.1.1-9. Concentration dependence of p-carotene depletion. Percentage of depletion of 
initial P-carotene concentration in three days relative to initial concentration. [%Depletion= 
(Initial p-carotene concentration -p-carotene concentration after 3 days/ Initial -p-carotene 
concentration) xlOO].
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3.1.2 Uptake of P-carotene by exponentially growing FEK4 cells and 
stability in the cell culture medium.
In order to monitor the uptake of p-carotene by FEK4 cells under the optimum 
conditions for measuring UVA induced HO-1 mRNA accumulation in cultured 
fibroblasts and to optimise our experimental conditions accordingly, we performed 
experiments to monitor uptake of p-carotene by exponentially growing FEK4 cells.
We introduced p-carotene to the cell cultures at the time of initial seeding and adjusted 
the seeding density so that the fibroblasts would be in exponentially growing phase and 
at numbers that would give a sufficient RNA yield for Northern Blot analysis 3.5 days 
later (3.5x105 cells/1 Ocm dish), the day of UVA irradiation of FEK4 cultures. To enable 
monitoring of cellular p-carotene levels under these conditions, a range of p-carotene 
concentrations (0.08, 0.3, 0.9, 2.5, 9.0 and 23.0 pM) was added to the growth medium 
of exponentially growing FEK4 cells at initial seeding and the cells were incubated for 
three days, point at which cells were detached from their plates, pelleted and frozen to 
be sent for HPLC analysis (See Methods).
Cellular p-carotene concentration increased with increasing levels of p-carotene in the 
medium at the lower concentrations tested (0.08, 0.3, 0.9, 2.5 pM) but reached a plateau 
at medium concentrations greater than 2.5 pM (Fig. 3.1.2-1). The maximum cellular p- 
carotene concentration achieved was - 2 0 0  pmol/1 0 6cells (equivalent to ~8 nmol/g wet 
tissue (IARC Working Group for the Evaluation of Cancer, 1998).
Isomerization of all-trans-p-carotene to its cis- isomers (9- and 13-cis-p-carotene) 
occurred in cells and the maximum isomerization level observed was 17%.
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Fig. 3.1.2-1. Concentration dependence of 3 day cellular uptake of P-carotene by 
exponentially growing FEK4 cells. Uptake of P-carotene by FEK4 when cultured for 3 days 
with 6 different p-carotene concentrations (0.08, 0.3, 0.9, 2.5, 9 and 23 pM), in the growth 
medium. Results are means +/- SE, n=5-8.
The extent of isomerization decreased as the medium concentrations applied to the 
cultures and the cellular levels of p-carotene increased (Fig. 3.1.2-2). The formation of 
apocarotenals in FEK4 followed a different pattern and detectable metabolism or 
degradation of cellular P-carotene to apocarotenals occurred only at the higher cellular 
P-carotene levels. The extent of apocarotenal formation in cells appears to be dependent 
on the cellular FEK4 p-carotene content and on the p-carotene medium concentration. 
It was different between the concentrations that resulted in a cellular p-carotene 
concentration of -200 pmol/million cells reaching a maximum of 18% conversion of 
total cellular p-carotene to apocarotenals in cells incubated with 23 pM p-carotene for 3 
days and with cellular P-carotene level -200 pmol/ million cells (Fig. 3.1.2-2).
6 8
1 . 0 - i
Fraction cis-p-carotene/ total p-carotene 
Fraction apocarotenals/ total p-carotene3  0 .9 -
% 0.20 io
op. ® 0 .1 8 - 
(A  0 )
m •H n _
0.04 -
0 .0 2 -
u_ 0.00
0.3 23.02.5
p -caro tene in m edium  (nM)
Fig. 3.1.2-2. Concentration dependence of fraction apocarotenals and cis—P-carotene of 
total cellular P-carotene. Apocarotenal formation and isomerisation of cellular P-carotene in 
FEK4 cultured for 3 days with 5 different p-carotene concentrations (0.3, 0.9, 2.5, 9 and 23 
pM), in the growth medium. Results are means +/- SD, n=4-6.
In preliminary experiments performed in Hoffman La Roche laboratories by A. Wyss to 
measure mRNA expression of p’,P-carotene-15, 15’ monooxygenase (central cleavage 
enzyme) and of 9’-10’ dioxygenase (excentric cleavage enzyme) in samples from FEK4 
cells it was shown that the only enzyme present at the mRNA level was 9’-10’ 
dioxygenase, which catalyses the cleavage of p-carotene to apocarotenals.
Under the conditions described above for monitoring of uptake of p-carotene by 
exponentially growing FEK4 cells, P-carotene added to the medium degraded during the 
3-day incubation period and the effect increased as a function of increasing carotenoid 
concentrations (0.08, 0.3, 0.9, 2.5, 8.7 and 23 p M ). When calculated as (Initial p- 
carotene medium concentration -  p-carotene medium concentration 3 days later) xl00/ 
Initial p-carotene medium concentration) it is clear that the depletion reaches a level of 
90% for the highest concentration used (23 pM) (Fig. 3.1.2-3). The amount of P- 
carotene taken up by exponentially growing FEK4 cells cannot account for the depletion 
from the medium, as it corresponds to 0.09-11.23% of the observed loss from the 
medium.
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Similar to the observations made in the medium of confluent FEK4 monolayers, no 
isomerization of all-trans-(3-carotene to its cis-isomer occurred in the medium under cell 
culture conditions during the three-day period, whereas in cells, cis-isomers were 
detected.
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Fig. 3.1.2-3. Concentration dependence of (3-carotene depletion. Percentage of depletion of 
initial (3-carotene concentration in three days relative to initial concentration. [%Depletion= 
(Initial p-carotene concentration -p-carotene concentration after 3 days/ Initial -p-carotene 
concentration ) xl00]. Results are means +/- SE, n=8.
Uptake by exponentially growing FEK4 cells from 1, 2.7, 3.3 pM p-carotene in the 
medium seeded at a density o f 3x l05 cells per 10cm dish reached a level of 
approximately 300 pmol/million cells in three days (Fig. 3.1.2-4). This cellular 
concentration of p-carotene in FEK4 cells exceeds that observed when the cells were 
seeded at higher a density of 3.5x105 cells per 10 cm dish and incubated for three days 
with 0.9 and 2.5 pM p-carotene in the medium (-110 and 180 pmol/million cells,
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respectively) (Fig. 3.1.2-1). A similar finding of increased cellular uptake when cells are 
seeded at low densities has been previously described (Iftikhar et al., 1996).
Fractions of cis-p-carotene and apocarotenals occurred in cells at levels 0.02-0.03 and 
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Fig. 3.1.2-4. Uptake of P-carotene by exponentially growing FEK4 cells from 1,2.7 and 3.3 
pM in the growth medium. Uptake of P-carotene by FEK4 when cultured for 3 days with 3 
different p-carotene concentrations (1, 2.7 and 3.3 pM), in the growth medium. Results shown 
are means, of duplicate measurements on duplicate dishes minimum and maximum values 
shown as -.
P-carotene at concentrations of 2.7 and 3.3 pM in the growth medium of exponentially 
growing FEK4 cells depleted, and the depletion of p-carotene in the medium of cells 
increased with increasing concentrations. The maximum percent depletion observed was 
-40%  at the highest concentration used (3.3 pM) (Fig 3.1.2-5). Consistent with our 
previous observations no detectable isomerization or apocarotenal formation occurred in 
the medium.
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Fig. 3.1.2-5. Stability of |3-carotene in the medium at concentrations of 1.0, 2.7 and 3.3
pM. Stability of (3-carotene at concentrations 1.0, 2.7 and 3.3 pM in the 
medium of exponentially growing FEK4 cells over a three day period, using THF as a carrier. 
Results are the means of two measurements on medium samples from two dishes; the minimum 
and maximum values represented as -. The signs for minimum and maximum values are not 
shown when they are almost identical to the means.
3.1.3 Uptake of p-carotene by growth arrested FEK4 cells and 
stability in the cell culture medium.
The uptake of p-carotene by growth arrested FEK4 cells was monitored under 
conditions as close as possible to the conditions we used for monitoring uptake by 
FEK4 cells in exponentially growing phase (see Materials and Methods). When arrested 
cell populations (pre-equilibrated for 7 days in 0.5% serum medium) were incubated 
with P-carotene at concentrations 1, 1.8 and 2.5 pM in the medium for 3 days, the 
maximum cellular content in P-carotene was ~60 pmol/million cells (Fig. 3.1.3-1). 
There was no evidence of a concentration dependence of the uptake in the range 
between 1 and 2.5 pM. When compared to the uptake of p-carotene by FEK4 in other 
growth phases the cellular content in p-carotene in growth arrested cells was lower with 
uptake being 2-4 fold lower from medium concentrations in the range between 1 and 2.5
7 2
pM. Isomerization and apocarotenal formation from all-trans-p-carotene occurred in 
growth arrested cells and fractions of the sum of 9- and 13-cis-p-carotene as well as 
fractions of apocarotenals were between 0.03 and 0.05.
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Fig. 3.1.3-1 Uptake of P-carotene by growth arrested FEK4 cells, p-carotene uptake by 
growth arrested FEK4 cells in three days by 1, 1.8 and 2.5 pM in the medium. Results are the 
means of duplicate measurements on duplicate dishes, the minimum and maximum values 
represented as -. The signs for minimum and maximum values are not shown when they are 
almost identical to the means.
During the three day observation p-carotene depleted in the medium of growth arrested 
FEK4 cells (Fig. 3.1.3.-2a). In this case as well, no isomerization of all-trans-P-carotene 
nor apocarotenal formation was detectable in the growth medium. Degradation of P- 
carotene in the medium reached a maximum of -30%  depletion of the initial 
concentration in three days (Fig. 3.1.3-2b). The amount of p-carotene lost from the 




Fig. 3.1.3-2.a. Stability of (3-carotene in the medium of growth arrested FEK4 cells.
Stability of 1, 1.8 and 2.5 |iM (3-carotene in the medium of growth arrested FEK4 cells over a 
three-day period. Results are means of duplicate measurements on duplicate dishes, the 
minimum and maximum values represented as -.
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Fig. 3.1.3-2b. Concentration dependence of (3-carotene depletion. Percentage of depletion of 
initial P-carotene concentration in three days relative to initial concentration. [%Depletion= 
(Initial p-carotene concentration -  p-carotene concentration after 3 days /Initial-p-carotene 
concentration ) xlOO]. Results are means of duplicate measurements on duplicate dishes, the 
minimum and maximum values represented as -.
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Overall, the uptake of p-carotene by FEK4 appears to be dependent on their growth 
phase. Exponentially growing FEK4 at low confluency took up P-carotene more readily 
than FEK4 in the other growth phases. The maximum cellular level of p-carotene 
achieved in the three day period from approximately 1, 2, and 3 pM concentrations of 
the carotenoid in the medium was -300 pmol/106cells in exponentially growing cells 
(when seeded at a density of 3xl05 cells per 10 cm dish), -180 pmol/106cells for the 
confluent FEK4 monolayers and -60 pmol/106cells in growth arrested FEK4 cells. 
Detectable isomerization of all-trans-P-carotene to its cis- isomer in the cells and 
metabolism to apocarotenals was observed at all growth phases and at similar levels. 
Cis formation ranged from 2.5 to 5% of total cellular p-carotene and apocarotenal 
formation ranged from 2.5 to 6 % of total cellular P-carotene. Overall, the stability of 
similar p-carotene concentrations (approximately 1, 2, 3 pM) in the medium of FEK4 
cells in different growth phases is greater in the growth medium of confluent FEK4 
monolayers (maximum percentage of depletion - 2 0 %) than in the culture medium of 
growth arrested (maximum percentage of depletion -30%) or exponentially growing 
FEK4 (maximum percentage of depletion -45%).
3.1.4 Spectrophotometry of p-carotene in THF
The p-carotene solutions to be added to the cell cultures were measured 
spectrophotometrically to control for errors in the weighing procedure to prepare 
solutions. To our knowledge the extinction coefficient of p-carotene in tetrahydrofuran 
(THF) is not published and we did the appropriate experiments to define it.
After performing wavelength scans of p-carotene solutions in THF the maximum 
absorption for p-carotene in this solvent was determined to be 459nm. At that 
wavelength we measured the absorption of P-carotene at concentrations ranging from 1 
to 5 pM and calculated the extinction coefficient €=135,110 cm /mol, X m ax  459.
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Fig.3.1.4-1 Standard curve for spectrophotometry of P~ carotene in THF, A,max 459nm. Results 
are means +/- SD, n=3
3.2 D egradation o f  cellu lar P-carotene by U V A  irradiation  o f  
FEK 4 fibroblasts
Degradation of cellular p-carotene content by 250 kJ/m2 of UVA in FEK4 fibroblasts 
was considerable in all growth phases (Fig. 3.2-1,-2,-3). Interestingly, although the 
percentage of degradation of cellular p-carotene was similar for both growth arrested 
and exponentially growing FEK4 cells being approximately 70%, cellular P-carotene 
appears to degrade less in cells forming confluent FEK4 monolayers with a 38% 
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Fig. 3.2-1. Degradation of cellular p-carotene content by UVA 250 kJ/m2 in confluent 
monolayers. Degradation of cellular p-carotene content by UVA 250 kJ/m2 in confluent FEK4 
monolayers Results shown are the means of duplicate measurements on duplicate dishes, the 
maximum and minimum values represented as -.
Sham irradiated 
UVA (250kJ/m2)
Fig. 3.2-2. Degradation of cellular P-carotene content by UVA 250 kJ/m2 in exponentially 
growing FEK4 cells. Results shown are the means of duplicate measurements on duplicate 
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Fig. 3.2-3 Degradation of cellular P-carotene content by UVA 250 kJ/m2 in growth 
arrested FEK4 monolayers. Results shown are means of duplicate measurements on duplicate 
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Fig. 3.2-4 Degradation of cellular p-carotene by UVA (250 kJ/m2). The percentage of 
degradation of cellular p-carotene by UVA (250 kJ/m2) in confluent, exponentially growing 
and growth arrested FEK4 monolayers. Data are derived from Figs 3.2-1,-2,-3.
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Furthermore, in all three cases UVA irradiation (250 kJ/m2) resulted in a significant 
(p<0.05) increase in cellular levels of apocarotenals (Data shown for growing cells only, 
(Fig.3.2.-5).
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Fig. 3.2-5. The level of apocarotenals as a fraction of total cellular (3-carotene content 
following UVA irradiation (250 kJ/m2). Controls are identical sham irradiated FEK4 
monolayers. Results are means of duplicate measurements on duplicate dishes, the minimum 
and maximum values represented as -.
3.3 Kinetics of lycopene uptake by FEK4 cells and stability in 
the medium
3.3.1 Uptake of lycopene by exponentially growing FEK4 cells and its 
stability in the medium.
The uptake of 96.7% all-trans lycopene by exponentially growing FEK4 was monitored 
over a 4-day period. The maximum cellular concentration achieved in the three day 
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Fig. 3.3.1-1. Lycopene uptake by exponentially growing FEK4 cells over 4 days from 1.9, 
3.7, and 6.7 pM lycopene in the medium. Results shown are the means, +/- SD (n=3), or the 
means and minimum and maximum values of duplicate measurements on duplicate dishes, the 
minimum and maximum values represented as -.
In 3 days the maximum cellular content in lycopene was -65 pmol lycopene/million 
cells and was further reduced after the third day of incubation. When exponentially 
growing FEK4 cells were incubated for three days with lycopene at concentrations of 
1.9 or 3.7 pM in the medium, the maximum cellular level observed was -31.7 and -22 
pmol/million cells, respectively. When compared to the level of cellular P-carotene 
concentration of -150 pmol/million cells or -180 pmol/million cells achieved after a 3 
day incubation of exponentially growing FEK4 cells with 2.5 pM or 9 pM P-carotene 
in the medium (see Fig. 3.1.2-1 for comparison) the uptake of lycopene by 
exponentially growing FEK4 cells appears to be 3 to 5 fold lower.
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In cells the isomers detected were all-trans and 5-cis lycopene, the major isomer being 
the all-trans that accounted for 82-100% of total lycopene. The 5-cis isomer not 
detectable on the first day of incubation, accounted for the 5-20% of total lycopene on 
the second day of incubation, and for 5-7% and 3-5% of total lycopene on the third and 
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Fig. 3.3.1-2. Cellular lycopene isomers when cells were incubated with 1.9,3.7, and 6.7 pM 
of the carotenoid in the cell culture medium for 4 days. Results shown are means, minimum 
and maximum values of measurements on duplicate or triplicate dishes, the minimum and 
maximum values represented as The signs for minimum and maximum values are not shown 
when they are almost identical to the means.
The percentage of the 5-cis lycopene isomer of total lycopene in cells was inversely 
related to the concentration of lycopene in the medium of exponentially growing FEK4 
cells. When the cells were incubated with a concentration of 1.9 pM lycopene in the 
medium the percentage accounted for ~ 20% of total cellular lycopene whereas this 
percentage was ~5% when the concentration of lycopene in the medium was 6.7 pM.
The stability of lycopene in the growth medium of exponentially growing FEK4 
monolayers was monitored over a four-day period for three lycopene concentrations 
(1.9, 3.7 and 6.7 pM) in the medium (Fig. 3.3.1-3). Total lycopene in the medium 
depleted rapidly and depletion increased with increasing medium concentrations. After
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a 1-day incubation the % depletion [% depletion = (Initial lycopene concentration - 
lycopene concentration after 1 day/ Initial lycopene concentration) x 100] was 40, 50 
and 59% of initial lycopene medium concentrations of 1.9, 3.7 6.7 pM, respectively. 
The maximum % depletion observed was 75% for the highest concentration tested (6.7 
pM) after a 4-day incubation period.
Three isomers were detected in the growth medium of FEK4 cells all-trans-, 5-cis and 
13-cis-lycopene. On day 1 of lycopene addition to the cell cultures the all-trans 
lycopene and accounted for the 97% of total lycopene in the medium. In all tested 
concentrations of lycopene in the medium this was the major isomer detected and 
accounted for 86-100% of total lycopene in the medium (Fig. 3.3.1-4a). The maximum 
level of 5-cis-lycopene detected was 8% and that of 13-cis-lycopene 6%, when 
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Fig. 3.3.1-3. Stability of 1.9, 3.7 and 6.7 pM lycopene in the medium of exponentially 
growing FEK4 cells. Stability of 1.9, 3.7 and 6.7 pM lycopene in the medium of exponentially 
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Fig. 3.3.1-4a. Percentage of all-trans-lycopene of total lycopene in the growth medium of 
exponentially growing FEK4 cells over a 4-day period. Percentage of all trans lycopene from 
1.9, 3.7 and 6.7 pM initial lycopene concentrations applied to the cell cultures monitored over a 
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Fig. 3.3.1-4b. Percentage of 5-cis-lycopene of total lycopene in the growth medium of
exponentially growing FEK4 cells. Percentage of 5-cis lycopene from 1.9, 3.7 and 6.7 
pM initial lycopene concentrations applied to the cell cultures over a 4-day period. Results are 
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Fig. 3.3.1-4c. Percentage of 13-cis-lycopene of total lycopene in the growth medium of 
exponentially growing FEK4 cells Percentage of 13-cis-lycopene from 1.9, 3.7 and 6.7 
pM initial lycopene concentrations applied to the cell cultures monitored over a four day period. 
Results are means +/- SD, n=3.
Overall, the stability of lycopene, as well as that of p-carotene, in the cell culture 
medium was poor over the three- to four-day observation period. To our knowledge this 
finding is in agreement with all publications regarding delivery of carotenoids in THF. 
We observed a concentration dependent depletion of the carotenoids in the medium. A 
similar finding has been reported by Bertram (1991), who suggested that the relative 
stability of the lower carotenoid concentrations could be attributed to the binding of P- 
carotene to protein components in the medium. Superior stability of carotenoids in the 
medium has been described when carotenoids were introduced to the cell cultures as p- 
carotene enriched bovine serum or in methyl-P-cyclodextrin, nanoparticle and in beadlet 
formulations, but different problems are associated with each delivery system See 
introduction). Precipitation of carotenoids upon addition to the culture medium has been 
occasionally reported (Lowe et al., 1999; Offord et a l,  2002; Bertram et a l , 1991). No 
precipitation was observed in the experiments presented here, as seen macroscopically 
or by use of light microscopy. Furthermore, the isomer composition of the medium 
samples on DayO was identical to that of the carotenoid in the crystalline state,
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indicating that no isomerisation occurred during the preparation of the carotenoid 
solutions in THF.
3.3.2 Spectrophotometry of lycopene in THF
The lycopene solutions to be added to the cell cultures were measured 
spectrophotometrically to control for errors in the prepared solutions. To define the 
extinction coefficient of lycopene in tetrahydrofuran (THF), we performed wavelength 
scans of lycopene solutions in THF and the maximum absorption for lycopene in this 
solvent was defined to be 480nm. At that wavelength we measured the absorption of 
lycopene at concentrations ranging from 1 to 5pM and calculated the extinction 
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Fig. 3.3.2-1. Standard curve for spectrophotometry of lycopene in THF, A.max 480nm. Results 
are the means +/- SD, n=3. Error bars are smaller than the symbol when not shown.
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3.4 Growth Curves
When (3-carotene was added at initial seeding of FEK4 cells at concentrations 0.5, 5 and 
6  |iM it did not significantly affect growth of FEK4 cells in three days, when compared 
to control cells (Fig. 3.4-1). These results are in agreement with published results 
regarding the effect of p- carotene on growth of normal human cells (Frommel et a l, 
1995; Okai and Okai, 1996) p-carotene reduces growth of tumor cell lines (Palozza et 
al., 2001; Iftikhar et al., 1996; Karas et al., 2000; Nara et al., 2001; Prakash et al., 
2001).
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Fig. 3.4-1. Growth curve of FEK4 cells with or without p-carotene 0.5, 5 and 6 pM in the 
medium. Results are means +/-SD, n=3.
Lycopene is well known to induce a growth delay in cancerous cell lines (Karas et al., 
2000; Nara et al., 2001; Ben Dor et al., 2001, Prakash et al., 2001) and this has been 
also observed in normal human fibroblasts (Levy et al., 1995). We performed 
experiments in order to assess whether such an effect occurred in FEK4 cultures when 
incubated with lycopene at concentrations 0.5 and 5 pM in the medium and whether a 
difference between growth of cultures incubated with p-carotene or lycopene would 
become apparent. When the cells were incubated with 5 pM lycopene in the medium we
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observed an approximately 10 hr growth delay. The cell populations incubated with 5 
pM lycopene were reduced after -36 hrs (p=0.05) and after -50 hrs (p<0.05), when 
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Fig. 3.4-2. Growth curve of FEK4 cells with or without lycopene 0.5 and 5 (iM in medium. 
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Fig. 3.4-3. Growth curve of FEK4 cells with or without P-carotene or lycopene 5 pM in the 
culture medium. Results are means +/-SD, n=3.
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3.5 R eal Tim e PC R  L ightC ycler
3.5.1 Description of the LightCycler Real Time PCR
Basic Description of the Instrument. The LightCycler (Fig. 3.5.1-1) consists of an 
upper unit and a lower unit. The upper unit contains the heating coil. The lower unit 
contains the thermal chamber, fluorimeter, drive units, electronic boards and power 
supply. Hot or ambient temperature air, introduced into the thermal chamber, regulates 
the temperature of the sample capillaries. A heating coil heats the air, which is then fed 
into the chamber by a fan.
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Fig. 3.5.1-1 Schematic of the LightCycler. The figure is reproduced from the LightCycler 
Operator's Manual Version JS
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The fan ensures efficient air circulation and temperature homogeneity during the 
heating cycle and operates at a higher speed to ensure adequate cooling during the 
cooling cycle. Within the thermal chamber is the sample carousel. The carousel holds 32 
samples in glass capillaries that serve as cuvettes for fluorimetric determination of the 
PCR products formed. The glass capillaries permit reaction volume to be 10-20 pi. 
Their optimised surface-to-volume ratio guarantees rapid thermal transfer within the 
reaction mixture. As a result, the temperature transition times during PCR are fast and 
the total time that is required for each cycle is approximately 20 seconds. The thermal 
chamber is directly connected to the optical system of the fluorimeter that is used for 
detection purposes. A blue diode (LED) with maximum emission of 470 nm serves as 
the energy source for sample excitation. Fluorescence is detected at 530 nm, 640 nm, 
and 710 nm with the aid of photohybrids. For measurements, a stepper motor rotates 
the sample carousel to position the capillary tip at the focal point of the fluorimeter 
optics. For online display, data are transmitted to and from a PC via a serial interface.
Programming and Run. To perform a LightCycler run, the protocol for thermocycling 
and fluorescence acquisition has to be programmed, i.e. the temperatures for 
denaturation, annealing and extension have to be determined as well as the respective 
times. Additionally, the location for data acquisition events needs to be specified, as 
well as sample information and other settings, for later data analysis. The LightCycler 
Run Software provides the tools for programming the experimental protocol which 
serves as the running pattern for multiple LightCycler runs, displays appropriate screens 
for performing and monitoring the LightCycler Run, loads the programmed data in the 
LightCycler instrument, starts and controls the machine and stores the acquired data on 
the PC.
Principles of Fluorimetric Online Detection. There are two different methods for 
online detection and evaluation of fluorimetric PCR reactions in glass capillaries. The 
PCR products formed during the PCR reaction may be detected via either: fluorophores 
that bind to all double-stranded DNA molecules regardless of sequence, e.g., the 
double-stranded DNA binding dye SYBR Green I, or fluorophores coupled to sequence- 
specific oligonucleotide hybridization probes that only detect certain PCR products.
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In this study, the sequence-independent detection with SYBR Green I was used, a dye 
that binds specifically to double-stranded DNA (dsDNA). Its inherent fluorescence is 
enhanced when it binds to the minor groove of double-stranded DNA. During PCR, 
SYBR Green I binds to DNA products as they are synthesised. Thus, the increase in 
SYBR Green I fluorescence, when measured at the end of each elongation cycle, 
indicates the amount of PCR product formed during that cycle. The LightCycler 
measures the fluorimetric intensity of SYBR Green I at the end of each elongation 
phase. The maximal emission of DNA stained with SYBR Green I occurs at 521 nm. 
When a LightCycler PCR run is started, the monitor switches to the ‘run screen’ that 
displays actual fluorescence values, the development of fluorescence during the run, and 
the actual temperature online.
Display and Analysis of Quantification Data. For analysis of quantification data, the 
LightCycler Software only considers fluorescence values measured in the exponentially 
growing phase of the PCR amplification process. This phase is referred to as the ‘log- 
linear’ phase, because the exponential curve is transformed to a linear curve upon 
logarithmic plotting. Both methods used for quantification with the LightCycler 
Software (Fit Points Method and Second Derivative Maximum Method) refer to the log- 
linear phase of PCR for quantification. Analysis during log phase permits many genes 
(over a wide input target range) to be analysed under comparable conditions, without 
concern of reaching reaction plateau at different cycles (Heid et al, 1996). Comparable 
fluorescence values of different samples and standards are then used to define a 
standard curve, where concentrations can be allocated to the Crossing Points.
Crossing Points represent cycle numbers, at which fluorescence signal reaches an 
arbitrary but defined threshold value within the early exponential phase of the reaction. 
The Crossing Point is dependent on the starting amount of target in the sample -  and is 
inversely related to the amounts of starting material (Higuchi et a l, 1993). This 
relationship is used for quantitative analysis with the LightCycler software.
Quantification Methods. Two different methods for quantification can be used with 
the LightCycler Software: the Fit Points Method and the Second Derivative Maximum 
Method. Both methods are generating standard curves to calculate unknown samples.
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For standard curve, the standard concentrations are plotted versus the crossing points (or 
threshold cycles). The two methods differ in the way of threshold cycle determination.
In the Fit Points Method, the quantitative analysis of PCR data is influenced by the user, 
in the adjustment of the noise band and of the baseline. The Fit Points method requires a 
setting of baselines to a comparable level, to allow comparison of crossing point values 
of different samples in the same LightCycler run and between different runs. To restrict 
the quantification to the exponentially growing PCR part, selection of Fit Points number 
should be restricted to the linearly plotted phase of the PCR (in the semi-logarithmic 
plotting) curve.
The Second Derivative Maximum Method for quantification is automatically 
determining the crossing points for the individual samples. This is achieved by a 
software algorithm, which identifies the first turning point of the fluorescence curve, 
which serves as the Crossing Point in this calculation method. This turning point 
corresponds to the first maximum of the second derivative curve, thus explaining the 
name of the method. Both methods for quantification of cDNA levels are efficient. 
MgCL concentration needs to be optimised for PCR efficiency, as judged by the 
crossing point of each PCR amplification and by a good separation of melting peaks of 
products and by-products. This enables fluorescence measurement at a temperature at 
which primer-dimers will be denatured.
Display and Analysis of Melting Curve Data. A melting curve is produced following 
the completion of PCR, in which the fluorescence of the samples is monitored while the 
temperature is increased. Briefly, a melt program that is included in all LightCycler 
protocols using SYBR Green I as detection fluorophore is linked to the cycling 
program. It contains three steps: a rapid denaturation step, a short hold at optimum 
annealing temperature and a slow denaturation step. During the final denaturation step, 
fluorescence is acquired continuously or stepwise (0.2 °C) to generate a high resolution 
melting curve for every sample. Due to the melting behaviour of DNA, fluorescence 
will decrease with the increase of temperature. In case of the SYBR Green I format, this 
is due to the separation of double strands and consequently the release of SYBR Green I 
molecules, resulting in a drop in fluorescence near the denaturation temperature. The
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melting curve of a PCR product depends on GC content, length and sequence, PCR 
products can be distinguished by their melting curves (Gonzalez and Saiz-Jimenez, 
2002; Ririe et al., 1997). The LightCycler software differentiates the melting curve data 
and the first negative derivative (-dF/dT) is displayed versus temperature, showing the 
melting peak(s) for each PCR product. The area under the peak is calculated by the 
LightCycler data analysis software. The peak area has a relationship to the relative 
amount of nucleic acid. For example, in SYBR Green I experiments, the size of the 
peaks representing each product will show a correlation to the amount of each product.
Relative Quantification Using Melting Peak Analysis. Although there is a 
relationship the Peak Area and the amount of nucleic acid contributing to the peak, 
conclusions have to be made carefully when using this tool. Experiments are required to 
provide more details on this interdependency. For an appropriate approach, it is 
important to consider that non-specific fluorescence has to be minimised for peak 
comparison. One of the factors that may influence experimental results when using this 
method is MgCb concentration in PCR reactions. In order to optimise MgCl2  
concentration for amplifications on the LightCycler to be analysed by melting curve 
analysis the aim is to have that concentration in the reaction mixture that will give the 
most robust melting peak and will not favour the formation of primer dimers. The 
balance of distance and ratio between peaks for the product and by products (i.e. primer- 
dimers), the area under peak and the height of the peak all need to be evaluated.
Real Time Fluorimeter (RTF). The Real Time Fluorimeter (RTF) allows continuous 
monitoring of fluorescence of one sample and can be used to adjust the fluorimeter 
gains (enhancement factors in the fluorescence measuring channels) at comparable 
levels between different runs (LightCycler Software version 3).
3.5.2 Developing the methodology
Real time PCR is a technique several fold more sensitive than Northern Blot Analysis 
(Higuchi et al, 1993; Freeman, 1999) that allows measurement of the expression of 
multiple genes in the same sample with accuracy. However it is a relatively new
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technique which has to be carefully set up for the specific experiments to be carried out 
and to be controlled for possible errors (Freeman et ol, 1999).
In order to gain some much needed relevant experience with the new technique, we 
initially used duplex Taqman Real Time PCR in Hoffman La Roche (Switzerland), as 
guests in a laboratory in which Real Time PCR had been successfully used for assessing 
relative gene expression. With this method (see Materials and Methods) we analysed 
samples for HO-1 cDNA using rDNA as an internal control from experiments on which 
northern Blot analysis had already been performed to enable comparison of 
experimental results with the two methods. With this method we also analysed 
experiments with FEK4 cells in different growth phases treated with or without UVA 
250kJ/m and 1, 2 and 3 pM concentrations of p-carotene (results not shown). 
However, in the case of arrested cells threshold cycle (Ct) values for the internal control, 
were diverse and highly indicating very low and variable levels of rDNA in the reverse 
transcribed RNA samples. In cell extracts from cells that are growth arrested under 
serum starvation specific rRNA synthesis in vitro can be suppressed by a polymerase-I 
transcription inhibitory activity (PIN) (Kermekchiev and Muramatsu, 1993). This 
activity changes under different physiological states of the cell and reaches a maximal 
level soon after serum depletion and disappears readily when the cells are allowed to 
recover in serum rich medium. Through these first experiments valuable experience was 
gained and also the knowledge that rRNA was not a suitable internal control for 
measuring HO-1 cDNA levels in FEK4 cells at different growth phases.
3.5.2.1 Melting Peaks Analysis (Light Cycler)
The first method we used for analysing samples for HO-1 mRNA/ GAPDH mRNA 
levels with the LightCycler was the ‘melting peaks analysis’. When more than one 
primer sets are included in the PCR reaction mixture of samples reverse transcribed 
from total RNA, peak areas can be used to measure relative cDNA concentrations. In a 
well controlled experiment the ratio between peaks can be used for assessing the
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relative concentrations of up to three genes (LightCycler manual; Bernard et al., 1998; 
Oleastro et a l , 2003).
The major objective was to measure the ratio of HO-1 mRNA/GAPDH mRNA in RNA 
samples from FEK4 cells rather than quantitating mRNA levels and therefore we 
followed the approach that allows the direct measurement of the ratio of the target gene 
mRNA versus reference gene mRNA in the same sample.
The design of P3 and P4 primers for HO-1 had already been proved to be successful in 
preliminary experiments with Taqman Real Time PCR (Hoffman La Roche 
Laboratories) and there was a long experience in the lab with the G1 and G2 primers for 
GAPDH. In order to optimise the Light Cycler PCR reactions with these primers we 
tested for the optimum primer annealing temperatures and for optimum MgCL 
concentrations for robust PCR reactions under the specific conditions. The optimum 
annealing temperature was 52°C for the primers P3 and P4 and 55°C for the primers G1 
and G2. Both sets of primers worked at a satisfactory level in LightCycler PCR 
amplifications, at a primer annealing temperature of 52°C. After performing 
LightCycler Runs of serial dilutions of HO-1 and GAPDH linearised plasmids and 
reverse transcribed samples, the optimum plasmid concentration for measuring HO-1 
and GAPDH cDNAs in RT samples from our experiments was determined to be 
approximately 104 and 106 copies/pl, respectively. We tested the effect of MgCb 
concentration at concentrations ranging from 2 to 6  mM on the amplification of 
2.68x104  copies of a XhoI/BamHI linearised HO-1 plasmid with the primers P3 and P4 
and the optimum MgCL concentration was found to be 3 mM. Representative 
LightCycler results are shown on (Fig. 3.5.2.1-1A, B, C). The Tm of the HO-1 
amplicon was 85.7°C. The amplification of a Hindlll/EcoRI linearised GAPDH plasmid 
was optimum at a MgCh concentration of both 3 and 4 mM. The Tm of the PCR 
product was 90.5°C (results not shown).
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Fig. 3.5.2.1-1. Dependence of PCR amplifications on the concentration of MgCl2.
(A) At MgCl2 concentrations 3, 4, 5 and 6 mM the amplification of 26,800 copies of 
XhoI/BamHI linearised HO-1 plasmid was equally efficient and the crossing points were 
identical (B) Melting curves of amplifications with 3, 4, 5 and 6 mM MgCl2 in the PCR reaction 
mixture and (C) their corresponding melting peaks. When 3 mM MgCl2 is used, the peak is 
more robust than with the other MgCl2 concentrations tested (4, 5 and 6 mM).
95
In view of these findings it should be feasible to run both reactions under the same PCR 
conditions (primer annealing temperature 52°C and 3 mM MgCb). The elongation time 
was chosen to be adequate for the elongation of the longest amplicon (GAPDH).
Real Time PCR amplification reactions of 2 p.1 RT aliquots were performed with 
primers for HO-1 and GAPDH cDNA (primers P3, P4, G l, G2) at a final concentration 
of 0.5 mM each and the ratio of the two cDNAs was calculated using melting curve 
analysis. The PCR amplification protocol used consisted of an initial denaturation at 
95°C for 30s followed by 30 cycles of 95°C for Os, 52°C for 5s, 72°C for 8s. With this 
cycling protocol the PCR amplification reactions of RT samples were in the exponential 
phase and did not reach a reaction plateau. The experimental result showed that there is 













Fig. 3.5.2.1-2. HO-1 versus GAPDH ratio analysed with Melting Peaks analysis. The ratio 
HO-1 cDNA vs GAPDH cDNA in two RT samples from FEK4 cells treated with UVA 
250kJ/m2 and incubated for 4 h post irradiation, as seen on the LightCycler melting peaks 
analysis screen. The respective amplicons are distinguished by their corresponding Tm, which is 
85.7°C and 90.5°C for the HO-1 and GAPDH amplicons respectively.
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The change of the ratio of HO-1 cDNA versus GAPDH cDNA in RT samples from 
FEK4 cells 4 hours after UVA (250 kJ/m ) irradiation over that in RT samples from 
corresponding sham irradiated controls, as seen on the melting peaks analysis screen 
with the LightCycler is shown on Fig 3.5.2.1-3. In this case, the fold increase of HO-1 
cDNA (normalised over GAPDH) in the RT samples from UVA irradiated FEK4 cells 
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Fig. 3.5.2.1-3. The ratio of HO-1 cDNA versus GAPDH cDNA in RT samples from UVA 
(250 kJ/m2) and sham irradiated FEK4 cells. The black and red lines correspond to two RT 
samples from UVA (250 kJ/m2) irradiated FEK4 cells and the blue and green lines correspond 
to two RT samples from sham irradiated controls. The peaks corresponding to the HO-1 and 
GAPDH cDNA amplicons are distinguished from their melting temperatures that are 
85.7°C and 90.5°C, respectively. In this case, the fold increase of HO-1 cDNA (normalised 
over GAPDH) in the RT samples from UVA irradiated FEK4 cells was calculated to be 
approximately 9 fold over control values.
The first LightCycler experiments were run on samples in which the fold increase of 
HO-1 mRNA induction by UVA had already been quantified with Northern Blot 
analysis (vs GAPDH) and Taqman Real time PCR (vs rRNA), to enable direct 
comparison of the experimental results (Fig. 3.5.2.1-4). The comparison of the analysis 
of HO-1 mRNA accumulation 2, 4, 6, and 8 h after UVA (250 kJ/m2) irradiation of 
FEK4 cells with the three methods shows a similar pattern of induction, although the 
fold accumulation of HO-1 mRNA vs reference gene does not compare in absolute 
values.
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The fold induction when measured with Taqman Real time PCR is higher when 
compared with the same induction measured with other two methods. The difference 
almost certainly arises from a more accurate estimate of the very low levels of basal 
gene expression that will strongly affect the calculated fold increase. The melting peaks 
analysis with the LightCycler gave the lowest values when compared to Northern Blot 
analysis and Taqman. However, the results compared well with published results 
showing a maximum fold increase of HO-1 mRNA accumulation by UVA (250 kJ/m ) 
six hours after irradiation (Applegate et al., 1995b; Kvam et al., 1999).
Northern Blot Analysis 
Taqman Real time PCR 







0 1 2 3 5 6 7 84
Time (h)
Fig. 3.5.2.1-4. HO-1 mRNA kinetics after UVA irradiation (UVA 250kJ/m2). Fold increase 
of HO-1 mRNA over control values 2, 4, 6, and 8 hours after UVA irradiation (UVA 250kJ/m2) 
as measured with the Taqman assay, Northern Blot Analysis and Melting peaks analysis with 
the LightCycler. The results shown are the mean values from two experiments, with the 
exception of Northern Blot Analysis (results of a single experiment).
With this method we also analysed the ratio of HO-1 cDNA vs GAPDH cDNA levels in 
reverse transcribed (RT) samples from experiments in which growth arrested or 
exponentially growing FEK4 cells had been treated with or without UVA irradiation 
and p-carotene. A repeated observation was that in samples where the HO-1 mRNA 
induction was predicted to be (or had been already shown to be with of Taqman and 
Northern Blot analysis) relatively high, the melting peaks analysis could not always
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calculate the ratio of HO-1 cDNA /GAPDH cDNA. Such an example as seen in the 
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Fig. 3.5.2.1-5. The melting peaks analysis screen from a RT sample with large ratio of HO-1 
cDNA/GAPDH cDNA. The melting peaks analysis screen for a RT sample from exponentially 
growing FEK4 cells irradiated UVA (200 kJ/m2) following a 3 day incubation with 1 jiM 13- 
carotene in the medium. In this case, the ratio of HO-1 cDNA/GAPDH cDNA could not be 
quantified.
Additionally, a concern regarding the accuracy of this method for quantitation of 
relative gene expression is related to the fact that this is based on fluorescence 
measurements acquired from the final phase of PCR amplifications (Wittwer et a l , 
1997). We also performed an experiment with HO-1: GAPDH plasmids at copy number 
ratios of 10:1, 5:1, 2:1 and 1:1. The range of total copy number decreased in the order 
10:1, 5:1, 2:1 to 1:1 and was between 2.2xl04  and 11.9xl04  in the PCR reactions. The 
reactions with a higher HO-1: GAPDH ratio (10:1 and 5:1) reached a plateau whereas 
the reactions with a smaller HO-1: GAPDH ratio (2:1 and 10:1) did not. The results do 
not reflect the ratio of plasmids that were used as target templates (Table 3.5.2.1-1).
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For the reasons mentioned above, the decision was taken to replace the method for the 
quantitation of relative HO-1 mRNA levels.
Plasmid ratio HO-1 GAPDH HO/GAPDH Fold increase 
over 1 : 1
HO-1: GAPDH (1:1) 41.3 6.3 6.6 1.0
HO-1: GAPDH (2:1) 43.3 4.8 9.2 1.4
HO-1: GAPDH (5:1) 51.6 4.9 10.6 1.6
HO-1: GAPDH (10:1) 50.9 3.6 14.1 2.1
Table 3.5.2.1-1. Results of Melting Peaks Analysis of PCR amplifications of HO-1 and 
GAPDH linearised plasmids. Melting peaks analysis of HO-1: GAPDH at ratios of 1:1, 2:1, 
5:1 and 10:1. Results shown are from a single experiment.
3.5.2.2 Estimation o f HO-1 and GAPDH mRNA levels with use of 
crossing points o f PCR amplification reactions with the Second 
Derivative Maximum and Fit Points method (LightCycler software 
version 3).
The method used to assess the level of HO-1 and GAPDH cDNAs for each sample was 
replaced by the Second Derivative Maximum Method or the Fit Points method with use 
of the double-strand-specific dye SYBR Green I.
The crossing point of each sample is dependent on the starting amount of target in the 
sample -  and is inversely related to the amounts of starting material. This method is 
based on the generation of a standard curve in which crossing points of PCR 
amplifications are allocated to serial dilutions of template DNA.
1 0 0
Since, intercalating dyes such a SYBR Green I bind non-specifically to DNA duplexes, 
non-specific amplification products such as primer-dimers can contribute to the 
fluorescence signal and result in inaccuracies in quantitation. We did not repeat the 
experiments for optimum MgCL concentration. MgCh was used at a concentration of 3 
mM in the PCR reactions and resulted to a good separation of peaks for PCR products 
and non-specific PCR by-products. However, in the case of HO-1 plasmid 
amplification, primer-dimers were contributing to the measured fluorescence, as seen 
from the melting curve analysis. The melting temperatures of the non specific PCR by­
products were in the range between 60°C and 80°C (results not shown). Therefore, 
fluorescence measurements in LightCycler runs for the determination of HO-1 cDNA 
levels in each sample were programmed to be taken at a temperature of 81°C after the 
end of the elongation step (72°C) in each PCR cycle.
In order to determine the levels of HO-1 cDNAs in RT samples we included in each 
LightCycler run serial dilutions of a XhoI/BamHI linearised HO-1 plasmid from the 
human heme oxygenase clone 2/10 (Keyse and Tyrrell, 1989) at copy numbers ranging 
from 2.7x103 to 2.7x107. Serial dilutions of a HindllUEcoRl linearised GAPDH 
plasmid of the rat GAPDH gene at copy numbers ranging from 5.4x10 to 5.4x10 or 
from 5.4xl04  to 5.4xl07 were included in each LightCycler run for GAPDH cDNA 
quantitation in RT samples. The quantitation was based on the crossing points of the 
plasmid dilutions that were included in duplicate in each LightCycler run. However, in 
this way a large inter-run variability was observed and measurements of the same 
sample in different runs, using the same method, gave a different value for HO-1 and 
GAPDH cDNA. This happened despite the fact that the standard curve produced 
appeared to have an excellent regression (R ~1). An illustrating example of the results 
from one of the first experiments for quantitation GAPDH levels with this method is 
shown on (Fig 3.5.2.2-1),
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Fig. 3.5.2.2-1. Standard curve for the amplification of a rat GAPDH plasmid with primers
G1 and G2. Serial dilutions of the rat GAPDH plasmid at copy numbers ranging from at copy 
numbers ranging from 5.4x103 to 5.4x106 are included in duplicate for the determination of the 
GAPDH c DNA content in RT samples. The analysis is carried out with the Fit Points 
Method [Thermal profile of PCR amplification of a 178 bp fragment of the GAPDH cDNA: a 
denaturation step at 95°C was for 30 sec followed by 30 cycles of 95 for Osec, 52 for 5sec, 72 
for 8sec].
An inter-run variability for measurements with the LightCycler has been previously 
described as well as a variation of measurement depending on the position of the sample 
on the LightCycler carousel (Wilhelm et al., 2000). This variation was shown to be 
independent of primer annealing temperatures and times as well as denaturation time.
We therefore looked for another solution and followed the approach described by Paton 
et al. (2000) and programmed the fluorescence gains (acquisitions) of the LightCycler to 
be the same at each run by using the Real Time Fluorimeter (RTF) for a control sample. 
The crossing points were determined with use of the ‘Fit Points method’. To derive the 
standard curve, the cycle at which each dilution reached an arbitrary fluorescence (value
3.0) was plotted against the logarithm of the initial copy number of the plasmid. The 
quantitation was based on the crossing cycle of each sample, which was then 
extrapolated to the standard curve (Figs. 3.5.2.2-2 and -3). For each sample the ratio of 
copy numbers was calculated. The HO-1 cDNA and GAPDH quantitation for each 
sample was analysed in triplicate and the profiles of each triplicate coincided 
reproducibly for the HO-1 cDNA, but not for the GAPDH cDNA. Consequently, the 
samples that were analysed with this method for estimation of HO-1 mRNA levels and 
normalised versus the housekeeping gene GAPDH had high errors.
To correct the problem with GAPDH amplification we changed the annealing 
temperature for the primers G1 and G2 to 55°C that had proved to be the optimum 
annealing temperature for these primers. So the standard protocol for PCR amplification 
of a 178bp fragment of the GAPDH cDNA G1 and G2 was changed and the new 
protocol consisted of a denaturation step at 95°C for 30 sec followed by 40 cycles of 
95°C (0 sec), 55°C (5 sec), 72°C (7 sec).
-9.5
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Fig. 3.5.2.2-2 Standard curve for amplification of a 74bp HO-1 amplicon (Fluorescence 
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Fig. 3.5.2.2-3 Standard curve for amplification of a 178bp GAPDH amplicon (Tan 55°C, 3mM 
MgCl2) with the LightCycler. Results show means, n=3.
However, this step did not greatly reduce the error in GAPDH quantitation with the 
LightCycler. We then hypothesized that the problems encountered could be due to the 
use of rat plasmid for deriving the standard curve for the quantification of GAPDH in 
reverse transcribed samples from human FEK4 cells. DNA concentration has been 
shown to differently affect the efficiency of PCR amplifications depending upon the 
source from which the DNA was extracted (Harris and Jones, 1997). The PCR 
amplification product when the rat plasmid is used as DNA template and the amplicon 
of GAPDH cDNA present in the RT samples are different in the percent GC content.
The primers G1 and G2 hybridise to the nucleotides (nts) 829-848 and 978 to 1006 of 
the published human GAPDH cDNA sequence (Arcari et al., 1984) and to the nts 763- 
783 and 921-940 of the published rat GAPDH cDNA sequence (Tso et al., 1985). The 
amplicon after PCR amplification of the rat plasmid and the human is of identical size 
(178bp), but the percent GC content is 52% for the rat amplicon and 57% for the human 
as seen from the direct comparison of the two cDNAs (Tso et al., 1985). A difference in 
% GC content between the two amplicons is depicted in the melting peaks of the 
amplicon of this plasmid and the amplicon in RT samples (Fig. 3.5.2.2-4),
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Fig. 3.5.2.2-4. M elting peaks of PCR products of the rat GAPDH plasmid and of RT 
samples with the primers G1 and G2. The Tm of the amplicon after PCR reactions with the 
primers G1 and G2 using the rat plasmid as DNA template is 87.5°C. The Tm of the amplicon 
after PCR amplification of RT samples from human cells with the primers G1 and G2 is 89.3°C.
The decision was taken to use a commercially available human GAPDH cDNA control 
probe to replace the rat plasmid we used to derive the standard curve and this coincided 
with the update of the LightCycler software (version 3.5). The new method used for 
GAPDH quantitation is described in the next section (section 3.5.2.3).
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3.5.2.3 Measurement of crossing point o f PCR amplification reactions with 
the LightCycler version 3.5
The LightCycler Software 3.5 includes automated Fluorescence gain adjustment and 
bypasses user-defined settings for fluorescence gains. Adjusting the fluorescence 
settings was an important step in the previous protocol to control for inter- run 
variability.
For this reason, the standard curves include a ‘calibrator sample’. At this point the 
concentration of the respective cDNA is assessed in the calibrator sample. The 
‘calibrator is included in all subsequent runs as a standard of defined concentration. In 
subsequent LightCycler runs the calibrator is used to ‘import’ the respective standard 
curve that is stored on the PC. The LightCycler software then calculates the 
concentration of the gene in question in each sample.
The software update coincided with the change of the GAPDH cDNA we used for 
deriving the standard curve. We used a commercially available human GAPDH cDNA 
control probe (Clonetech Laboratories, USA) as template DNA at copy numbers 
ranging from 8.3x 104 to 107 to derive the standard curve for GAPDH quantitation and 
used the LightCycler software version 3.5 for measurements.
These changes did minimise the error in GAPDH quantitation with use of the 
LightCycler and was used for following experiments. There were no further changes 
regarding PCR amplification protocol for measurements of HO-1 cDNA levels.
For following experiments we proceeded with the conditions and PCR reaction 
protocols as described in Materials and methods in section 2.4.2.2.
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3.6 Modulation of UVA induced HO-1 mRNA accumulation 
by carotenoids
For the first experiments presented in section 3.6, the mRNA levels of HO-1 and the 
housekeeping gene GAPDH that was used as a control, were measured by use of 
Northern Blot analysis. For following experiments, real time LightCycler RT-PCR was 
employed for the estimations of HO-1 and GAPDH mRNA levels with the exception of 
one in which Taqman real time PCR was used. In the case of measurements with 
Taqman Real Time RT-PCR the internal control used was rRNA instead of GAPDH. 
The methodology employed each time is clearly stated in text and figure legends.
3.6.1 Modulation of UVA induced HO-1 mRNA accumulation by p- 
carotene.
UVA (100 and 250 kJ/m2) induces HO-1 mRNA accumulation in FEK4 cells at levels 
that permit monitoring its modulation by carotenoids. As shown with use of Northern 
Blot Analysis, p-carotene modulates this induction at medium concentrations of 0.07, 
0.8, 2.3, 8.0 and 21.0 pM in a different manner when the FEK4 monolayers are 
irradiated at a UVA dose of 100 or 250 kJ/m2. At a UVA dose of 100 kJ/m2  and at all 
tested concentrations except for the highest (21 pM) p-carotene appears to be only 
slightly modulating the HO-1 mRNA levels (p>0.05), if at all (Fig. 3.6.1-1). However, 
at a concentration of 21 pM P-carotene, significantly suppressed the UVA induced HO- 
1 mRNA accumulation (p<0.05). On the other hand, at a UVA dose of 250 kJ/m2  P- 
carotene shows a modulation that is clearly p-carotene concentration dependent (Fig.
3.6.1-2). At a p-carotene concentration of 0.2 pM, there was a significant enhancement 
of UVA induced HO-1 mRNA accumulation when compared with the irradiated control 
in the absence of P-carotene (p<0.05). However, at the highest concentrations tested 
(2.3, 8.0 and 21.0 pM) p-carotene exhibits a significant dose-dependent decrease of 
UVA-induced HO-1 mRNA levels. At the two highest concentrations (8.0 and 21.0 pM) 
tested, the HO-1 mRNA levels are lowered to the levels of sham-irradiated FEK4. It
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should also be noted that the difference between the level of suppression of UVA 
induced HO-1 activation at 2.3 pM p-carotene versus 8 and 21 pM is significant 
(p<0.05). It appears that this effect is specific for HO-1 and that the down regulation of 
HO-1 is not due to a general suppression of gene expression in the cell by P-carotene as 
GAPDH levels remain unaffected by the test agents.
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Fig. 3.6.1-1. Modulation of UVA induced HO-1 mRNA accumulation by P-carotene. The
modulation of UVA induced HO-1 mRNA levels (UVA 100 kJ/m2) normalised over GAPDH 
mRNA in FEK4 by 0.07, 0.2, 0.8, 2.3, 8.0 and 21 pM P-carotene. Results are means +/-SD, 
n=3-4. The value for irradiated control in the absence of P-carotene is 7.47±0.39. A typical 
Northern Blot of a single experiment is included. *: Significance level when compared with the 
irradiated control in the absence of p-carotene, p<0.05.
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Fig. 3.6.1-2. Modulation of UVA induced HO-lmRNA accumulation by P-carotene. The
modulation of UVA induced HO-1 mRNA levels (UVA 250 kJ/m2) normalised over GAPDH 
mRNA in FEK4 by 0.07, 0.2, 0.8, 2.3, 8.0 and 21 pM P-carotene. Results are means +/-SD, 
n=3-4. The value for irradiated control in the absence of P-carotene is 5.7±0.6. A typical 
Northern Blot of a single experiment is included. *: Significance level when compared with the 
irradiated control in the absence of P-carotene, p<0.05. **: Significance level when compared 
with the irradiated control in the absence of p-carotene p<0.005.
We also performed Northern Blot analysis of FEK4 cells treated identically without 
including the extensive washing step (see Materials and Methods), to test for the 
importance of this washing step when measuring HO-1 mRNA accumulation. The 
values for UVA induced HO-1 mRNA levels over control obtained from two 
experiments for measuring the modulation UVA (250 kJ/m ) induced HO-1 mRNA by 
0.07, 0.2, 0.8, 2.3, 8.0 and 21 pM p-carotene performed in this way (Fig. 3.6.1-3) were 
different from those with extensive washing (Fig. 3.6.1-2). It appears that p-carotene 
interferes at a variable extent with observations on the modulation of UVA induced HO- 
1 gene expression, when not prevented from sticking to the cell surface by the extensive 
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Fig. 3.6.1-3. Modulation of UVA induced HO-1 mRNA accumulation by p-carotene in 
FEK4 monolayers washed once with PBS. The modulation of UVA induced HO-1 mRNA 
levels (UVA 250 kJ/m2) normalised over GAPDH mRNA in FEK4 by 0.07, 0.2, 0.8, 2.3, 8.0 
and 21 juM P-carotene, as measured with Northern Blot Analysis when the extensive washing 
step was excluded. Results shown are the means of two experiments; the minimum and 
maximum values are represented as -.
The modulation of UVA induced HO-1 mRNA levels (UVA 250 kJ/m2) in FEK4 by 
0.07, 0.2, 0.8, 2.3, 8.0 and 21 pM P-carotene was also measured with a 5’ nuclease PCR 
assay using the ABI PRISM 7700 Sequence detector (Taqman) after reverse 
transcription of each total RNA sample. The internal control used was rRNA. The 
results obtained are similar although fewer samples were included in the measurements 
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Fig. 3.6.1-4. The modulation of HO-1 mRNA induction in FEK4 UVA irradiated at 250 kJ/m2 
by 0.07, 0.2, 0.8, 2.3 and 8.0 pM P-carotene, as measured with Taqman. Results show means 
+/- SD, w=l-3. (Each of the values is the mean of triplicate measurements).
In experiments carried out with Real Time RT-PCR (LightCycler) (Fit Points method) 
to measure the modulation of UVA (100, 200, 250 kJ/m2) induced HO-1 gene 
expression by 1 pM p-carotene no suppression of UVA induced HO-1 mRNA was 
observed at any of the UVA doses tested (100, 200, 250 kJ/m2) (Fig. 3.6.1-5). This is in 
accordance with our previous observations (Figs. 3.6.1.-1, -2). It should be noted, 
however, that in this experiment the HO-1 measurements were normalised against 
GAPDH levels, which were calculated by use of a standard curve derived from serial 
dilutions of rat GAPDH plasmid that introduced errors in normalised measurements.
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Fig. 3.6.1-5. Modulation of UVA induced HO-1 mRNA accumulation by (3-carotene. The
modulation of UVA induced HO-1 mRNA levels (UVA 100, 200 and 250 kJ/m2) normalised 
over GAPDH mRNA in FEK4 by 1 pM p-carotene. Results are means +SD, n=3-4, When no 
error bars are shown the results are means of two experiments.
In additional experiments that were carried out with Real Time RT-PCR (LightCycler) 
[Analysis of crossing point of PCR amplifications] to measure HO-1 mRNA levels it 
was demonstrated that at a concentration of 5 pM P-carotene, the suppression of HO-1 
mRNA accumulation increases with increasing UVA dose applied. A very significant 
suppression of UVA induced HO-1 expression (p<0.005) occurs at the highest UVA 
doses tested (200 and 250 kJ/m2) (Fig. 3.6.1-6).
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Fig. 3.6.1-6. HO-1 mRNA accumulation in FEK4 cells after UVA (100, 200,250 kJ/m2) +/- 
5 pM (3-carotene. The modulation of UVA induced HO-1 mRNA levels (normalised over 
GAPDH mRNA) by 5 pM p-carotene in the medium at different UVA doses (100, 200, 250 
kJ/m2), as measured with Real Time PCR (LightCycler) Results are means +SD, n=3-4.**: 
Significance level when compared with the irradiated control in the absence of p-carotene, 
p<0.005.
3.6.2 Modulation of UVA induced HO-1 mRNA accumulation by 
lycopene.
We have measured the modulation of HO-1 mRNA accumulation induced by UVA (50, 
100 and 250 kJ/m2) in exponentially growing FEK4 cells by 0.1, 0.3, 1.2, 3.0 and 8.8 
pM lycopene using the LightCycler Real-Time PCR [Analysis of crossing point of PCR 
amplifications]. All results were normalised against the housekeeping gene GAPDH. At 
a UVA dose of 50 kJ/m2 lycopene suppressed significantly the UVA induced HO-1 
mRNA accumulation only at the lowest lycopene dose tested (0.1 pM) (Fig. 3.6.2-1). 
However, the observed lack of suppression of UVA (50 kJ/m2) induced HO-1 mRNA 
levels by 0.3, 1.2, 3.0 and 8.8 pM lycopene is most probably due to the low levels of 
induction of HO-1 mRNA accumulation by a UVA dose of 50 kJ/m2 over sham 
irradiated controls. The fold induction of HO-1 mRNA accumulation by this UVA dose 













L ycopene in culture  m edium  (pM)
Fig. 3.6.2-1. Modulation of UVA (50 kJ/m2) induced HO-1 mRNA accumulation by 
lycopene. The modulation of UVA induced HO-1 mRNA levels (UVA 50 kJ/m2) normalised 
over GAPDH mRNA in FEK4 by 0.1, 0.3, 1.2, 3.0 and 8.8 pM lycopene, as measured with 
RealTime PCR (LightCycler). Results are means +/- SD, «=3-4. *: Significance level when 
compared with the irradiated control in the absence of lycopene, p<0.05.
At a UVA fluence of 100 kJ/m2 lycopene significantly suppressed the UVA induced 
HO-1 mRNA accumulation at all medium concentrations of lycopene tested in 
exponentially growing FEK4 cells (Fig 3.6.2-2). This effect is markedly different to the 
observed effect of P-carotene on the modulation of UVA (100 kJ/m2) induced HO-1 
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Fig. 3.6.2-2. Modulation of UVA (100 kJ/m2) induced HO-1 mRNA accumulation by 
lycopene. The modulation of UVA induced HO-1 mRNA levels (UVA 100 kJ/m2) normalised 
over GAPDH mRNA in FEK4 by 0.1, 0.3, 1.2, 3.0 and 8.8 pM lycopene, as measured with 
RealTime PCR (LightCycler). Results are means +/- SD, «=3-4. *: Significance level when 
compared with the irradiated control in the absence of lycopene, p<0.05.
At a UVA fluence of 250 kJ/m2 lycopene significantly suppressed the UVA induced 
HO-1 mRNA accumulation when present at 0.1, 0.3, and 1.2 pM concentrations in the 
medium (Fig. 3.6.2-3). The effect was not significant at the highest lycopene dose tested 
(3.0 pM) (p>0.05), exhibiting a different pattern of suppression of UVA induced HO-1 
gene expression when compared to the suppression afforded by p-carotene, which is 
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Fig. 3.6.2-3. Modulation of UVA (250 kJ/m2) induced HO-1 mRNA accumulation by 
lycopene. The modulation of UVA induced HO-1 mRNA levels (UVA 250 kJ/m2) normalised 
over GAPDH mRNA in FEK4 by 0.1, 0.3, 1.2 and 3.0 pM lycopene, as measured with 
RealTime PCR (LightCycler). Results are means +/- SD, n -3-4. *: Significance level when 
compared with the irradiated control in the absence of lycopene, p<0.05.
It is noteworthy, though, that lycopene at medium concentrations of 0.1, 0.3, 3.0 and 8.8 
pM significantly (p<0.05) induced HO-1 mRNA accumulation when compared to HO- 
1 mRNA levels in vehicle treated cells (Fig. 3.6.2-4). The maximum level of induction 
of HO-1 mRNA in FEK4 cells by lycopene was observed after incubation of cells with 
the highest lycopene concentration tested (8.8 pM) and was approximately 6 fold over 
control values.
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Fig. 3.6.2-4. Modulation of HO-1 mRNA accumulation by lycopene. The modulation of 
HO-1 mRNA levels normalised over GAPDH mRNA in FEK4 incubated with 0.1, 0.3, 1.2, 
3.0 and 8.8 pM lycopene, as measured with RealTime PCR (LightCycler). Results are 




Previous studies have demonstrated not only that singlet oxygen is involved in UVA 
activation of genes, but that pure singlet oxygen generators strongly activate the 
expression of a number of genes (for review see Ryter and Tyrrell, 1998). Evidence 
exists for singlet oxygen involvement in the UVA mediated activation of HO-1 gene 
expression (Basu-Modak and Tyrrell, 1993). Carotenoids are powerful singlet oxygen 
quenchers and have been shown to quench singlet oxygen at rates approaching diffusion 
control in organic solvents (Edge and Truscott, 1999). Both p-carotene and lycopene 
suppress the UVA induced HO-1 mRNA accumulation (Figs. 3.6.1-2, 3.6.2-2, -3) and 
the possibility that they exert this effect through their activity as singlet oxygen 
quenchers is feasible. However, given that p-carotene, a provitamin A carotenoid, 
suppresses the UVA induced HO-1 mRNA accumulation as a function of concentration 
in the medium and UVA dose applied to the cell cultures, an alternative hypothesis that 
includes retinoid signaling and nuclear receptor activation could be considered, 
especially for p-carotene.
Under the conditions used, a physiological dose of UVA (250 kJ/m ) induces HO-1 
mRNA accumulation in FEK4 cells several fold over control values. This induction is 
suppressed when exponentially growing FEK4 cells are incubated for three days with
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0.07, 0.2, 0.8, 2.3, 8.0 or 21.0 pM p-carotene in the medium prior to irradiation in a 
concentration dependent manner (Fig. 3.6.1-2). This suppression is very significant 
when the concentration of p-carotene in the medium exceeds 4.7 pM, the estimated 
carotenoid content in human skin (Peng et al., 1995). A contrasting lack of suppression 
was observed when exponentially growing FEK4 cells were incubated with the above 
concentrations of p-carotene in the medium under identical conditions and then UVA 
irradiated with a lower dose of 100 kJ/m . In this case, the UVA (100 kJ/m ) induced 
HO-1 mRNA levels were not suppressed, with the exception of the highest p-carotene 
concentration in the medium (21 pM) (Fig. 3.6.1-1).
The dependence of the modulation of UVA induced HO-1 gene expression by P- 
carotene on the UVA dose applied to the cell cultures was also observed when FEK4 
cells were incubated with 5 pM p-carotene in the medium for three days and irradiated 
with three different UVA doses. At a UVA dose of 100 kJ/m no suppression of the 
UVA induced HO-1 mRNA gene expression was observed, whereas the suppression of 
UVA induced HO-1 mRNA was very significant (p<0.005) for the higher UVA doses 
tested (200 and 250 kJ/m2) (Fig 3.6.1-6).
On the other hand, when exponentially growing FEK4 cells were incubated for three 
days with lycopene at concentrations of 0.1, 0.3, 1.2, 3.0 and 8 . 8  pM in the medium the 
UVA (100 kJ/m ) induced HO-1 mRNA levels were suppressed and there was no 
concentration dependence in the observed effect (Fig. 3.6.2-2). The UVA (250 kJ/m ) 
induced HO-1 mRNA accumulation was suppressed following a three day incubation of 
FEK4 cells with 0.1, 0.3, 1.2 pM lycopene in the medium but not after a three day 
incubation of cells with a higher concentration of lycopene in the medium (3 pM) (Fig.
3.6.2-3).
Under the conditions used the pattern of modulation of UVA induced HO-1 mRNA 
accumulation by lycopene and p-carotene is rather different and possibly suggesting 
different modes of action for each carotenoid.
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The data presented here (Figs. 3.6.1 -2, - 6  and 3.6.2-2, -3) could be interpreted either as 
an indication of lC>2 quenching by the two carotenoids or, alternatively, as an indication 
of activation of nuclear receptors, especially by (5-carotene. Which mechanism is more 
likely involved in the consequent suppression of UVA mediated oxidative stress by 13- 
carotene and lycopene is an issue open to discussion that clearly remains to be 
elucidated. However, in view of the experimental results obtained from this study a 
singlet oxygen quenching appears to be a more likely mode of action for lycopene and 
nuclear receptor activation is probably the best way to explain the suppression of UVA 
induced HO-1 mRNA levels by p-carotene.
If lC>2 quenching by the carotenoids were regarded as the sole mechanism by which the 
carotenoids suppress the UVA induced HO-1 suppression, the lack of suppression at a 
UVA dose of 100 kJ/m by P-carotene at concentrations in the medium from 0.07 to 8  
pM and the contrasting suppression by lycopene at similar concentrations in the 
medium (0.1- 8 . 8  pM) would be difficult to explain. This striking difference is further 
underlined if the increased p-carotene cellular levels relative to the cellular levels of 
lycopene at the time of UVA irradiation (Figs. 3.1.2.-1 and 3.3.1-1) are taken into 
account.
On the other hand, substantial evidence exists for the possibility of activation of RARs 
and RXRs by metabolites of p-carotene (Ponnamperuma et al., 2000; Liu et al. 2000; 
Wang et al, 1999b) and although ongoing research is tentatively addressing this issue 
regarding metabolites (or possible metabolites) of other carotenoids including lycopene 
(Ben-Dor et a l , 2001; Stahl et a l , 2000), to date no such metabolite of lycopene has 
been found. Regarding the mechanism of action of P-carotene in our system, the 
activation of the RAR/RXR and PPAR/RXR heterodimers cannot be excluded. The 
activation of the PPARa/RXR heterodimer accounts for regulation of P- and co- 
oxidation pathways and for negative interference with the AP-1, STAT and NF-kB 
signalling pathways (for review see Chinetti et al, 2000), as well as for regulation of 
vitamin A homeostasis through the transcriptional control of cellular retinol binding 
protein (CRBP) II (Suruga et al, 1999). A mechanism similar to the p-oxidation of fatty 
acids has been proposed for retinoic acid (RA) formation from assymetric cleavage of
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p-carotene and the intermediates of such a pathway (Wang et al., 1996), apocarotenals, 
have been detected in our system in sham and UVA irradiated FEK4 cells.
Furthermore, cyclooxygenase metabolites are natural ligands for PPARs (Kliewer et al., 
1999) and their level increases with increasing UVA dose (Hanson and DeLeo, 1989; 
1990; Bachelor et al., 2002). In the PPAR/RXR heterodimer both receptors are 
independently and synergistically activated by their responsive ligands (Desvergne and 
Wahli, 1999). Putative AP-1 binding sites are present in the promoter regions of 
numerous UVA activated genes and the involvement of c-fos and c-jun in the activation 
of such elements has been clearly demonstrated for HO-1 (Camhi et a l, 1998). At 
present it is not known whether UVA induction of HO-1 is driven by AP-1. However, 
an increase of c-fos and c-jun by UVA at the mRNA level has been demonstrated in 
FEK4 cells (Soriani et al., 2000). If the observed effects of p-carotene on UVA induced 
HO-1 mRNA were regulated by the PPAR/RXR heterodimer, then the increase of 
cyclooxygenase metabolites with increasing UVA dose may lead to an increased 
activation of the PPAR/RXR heterodimer and an increased suppression of the HO-1 
mRNA levels with increasing UVA doses, in the presence of 9-cis retinoic acid, which 
is a ligand for RXRs (Heyman et al, 1992). To date, the involvement of the PPAR/RXR 
heterodimer in the mediation of the effects of p-carotene in vivo has not been examined.
Formation of apocarotenals, the products of chemical or enzymatic (Wang et al, 1996; 
Kiefer et a l 2001) asymmetric cleavage of p-carotene, were monitored in our system. 
When exponentially growing FEK4 cells were incubated with 0.3, 0.9, 2.5, 9 and 23 pM 
p-carotene for three days, apocarotenal formation in cells was considerable (approx. 2 0  
pmol/million cells) at the higher concentrations (Fig 3.1.2-2) where the suppression of 
UVA (250 kJ/m2) induced HO-1 gene activation by p-carotene peaked (Fig 3.6.1-2).
P-carotene is a provitamin A carotenoid so that its biological activity could result from 
its conversion to retinol or retinoid metabolites (Rock et al, 1997; I ARC Working 
Group for the Evaluation of Cancer, 1998). In the experiments presented here, no retinol 
was detected either in the cell culture medium or in the cell pellets. However, when 3 
pM of P-carotene dissolved in THF was added to the growth medium of mouse 
embyonic fibroblasts (BALBc/c 3T3 cells) (Wei et al., 1998). It is possible that
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interspecies variation could account for this difference as rodents exhibit different 
patterns of p-carotene metabolism (Rock, 1997).
Also the isomerisation pattern for both lycopene and p-carotene was monitored in the 
experiments. In our system, cellular P-carotene isomerised to ds-p-carotene and the 
level of the cis isomer was in the range from 4-7 pmol/million cells when exponentially 
growing FEK4 cells were incubated for three days with all-trans P-carotene at initial 
concentrations of 0.3, 0.9, 2.5, 9 and 23 pM in the medium. When seen as a percentage 
of the total cellular P-carotene the isomerisation extent ranged from 4 to 17% (Fig.
3.1.2-2). It has been demonstrated (Wang et a l, 1994; Herbuteme, et al., 1995) that 9- 
cis-p-carotene can serve as a precursor of 9-cis-retinoic acid. We did not specify the 
exact isomerisation(s) involved, but formation of 9-cis-P-carotene is, at least to an 
extent, a likely event.
On the day of UVA irradiation of exponentially growing FEK4 cells the major lycopene 
isomer detected in cells following a three day incubation with all-trans-lycopene was the 
all- trans lycopene isomer that accounted for 82-100% of total lycopene in cells. The 5- 
cis-lycopene isomer was also detected and accounted for ~ 5% of total lycopene in cells 
(Fig. 3.3.1-2). However, to date, although 2-13 different lycopene isomers have been 
detected in plasma and 14-18 in human tissues, the biological relevance of cis-isomers 
of lycopene remains as yet unknown. The relevant knowledge is limited to indications 
that cis isomeric form is more bioavailable than the trans (Re et a l, 2001, For reviews 
see Clinton, 1998; Rao and Agarwal, 1999).
Overall, media p-carotene concentrations do not necessarily reflect cellular content in P- 
carotene, as the uptake of p-carotene by cells in culture depends not only on the delivery 
method used (Figs. 3.1.1-1, -2), cell line and size (Wei et al., 1998, Iftikhar et al, 1996; 
Palozza, 200V, but also on seeding density (Iftikhar, 1996) and growth phase (Figs. 
3.1.1-6,3.1.2-4,3.13-1).
The reasons for the differences observed in uptake of p-carotene by different cell lines 
has not been established. Two distinct mechanisms have been proposed in the literature.
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One involves energy independent passive transport of p-carotene across the cellular 
membrane and the other involves metabolically driven endocytosis (Scita et al., 1992; 
Grolier et al., 1992). It has been suggested that the increased uptake of P-carotene 
(Kennedy and Krinsky, 1994; Palozza et al., 1996) by tumor cells might be due to 
increased rate of endocytosis (Schwartz et al., 1991).
The kinetics of carotenoid uptake by FEK4 cells were established in this study with two 
delivery systems (THF or THF/EtOH) and THF was selected as the optimum carrier for 
P-carotene to the cultured cells. We used THF to deliver P-carotene to FEK4 cells in 
culture and the maximum cellular p-carotene concentration achieved after a three day 
incubation of FEK4 cells with the carotenoid in the medium was 300 pmol/106cells 
(Fig. 3.1.2-4). This cellular concentration is equivalent to ~12 nmol/g wet tissue (IARC 
Working Group for the Evaluation of Cancer, 1998). With THF as the delivery system 
in mouse embryo fibroblasts (C3H/10T1/2) an intracellular p-carotene level of 430 
pmol/106cells was measured after a 24h treatment with 10 pM p-carotene (Cooney et 
al., 1993). A 24 hour incubation of WiDr cells with 50 pM p-carotene resulted in a 
cellular concentration of 130 pmol/million cells (Palozza et al., 2001). A cellular level 
of 80 pmol/million cells was obtained after a 48h incubation of Chinese hamster ovary 
cells with 0.07 pM p-carotene (Stich and Dunn, 1986).
Incubation of FEK4 cells with lycopene in the medium resulted in intracellular levels 
that were several fold lower than those following an incubation with p-carotene in the 
medium. The maximum level observed after a 3-day incubation of FEK4 cells with 6.7 
pM lycopene in the medium was ~75 pmol lycopene/million cells (Fig. 3.3.1-1), 
whereas after under comparable conditions the cellular concentration of p-carotene was 
~180 pmol/million cells (Fig. 3.1.2-1). A similar finding of lower uptake of lycopene by 
cultured cells when compared to the uptake of p-carotene under comparable conditions 
has been previously described with mouse embryo fibroblasts (C3F1/10T1/2) (Bertram 
et a l , 1991) and with KB-1 human oral tumor cells (Livny et al., 2002), as models. 
Interestingly, in the study of Livny and associates, a two-day incubation of KB-1 cells 
with 7 pM p-carotene or lycopene in the medium resulted in an approximately 13 fold
123
greater accumulation of p-carotene when compared to that of lycopene (Livny et al., 
2002).
For many years, cell culture studies with carotenoids have been greatly hindered 
because of the extreme lipophilicity and instability of these compounds in oxygen 
containing atmospheres (Bertram, 1991; Britton, 1995; Martin et a l, 1997). Numerous 
methods have been proposed to overcome the problems related to the hydrophobicity of 
the carotenoids. For example, various types of liposomes have been employed, for 
delivery. However, rather low carotenoid cellular levels can be achieved with this 
method (Lowe et al., 1999) and cytotoxic effects of some liposome constituents have 
been reported (IARC Working Group for the Evaluation of Cancer, 1998). Water- 
miscible beadlet formulations have also been used, but this method is limited in that the 
beadlet formulation contains many other chemical constituents (90%). A number of 
organic solvents (hexane, chloroform dimethylsulfoxide (DMSO) and acetone: DMSO 
mixtures) have also been used for the delivery of p-carotene to cells, however, different 
problems have been associated with each solvent. (Bertram et al., 1991, 1999; Cooney 
et al., 1993). Other methods for delivery of carotenoids to cultured cells include 
carotenoid -enriched bovine serum (Williams et al., 2000) and nanoparticle 
formulations (Offord et al., 2002). Tetrahydrofuran (THF) has been reported to be one 
of the best solvents for p-carotene (Khachik et al., 1988) and to be effective in 
delivering carotenoids to cells with no apparent cytotoxicity and this method is being 
increasingly used since its introduction for this purpose (Cooney et al., 1993).
The use of methyl-p-cyclodextrin (MpCD) has also recently been reported as a novel 
delivery system of carotenoids to cells in culture with high cellular carotenoid levels 
achieved. Human skin fibroblasts (HFP-1) accumulated 560-780 pmol/106cells after a 
24hr incubation with 5 pM p-carotene and no isomerization was detectable in cells or 
medium (Pfitzner et al., 2000). Overall, the delivery method might be of crucial 
importance not only because of the cellular level of p-carotene achieved and the 
isomerization allowed, but also because of possible interference of the vehicle employed 
with the measured biological end point.
124
In this context, it is interesting that our results contrast with those of a previous study 
published by Obermuller-Jevic and associates (1999), in which P-carotene at 0.5 and 5 
pM concentrations in the medium enhanced the level of the HO-1 gene expression 1.3 
and 2.7 fold, respectively, in normal human skin fibroblasts irradiated with a UVA dose 
of 200 kJ/m over that observed with UVA alone.
A major difference may lie in the vehicle employed. Methyl-p-cyclodextrin (as used in 
the above mentioned study) is an efficient way of introducing carotenoids into cell 
culture (Pfitzner et. a l , 2000). However, cyclodextrins are cyclic polysaccharides with a 
hydrophobic cavity that extract cholesterol from lipid bilayers (Radhakrishnan and 
McConnell, 2000) and are frequently used agents for cholesterol depletion in studies of 
lipid raft disruption (Simons and Toomre, 2000). There is considerable evidence that 
extraction of cholesterol from membranes affects the rate of cholesterol biosynthesis in 
these cells (Radhakrishnan et al, 2000). Furthermore, p-Cyclodextrin leads to 
modulation of signalling pathways (Moran and Miceli, 1998; Roy et. al., 1999; 
Gniadecki et al., 2002). Therefore, it appears likely that methyl-p-cyclodextrin will 
complicate interpretation of experiments using additional modifying agents.
Although HO-1 appears to have a protective/anti-inflammatory role (see section 1.3), 
the induction of this enzyme is considered a marker of oxidative stress and, therefore, 
the suppression of this inducible response is considered as an indication of reduced 
oxidative stress. In this context it is noteworthy to mention that p-carotene and lycopene 
did not suppress the basal levels of HO-1 mRNA, as seen of the levels of sham 
irradiated FEK4 treated with the carotenoids. Interestingly, treatment of FEK4 cells 
with lycopene significantly induced basal levels of HO-1 mRNA (Fig. 3.6.2-4).
Carotenoids are well known for their ability to quench singlet oxygen (see introduction). 
However, the use of p-carotene as a protective agent against oxidative damage in 
humans is currently under discussion, because of the findings of supplementation trials 
involving p-carotene (Omenn et al., 1996; ATBC, 1994). These studies indicated that p- 
carotene supplementation is of little or no value in preventing cardiovascular disease, 
and the major cancers occurring in well nourished populations and may actually 
increase, rather than reduce, lung cancer incidence in asbestos exposed workers and
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smokers. As a consequence of these findings, the trials of (3-carotene have been 
terminated. It is consensus view, that more knowledge regarding transport, metabolism, 
tissue distribution and the molecular basis for the biological activities of carotenoids is 
needed in order to explain these unexpected findings and the mechanisms by which 
carotenoids might function in human tissues (Liu et al, 2000; Rock, 1997; Krinsky, 
2001; Mayne, 1996; Omaye et a l, 1997; Palozza, 1998). Furthermore, for similar 
events to be avoided with lycopene, extensive studies are necessary (Clinton, 1998).
This is the first study to point to the possibility of an involvement of the PPAR/RXR 
heterodimer in mediating the biological effects of p-carotene in humans and may help 
explain the different outcome of P-carotene supplementation in asbestos exposed 
workers and smokers relative to the other groups, since both smoking and exposure to 
asbestos induce a high expression of cyclooxygenase 2 (COX-2) (Anto et a l, 2002; 
Zijlstra et al., 1992; Schins and Donaldson, 2000). PPARs are currently being studied as 
targets for cancer prevention, but have also been shown to promote colon cancer in mice 
(reviewed in Kersten et al, 2000). Taking into account that the PPARs are thought to be 
major regulators of lipid absorption and metabolism (Kersten et al, 2000; Chawla et al, 
2001) it is interesting that P-carotene has been shown to affect the transcription of key 
enzymes in cholesterol biosynthesis, i.e HMG Co A reductase (Fuhrman et al., 1997; 
Moreno et al, 1995).
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4.1 Future research
For what concerns the modulation of UVA induced gene activation of HO-1 more 
experiments are needed in order to elucidate the underlying mechanism:
1. In order to examine whether the suppression of UVA induced HO-1 mRNA 
levels by p-carotene and lycopene is due to singlet oxygen quenching it would 
be of value
(i) to establish UVA dose response for the activation of HO-1 with or without P- 
carotene or lycopene (1, 2.5 and 5 pM) and an agent that enhances singlet oxygen 
lifetime (D2 O).
(ii) to establish the modulation of HO-1 mRNA levels in FEK4 cells exposed to 
singlet oxygen generated intracellularly from the thermal decomposition of an 
endoperoxide, such as 3,3’-(l,4-naphthylidene dipropionate (DNPO2 ), with or 
without p-carotene or lycopene (1,2.5 and 5 pM).
2. In order to investigate whether the suppression of HO-1 mRNA by carotenoids 
is accompanied by a suppression of protein levels and enzymatic activity, 
experiments need to be performed to establish the modulation of the UVA (100 
and 250 kJ/m ) induced HO-1 protein levels and activity in FEK4 cells by P- 
carotene or lycopene (1, 2.5 and 5 pM).
3. To further examine the hypothesis of COX-2 involvement in the observed 
suppression of UVA induction of HO-1 by carotenoids it would be important
(i) to establish the modulation of UVA induced COX-2 at the mRNA and 
protein level
(ii) to establish the activity of cox- 2  as a function of concentration of p-carotene 
and lycopene and UVA dose applied to the cell cultures.
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(iii) Establish the modulation of UVA induced HO-1 mRNA levels when the 
enzymatic activity of Cox-2 is selectively inhibited, by an agent that does not 
affect the constitutive form of the enzyme, such as celefoxib.
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A l. 1 Method for HPLC analysis of P-carotene and metabolites in cell culture 
medium samples and cell pellets (Georges Riss, Roche Vitamins Ltd)
Chemicals
All-trans-p-carotene, 9-cis-p-carotene, 13-cis-p-carotene, P-apo-4’-carotenal, p-apo-8’- 
carotenal, P-apo-12’-carotenal were from Roche Vitamins Ltd, Basel, Switzerland. 
Acetonitrile, tert-butylmethylether (t-BME), acetone and EtOH were from Merck, 
Darmstadt (Germany). Ammonium acetate, BHT, THF, and triethylamine for HPLC 
analysis were from Fluka Chemie AG, (Buchs, Switzerland). P-Cryptoxanthin 
pelargonate, the internal standard, was synthesized from P-cryptoxanthin and pelargonic 
acid chloride in a mixture of dichloromethane and pyridine according to reference [1]. 
HPLC grade solvents were additionally purified over basic aluminum oxide grade 1 
(Camag, Muttenz, Switzerland).
Quantitative analysis of apo-carotenals, all-trans-p-carotene and cis-P-carotene in 
cultured cell lines and cell culture medium.
All procedures were performed under dimmed light and under cooled conditions. The 
HPLC solvent was degassed by sonication, and the samples were cooled at 6°C in the 
autosampler tray. Stock solutions of pure standard compounds i.e. p-carotene, its 
isomers, and apo-carotenals were prepared by dissolving 3-5 mg of the compound in n- 
hexane/dichloromethane 80:20 (v/v) containing 0.25 % BHT (v/w). Immediately 
afterwards, concentrations of suitable dilutions were determined by spectrophotometric 
measurements. Working and calibration solutions were prepared by evaporating 
required volumes of the stock solutions to dryness and re-dissolving the residue in the 
sample solvent mixture as described below. P-Cryptoxanthin pelargonate (1.0 nmol/ml) 
was used as an internal standard to correct possible injection losses. The cell culture 
medium (25 pi) was extracted by adding 225 pi of a solvent mixture EtOH/tBME/THF, 
9:5:1 (v/v/v) containing the internal standard and 0.025% of BHT (v/w). The mixture 
was then vigorously vortexed for 1 minute and centrifuged for 3 minutes at 10 000 x g. 
Routinely, 25 pi of the clear supernatant were injected into the HPLC system.
The cell pellets were treated with 200pl acetone containing 0.025 % BHT (v/w) 
vortexed and dried in a speed-vac apparatus. The dried residue was redissolved in 200 
pi of the solvent mixture described above, vortexed for 1 minute and centrifuged for 3 
minutes at 10 000 x g. 25 pi or 50 pi of the clear supernatant were injected into the 
HPLC system. The chromatographic system consisted of a pump (L-6210), an 
autosampler (L-7200), a sensitive UV-VIS detector (L-7420) all from Merck-Hitachi, 
Ltd. (Tokyo, Japan) a solvent degasser unit (SDU 2003), and a column thermostat 
(Pelcooler), both from Labsource (Reinach, Switzerland).
HPLC analyses were performed isocratically on a C18-reversed phase column (Vydac 
218TP54, 4x250 mm, The Separations Group, Hesperia, USA) with
acetonitrile/tBME/aqueous ammonium acetate 80 mM/triethylamine,73:20:7:0.5, 
(v/v/v/v) as eluent. The flow rate was 1.5 ml/min, the peak detection was set at 450 nm. 
Chroma 2000 software from Bio-Tek Instruments (Basle, Switzerland) was used for 
system control, data acquisition and quantitative calculations.
References
1. Organikum; Johann Ambrosius Barth Verlag Heidelberg - Leipzig,20. Auflage; 
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A1.2. Method for HPLC analysis of all trans- , 5-cis-and 13-cis- lycopene in cell 
culture medium and cell pellets (Georges Riss, Roche Vitamins Ltd.)
Chemicals
All-E-Lycopene, (5Z)-Lycopene and (13Z)-lycopene were from the chemical 
laboratories of Roche Vitamins AG (Kaiseraugst, Switzerland). Acetonitrile, 2- 
Propanol, Methanol and Ethanol pro analysis were from Merck (Darmstadt, Germany). 
tert- butylmethylether p.a., dichloromethane, Ammonium acetate p.a, butylated 
hydroxytoluene p.a., Tetrahydrofuran p.a., N,N-Diisopropylethylamine,p.a. were from 
Fluka Chemie AG (Buchs, Switzerland).
HPLC grade solvents for stock solution and dilution as well sample solvent mixtures 
were additionally purified over basic aluminum oxide grade 1 from Camag (Muttenz, 
Switzerland).
Quantitative analysis of all-E-, 5-cis- and 13-cis lycopene in cell culture medium 
and cell pellets.
Stock solutions of pure standard compounds a//-2s-Lycopene (5Z)- and (13Z)-lycopene 
were prepared by dissolving 3-5 mg of the compound in n-hexane/ dichloromethane 
80:20 (v/v) containing 0.25 % of BHT (v/w). Immediately afterwards, concentrations of 
suitable dilutions were determined by spectrophotometric measurements, E (l%/lcm)= 
3450 at 470 nm in hexane containing 2% dichloromethane.
Working and calibration solutions were prepared by evaporating, under nitrogen, 
required volumes of the stock solutions to dryness and re-dissolving the residue in the 
sample solvent mixture as described below
All extraction and analytical procedures were carried out in brown glass, and in a 
darkened room. Cell culture medium (25 pi) was extracted by adding 225 pi of a 
solvent mixture Ethanol/tBME/THF, 9:5:1 (v/v/v), containing 0.025% of BHT (v/w). 
The mixture was then vigorously vortexed for one minute, and centrifuged for 3 
minutes at 10 000 x g. Routinely, 25 pi of the clear supernatant were injected into the 
HPLC system. The cell pellets were treated with 200 pi acetone containing 0.025 % 
BHT (v/w), vortexed and dried in a speed-vac apparatus. The dried residue was 
redissolved in 200 pi of the solvent mixture described above, vortexed for 1 minute and 
centrifuged for 3 minutes at 10 000 x g. Then, 25 pi or 50 pi of the clear supernatant 
were injected into the HPLC system. The chromatographic system consisted of a pump 
(System 520), an autosampler (565) a sensitive diode array detector (540+) all from 
Biotek-Instruments (Basel, Switzerland), as well as a solvent degasser unit (SDU 2003), 
and a column thermostat (Pelcooler) both from Labsource (Reinach, Switzerland).
HPLC analyses were performed isocratically on a C18-reversed phase column (Suplex- 
PKB-100 from Supelco (Bellafonte, PA, USA)) with acetonitrile / methanol / 2- 
propanol / aqueous ammonium acetate 2% / N,N-Diisopropylethylamine , 
455:500:20:25:0.0.2 , (v/v/v/v) with 50 mg/L BHT, as eluent. The flow rate was 0.6 
mL/min, and the peak detection was set at 470 nm. The solvent was degassed by 
sonication, and the samples were cooled at 7°C. Chroma 3000 software from Bio-Tek 
Instruments (Basel, Switzerland) was used for system control, data acquisition and 
quantitative calculations by the external standard method. Briefly, from the HPLC 
chromatograms of the standards, an average value of the relevant peak areas is divided 
by the corresponding spectrophotometrically measured concentration in a defined 
injection volume. This results in specific HPLC response factors (RF values) for each 
compound at defined chromatographic conditions.
A ppendix 2
Comparison of different washing procedures to remove p-carotene from the outer 
surface of cells incubated with 3 pM P-carotene (Regina Goralczyk, Roche Vitamins 
Ltd.)
HaCat cells were incubated with 3pmol/L P-carotene for 3 days with daily medium 
changes (medium: FAD, + 2% NU serum). Medium was removed, and cells were 
washed either 3x or 6x with the various washing buffers. The cells were harvested for 
carotenoid HPLC analysis by trypsinisation followed by centrifugation, p-carotene was 







PBS + BSA 2% 56.6 12.2
PBS + NU serum* 34.5 5.5
PBS + milkpowder 18.6 7.7
PBS + BSA/NU 1:1 46.5 17.9







PBS + BSA 2% 16.5 2.3
PBS + NU serum* 47.3 16.2
PBS + milkpowder 57.6 20.2
PBS + BSA/NU 1:1 72.7 19.5
PBS + BS A/milk powder 1:1 66.2 18.0
n=6
• NU serum = commercial semisynthetic medium containing 15% fetal calf serum
The best washing effect was observed, when cells were washed 6 x with PBS 2% BSA. 
This reduced the adherent P-carotene at most, with the lowest variation.
